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1 Introduction 
1.1 Proteolysis – An irreversible post-translational modification 
A variety of post-translational modifications vastly increase the number of differentially 
acting proteins from a given number of genes. These post-translational modifications include 
the addition of organic (e.g. glycosylation and acetylation), inorganic (e.g. phosphorylation 
and hydroxylation) and lipid groups (e.g. prenylation and GPI anchors) or the addition of 
chemical bonds (e.g. disulfide bonds). In addition, a widely irreversible post-translational 
modification is the proteolytic processing of proteins, which for instance includes the 
cleavage of ectodomains from transmembrane precursor proteins [Lothrop et al., 2013]. 
Proteolytic processing reveals an important mechanism for the regulation of both, inter- and 
intracellular signaling pathways in an either activatory or inhibitory manner. The release of 
ectodomains from transmembrane proteins – a process widely referred to as ectodomain 
shedding – contributes to initiate signaling by releasing ligands or receptors from a given 
cell. These ectodomains bind to their complementary target structure on the same or on a 
neighboring cell modulating cellular responses. Thus, released protein fragments not only 
can act in an autocrine manner on the same cell, but also in a paracrine or even endocrine 
manner [Wiley et al., 1998; Borrell-Pages et al., 2003]. In addition, shedding often precedes 
the subsequent processing by membrane-resident proteases (e.g.   γ-secretases), which in 
turn leads to the release of the intracellular domain of the processed protein by regulated 
intramembrane proteolysis (RIP) [Schroeter et al., 1998; De Strooper et al., 1999]. 
1.1.1 Proteases and peptidases 
At standard conditions, most biochemical processes could not be performed without 
enzymes. These large biomolecules catalyze biochemical processes by lowering the required 
activation energy and increasing the reaction rate of biochemical reactions. Proteases and 
peptidases form the largest family of enzymes in vertebrates [López-Otín & Bond, 2008; 
Sterchi, 2008]. Moreover, about 2 % of the proteins in all kinds of organisms are peptidases 
[see http://merops.sanger.ac.uk].  
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In proteolysis, proteases catalyze the enzymatic hydrolysis of internal (endoproteases) or 
terminal peptide bonds (exoproteases). Considering parameters such as activity, functional 
groups within the active center and the mechanism of catalysis, the repertoire of cellular 
proteases can be further divided into five different classes: (I) aspartic proteases, (II) 
threonine proteases, (III) cysteine proteases, (IV) serine proteases and (V) metalloproteases. 
In addition, the overall importance of proteolysis is reflected not only within the 
evolutionary conservation among all kingdoms of life, but also by the genomic complexity of 
this protein class [Rivera et al., 2010]. So far, the known human proteome contains at least 
569 (629 in rats and 644 in mouse) proteases or protease-like proteins and homologs 
[Puente et al., 2003]. Most of them either belong to cysteine (150), serine (176) or 
metalloproteases (194) [Rivera et al., 2010].  
 
Fig. 1.1: Classes of proteases with a focus on metalloproteases [http://merops.sanger.ac.uk/cgi-
bin/clan_index?type=P]. 
The subgroup of metalloproteases forms the largest group of proteases [Rawlings et al., 
2004]. In most cases, they contain one or two divalent zinc cations and share a conserved 
HEXXH zinc-binding motif. The zinc cations are coordinated at the active site by two histidine 
residues within an   α-helix [Bode et al., 1993]. Most metalloproteases belong to the 
metzincins superfamily, which is characterized by an elongated HEXXHXXGXXH/D zinc-
binding region with a methionine backing and a characteristic three-dimensional structure 
(“Met   Turn”) [Bode et al., 1993; Stöcker et al., 1995]. Whereas other groups of 
metalloproteases show inverted HXXEH zinc binding motifs (inverzincins) or bind other 
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divalent cations like manganese or cobalt (non-zincins) [Hooper, 1994], the metzincin 
superfamily comprises the subfamilies of astacins, matrix metalloproteinases (MMPs), 
adamalysins, serralysins, pappalysins and leishmanolysins. Focusing on metalloproteases, 
the above figure (Fig. 1.1) provides an overview on the different families of proteases. 
1.1.2 Reaction mechanism of metalloproteases 
Metalloendopeptidases such as members of the A Disintegrin And Metalloprotease (ADAM) 
or matrix metalloprotease (MMP) family catalyze the proteolysis of proteins within a 
hydrolytic reaction. The reaction mechanism of MMPs (MMPs) is depicted in figure 1.2. 
Thereby, the scissile amide carbonyl group is coordinated to the active-site zinc ion. The 
carbonyl group is attacked by one water molecule that is coordinated to the zinc ion and 
hydrogen bound to a conserved glutamic acid residue. The water molecule acts as a proton 
donator that is transferred to the nitrogen of the scissile amide via the conserved glutamic 
acid residue. Finally, this proton transfer results in the cleavage of the peptide bond. This 
process is promoted by the positively charged zinc ion, which stabilizes a negative charge at 
the carbon atom of the scissile amide. In addition, a conserved alanine residue stabilizes a 
positive charge distribution at the nitrogen atom of the scissile amide. [Amin and Welsh, 
2001; Lovejoy et al., 1994]. 
 
Fig. 1.2:  Reaction mechanism of metalloendoproteases on the example of matrix metalloproteases 
(MMPs). This figure has been adapted from Lovejoy and collegues [Lovejoy et al., 1994]. For detailed 
information refer to the text. 
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1.2 Ectodomain shedding 
The term ectodomain shedding denotes the proteolytic release of extracellular domains of 
transmembrane proteins that is mediated by a variety of different proteases at or near the 
cell surface [Arribas and Borroto, 2002; Ahmad et al., 2006; Brule et al., 2006]. Although 
basal shedding occurs in non-stimulated cells, it can dramatically be enhanced via different 
mechanisms, including non-physiologic phorbol ester compounds. As up to two percent of 
all cell surface molecules can be subjected to ectodomain shedding, these shed ectodomains 
make up a considerable fraction of soluble mediators [Arribas and Massagué, 1995; Arribas 
and Borroto, 2002]. 
 
Fig. 1.3:  ADAM17-mediated ectodomain shedding and subsequent regulated intramembrane 
proteolysis. (A) The extracellular domain of TNFα is released by ADAM17-mediated shedding. Proteolytic 
cleavage occurs in α-position. (B) In case of ADAM17- and ADAM10-mediated processing of Nothc, the 
remaining membrane stub is targeted by the γ-secretase presenilin in the process of regulated intramembrane 
proteolysis (RIP). (C) An intracellular fragment of Notch is released into the cytoplasm and can further 
translocate to the nucleus to mediate gene expression of several genes. 
Ectodomain shedding is involved in a variety of cellular processes, including maturation of 
growth factors or the modulation of membrane receptors and cellular adhesion molecules 
[Arribas and Borroto, 2003]. Certain growth factors and cytokines, such as members of the 
TNF and EGF families are synthesized as transmembrane precursor proteins. The 
extracellular domain of these proteins binds to cognate receptors on the same cell or on 
other cells. The release of the receptor-binding domain to the extracellular environment is 
mediated by ectodomain shedding [e.g. Myhre et al., 2004 and Dreymüller et al., 2012] and 
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affects subsequent signaling events. As depicted in figure 1.3, proTNFα   is   maturated by 
ADAM17 [Black et al., 1997; Moss et al., 1997b] and the released extracellular domain can 
bind to TNF receptors TNF-RI and TNF-RII on neighboring cells to act in a pro- or antiapoptotic 
manner or to induce the shedding of these receptors [Ashkenazi and Dixit, 1998; Hehlgans 
and Pfeffer, 2005]. In addition, ectodomain shedding represents a crucial step in the 
regulation of cell-cell and cell-matrix interactions, as the extracellular domains of cellular 
adhesion molecules are mediators of these interactions. One example for shed adhesion 
molecules is L-selectin, a homing receptor that mediates interactions between lymphocytes 
and endothelial venules and their migration into peripheral lymph nodes [Gallatin et al., 
1983]. In addition, L-selectin also participates in the recruitment of neutrophils into inflamed 
tissues by mediation of the initial attachment and slow rolling along the vascular 
endothelium [Springer, 1994; Lawrence et al., 1994]. Shedding of L-selectin can lead to a 
rapid decrease of surface levels of L-selectin [Kishimoto et al., 1995; Chen et al., 1995], 
thereby modulating the rolling velocity of neutrophils [Walcheck et al., 1996].  
1.3 The A Disintegrin And Metalloproteases (ADAMs) 
The A Disintegrin And Metalloproteases (ADAMs) belong to the superfamily of zinc-
dependent proteases, also known as metzincins [Stöcker et al., 1995]. They are glycosylated 
type-I transmembrane and secreted modular proteins with proteolytic and non-proteolytic 
functions. Due to their proteolytic activity, ADAM proteases play an important role in the 
regulation of cell adhesion and of ectodomain release of a plethora of cell surface proteins. 
This protein family was initially established by characterization of metalloproteases from 
snake venom and from sperm [Wolfsberg et al., 1995a; Wolfsberg et al., 1995b]. Orthologs 
of ADAM10 and ADAM17 have been identified in many species within the metazoa, 
including Caenorhabditis elegans and Drosophila melanogaster, via the primitive chordate 
Ciona intestinalis through Danio rerio and to the expanded family found in vertebrates 
[Huxley-Jones et al., 2007]. In addition, ADAM-like sequence motifs have also been 
discovered in the fission yeast Schizosaccharomyces pombe [Nakamura et al., 2004], but are 
apparently absent in Saccharomyces cerevisiae and plants. 
Besides, members of the ADAM family have been linked to a variety of different biological 
processes, including sperm-egg interactions [Blobel et al., 1992], cell fate determinations 
within the nervous system [Yang et al., 2006], cell migration [Guo et al., 2012; Bakken et al., 
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2009], axon guidance [Malinverno et al., 2010], muscle development [Coles et al., 2014], 
cancer progression [for instance reviewed by Murphy, 2008] and immunity.  
1.4 A Disintegrin And Metalloprotease 17 (ADAM17) 
Among the extended family of ADAMs, ADAM17 was the first ADAM to be implicated in 
ectodomain shedding by its identification as the TNFα converting enzyme (TACE) [Black et 
al., 1997; Moss et al., 1997a; Moss et al., 1997b; Black et al., 2003; Moss and Bartsch, 2004]. 
There, ADAM17 is involved in the orchestration of immunologic and inflammatory responses 
via activation of proTNFα   by   ectodomain shedding. Since then, ADAM17 has been 
established as an important sheddase in mammalian development [Peschon et al., 1998] 
with an even broader role in adults via the processing of a variety of other substrates, 
including for instance numerous cytokines and their receptors [Black et al., 1997; Black et al., 
2003]. Among others, ectodomain shedding of the cell surface protein Notch is linked to 
subsequent regulate intramembrane proteolysis  (RIP),  which  is  mediated  by  the  γ-secretase 
presenilin and generates a nucleus-targeted signal [Schroeter et al., 1998; De Strooper et al., 
1999]. ADAM17 is expressed in a variety of tissues including brain, heart, kidney and skeletal 
muscle [Black et al., 1997]. Meanwhile, the list of ADAM17 substrates contains more than 
seventy cell-surface proteins, which stresses its physiologic importance. However, the 
majority of these putative substrates have been evaluated in cell culture approaches and in 
vitro experiments often using non-physiologic stimuli [Gooz, 2010]. Although the in vivo 
relevance of individual ADAM17 cleavage processes still has to be elucidated, the early death 
of ADAM17 knock-out mice [Peschon et al., 1998] highlights its important physiologic role in 
organismic development. Further insights into the role of ADAM17 in vivo were investigated 
using the ADAM17 hypomorphic mouse model ADAM17ex/ex [Chalaris et al., 2010], which is 
described in section 1.4.7 in more detail. Interestingly, looking at phylogenetic trees, 
ADAM17 only shares limited sequence similarity with other ADAM family members and even 
with its closest relative ADAM10, sequence similarity is less than 30 % (Fig. 1.4) [Edwards et 
al., 2008].  
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Fig. 1.4:  Phylogenetic tree of human ADAMs based on protein sequences of the metalloprotease 
domains. The scale bar represents amino acid substitutions per site. 0.1 represents 10 % of sites having a 
substitution. This figure has been adapted from Edwards et al., 2008. 
1.4.1 ADAM17 – Domain structure 
Members of the ADAM subfamily share certain structural similarities, as they contain eight 
distinct protein subdomains (Fig. 1.5): (I) a N-terminal signal peptide, (II) a pro-domain, (III) a 
catalytic metalloprotease domain, (IV) a disintegrin-like domain, (V) a cysteine rich-region, 
(VI) an EGF-like domain, (VII) a transmembrane and (VIII) an intracellular C-terminal region.  
 
Fig. 1.5:  Schematic overview on modular architecture of ADAM17. Different domains are indicated as 
follows: N-terminal signal peptide (black box), prodomain (PRO), metalloprotease domain (MP), disintegrin-like 
domain (DIS) membrane proximal domain (MPD), transmembrane region (TM) and intracellular domain (ICD). 
In addition, putative phosphorylation sites and N-linked glycosylation sites are indicated. Image is based on 
sequence-dependent domain predictions by the SMART internet platform (smart.embl-heidelberg.de) 
according to murine ADAM17 protein sequence (NP_033745.4) and on further protein information from 
www.uniprot.org/uniprot/P78536. 
Since only 13 of the 21 human ADAMs are proteolytically active, it is likely that not only the 
metalloprotease domain, but also other domains contribute to the overall functions of 
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ADAM proteins. Thus, the prodomain acts in an inhibitory manner on the metalloprotease 
activity [Moss et al., 2007; Gonzales et al., 2008] and is removed by intracellular pro-protein 
convertases on the way to the plasma membrane within the secretory pathway [Endres et 
al., 2003; Seals & Courtneidge, 2003]. In addition, the prodomain is supposed to assist in 
correct protein folding as an intracellular chaperone [Roghani et al., 1999]. The proteolytic 
activity is mediated by the metalloprotease domain and determined by a conserved 
HEXXHXXGXXH motif [Bode et al., 1993]. Three histidine residues and one molecule of water 
are essential for the coordination of the divalent zinc cation within the active site [Stöcker et 
al., 1995].  
In some cases, the disintegrin-like domain has been shown to be important for interactions 
with integrins [Bridges et al., 2005], thereby influencing cell-cell contact [Edwards et al., 
2008]. For example, cell adhesion is mediated via interactions of the cysteine-rich region 
with syndecans and fibronectin [Iba et al., 1999]. In addition, the cysteine-rich region, which 
is part of the disintegrin domain, might also be involved in clustering of different ADAMs 
[Smith et al., 2002]. Adjacent to the transmembrane region, the EGF-like domain, which is 
present in most, but not all ADAMs, is thought to mediate the recognition of substrates in 
co-operation with the disintegrin-like domain [Caescu et al., 2009]. Moreover, this domain 
seems to be involved in the regulation of the activity of ADAM17, by mediating its 
multimerization [Lorenzen et al., 2011].  
Nevertheless, both, ADAM10 and ADAM17, show an atypical domain structure, as they do 
not include an EGF-like domain, but an alternate membrane proximal domain (MPD) that 
replaces the cysteine-rich region and the EGF-like domain [Janes et al., 2005; Takeda, 2008]. 
Contradictory, the term “EGF-like  domain”   is often used in ADAM17 literature. At present, 
the differential nomenclature for certain domains appears to be somehow contradictory 
within the ADAM17 literature. The hypervariable region of this MPD is placed in close 
proximity to the active site [Takeda, 2008]. Apparently, this is mediated by a conformational 
change between a closed and an open form of the MPD due to the activity of associated 
protein disulfide isomerase [Düsterhöft et al., 2013].  
The C-terminal cytoplasmic tail or intracellular region varies in length between different 
ADAMs, but mostly contains one or more proline-rich stretches that are supposed to interact 
with Src homology 3 (SH3) domain-containing signaling molecules [compare 
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http://uniprot.org/uniprot/Q9Z0F8]. In addition, the intracellular region of ADAM17 contains 
several putative phosphorylation sites that might influence recruitment or activation of 
ADAMs [compare http://uniprot.org/uniprot/Q9Z0F8]. Furthermore, yeast two-hybrid 
screens elucidated several intracellular binding-partners for ADAM17, including the mitotic 
arrest deficient 2 protein (MAD2) [Nelson et al., 1999], the protein-tyrosine phosphatase 
PTPH1 [Zheng et al., 2002] and the synapse-associated protein 97 (SAP97) [Peiretti et al., 
2003b]. 
1.4.2 Biosynthesis, maturation and trafficking of ADAM17 
The Adam17 gene is located on chromosome two in humans and on chromosome twelve in 
mice [Yamazaki et al., 1999]. ADAM17 mRNA was found in many tissues, implicating a 
ubiquitous and constitutive expression similar to housekeeping genes. Nevertheless, 
differences in ADAM17 mRNA levels were later detected in different tissues, developmental 
stages and diseases [Black et al., 1997; Arribas and Borroto, 2003]. 
Protein synthesis occurs at the rough endoplasmic reticulum, followed by subsequent 
removal of the N-terminal signal peptide (Fig. 1.6 C). The initial activity of the resulting 
proADAM17 molecule is inhibited during the translation process by its prodomain [Gonzales 
et al., 2004; Li et al., 2009]. Thus, proADAM17 translocates to the trans-Golgi compartment 
(Fig. 1.6 D), where zymogen maturation by proteolytic removal of the prodomain is 
mediated by the proprotein convertase furin (Fig. 1.6 E) [Schlöndorff et al., 2000; Srour et 
al., 2003]. The transport of ADAM17 from endoplasmic reticulum through the Golgi 
compartment has been shown to be dependent on iRhom2 that acts as a cargo receptor 
specifically on ADAM17 in macrophages [McIlwain et al., 2012; Lichtenthaler, 2012]. In 
contrast to other metalloproteases, the cysteine switch mechanism does not seem to be 
relevant for ADAM17 activity [Leonard et al., 2005]. In addition, further maturation of 
ADAM17 includes N-linked glycosylation [Peiretti et al., 2003a], which leads to the mature 
130 kDa form. Although data regarding phosphorylation of ADAM17 are contradictory in 
terms of shedding activity [Gooz, 2010], ERK-dependent phosphorylation of Thr735 has been 
shown to be necessary the entry into the secretory pathway [Soond et al., 2005]. Of note, a 
mechanistic concept of ADAM17 intracellular trafficking in different cell types is still missing 
[Gooz, 2010]. Moreover, the intracellular distribution of ADAM17 in different cell types also 
remains enigmatic. Although active ADAM17 predominately appears at the cell-surface 
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(Fig. 1.6 I), the majority of ADAM17 seems to be localized within the perinuclear 
compartment (Fig. 1.6 F) [Schlöndorff et al., 2000].  
Of note, in  hydroxamate  inhibitor  treated  macrophages,  TNFα  also  appeared  to  be  localized  
in an intracellular compartment [McGeehan et al., 1994], possible intracellular actions of 
ADAM17 are still matter of debate [Schlöndorff et al., 2000].  
 
Fig. 1.6:  Biosynthesis, maturation and intracellular trafficking of ADAM17. (A) Regulation of Adam17 
gene activity. (B) Expression of the Adam17 gene and export of Adam17 mRNA into the cytoplasm. 
(C) Translation of proADAM17 at the rough endoplasmic reticulum (rER). The immature proADAM17 molecule 
is released into the lumen of the ER and the signal peptide is removed. (D) Intracellular trafficking from rER to 
the Golgi compartment (cis) is mediated by the cargo receptor iRhom2. (E) Maturation of proADAM17 by 
proteolytic removal of the pro-domain by furin. (F) Possible intracellular storage of ADAM17 within a 
perinuclear compartment. (G) Glycosylation of the processed ADAM17 molecule within the trans-Golgi 
network. (H) Transport of mature ADAM17 to the plasma membrane via the secretory pathway. (I) ADAM17-
mediated release of the ectodomain of a transmembrane substrate by ectodomain shedding. 
1.4.3 Regulation and activity of ADAM17 
Despite TIMP-3, which is known to be a native inhibitor of ADAM17 [Amour et al., 1998], not 
much is known about the physiologic regulation of the activity of ADAM17. The phorbol 
ester “Phorbol-12-myristat-13-acetate” (PMA) is a strong, non-physiologic activator of 
protein kinase C (PKC) [Myers et al., 1985], and in turn leads to increased shedding activity 
[Arribas and Borroto, 2002]. Although the intracellular region of ADAM17 contains putative 
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p38 MAPK and PKC phosphorylation sites [Gechtman et al., 1999; Díaz-Rodríguez et al., 
1999], a loss of this intracellular region does not lead to a reduced susceptibility to PMA-
induced shedding [Reddy et al., 2000; Le Gall et al., 2010]. Thus, it was concluded that the 
intracellular region does not play a role for PMA-induced shedding, which also might imply 
an activation of ADAM17 independent from intracellular signaling pathways. Contradictory, 
inhibition of ADAM17-mediated shedding via blocking PKC and ERK has been reported [Xu & 
Derynck, 2010]. Moreover, investigations on ADAM10-mediated shedding of CD44 and 
ADAM17-mediated shedding of NRG1 indicate a predominant function of the substrates 
regarding control and specificity of shedding [Dang et al., 2013]. A missing consensus 
cleavage site and the inhibition of ADAM17-mediated shedding by antibodies directed 
against different ADAM17 substrates [Hansen et al., 2004] implicate structural aspects of the 
substrates to be important for the recognition by the protease. In addition, PMA-induced 
increase of ADAM17 shedding activity seems to be mediated by activation of extracellular 
protein disulfide isomerases (PDIs) [Willems et al., 2010; Düsterhöft et al., 2013]. Thus, PMA 
is supposed to lead to a production of reactive oxygen species (ROS), which inactivate PDIs 
and stabilize the active conformation of the ADAM17 membrane proximal domain via 
changes in disulfide bonds [Düsterhöft et al., 2013]. Furthermore, ADAM17 is located within 
lipid rafts [Tellier et al., 2006] and ADAM17-mediated shedding can be increased by 
depletion of cholesterol [Matthews et al., 2003]. 
The majority of endogenous ADAM17 molecules are not present at the plasma membrane, 
but stored intracellularily within the perinuclear compartment [Schlöndorff et al., 2000]. 
Phosphorylation of Thr735 is mediated by p38 MAPK and leads to the translocation of 
intracellular ADAM17 to the plasma membrane [Soond et al., 2005; Xu & Derynck, 2010]. 
Recently, phosphorylation of ADAM17 at Ser794 by the acidophilic polo-like kinase 2 (PLK2) 
was   shown   to   modulate   the   ADAM17   activity   in   case   of   shedding   of   TNFα   and   TNF-R 
[Schwarz et al., 2013]. Alternate mechanisms of activation of ADAM17-mediated shedding 
have been reported to occur via Toll-like receptor activation in case of CD62L [Morrison et 
al., 2010] and TNF-RI [Yu et al., 2011]. In addition, apoptosis has also been shown to 
influence the ADAM17-mediated shedding of CD62L [Wang et al., 2010] and human IL-6R 
[Chalaris et al., 2007]. 
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1.4.4 The ADAM17 degradome 
A large number of substrates have been described for ADAM17. As summarized in table 1.1, 
the reported degradome includes growth factors and cytokines, cell-surface receptors, 
adhesion molecules and other cell-surface proteins. The big diversity of substrates and their 
involvement in different cellular processes underscores the general importance of this 
protease [Pruessmeyer and Ludwig, 2008].  
Tab. 1.1.: The reported degradome of ADAM17.  
 substrate constitutive or Induced  
investigated 
system 
stimulus/ 
inhibitor reference 
Cy
to
ki
ne
s &
 G
ro
w
th
 fa
ct
or
s 
AREG I ADAM17
ΔZn/ΔZn 
keratinocytes 
PMA, 
recombinant 
ADAM17 
Sunnarborg et al., 2002 
CSF-1 I ADAM17
 –/– 
MEF PMA Horiuchi et al., 2007 
CX3CL1 C/I HUVECs; NIH3T3 
PMA, 
GM6001 Garton et al., 2001 
DLL1 C/I COS-7 PMA Dyczynska et al., 2007 
epigen C/I COS-7 PMA, BB94, GW, GI Sahin & Blobel, 2007 
EREG I A17–/– MEF PMA Sahin et al., 2004 
HB-EGF I A17
 –/– MEF, M2 
cells PMA, APMA Merlos-Suárez et al., 2001 
Jagged C/I HEK, CaSki 
shRNA, 
PMA, 
Ilomastat 
Parr-Sturgess et al., 2010 
KL-1 C/I A17 –/– MEF PMA Kawaguchi et al., 2007 
KL-2 C/I A17 –/– MEF PMA Kawaguchi et al., 2007 
LAG-3 C/I 
OTII murine 
transgenic T 
cells 
PMA, TAPI Li et al., 2007 
LTA C human Th1, Th17 cells - - - Young et al.,2010 
MICA I C1R, HeLa PMA, MMPI III, GW, GI Waldhauer et al., 2008 
MICB C/I U373, CV1 
PMA, BB94, 
TIMPs, 
siRNA 
Boutet et al., 2009 
NRG-1 C/I CHO, HeLa,  A17ΔZn/ΔZn MEF PMA Montero et al., 2000 
Pref-1 I COS cells PMA, GM6001 Wang et al., 2006  
Sema4D I platelets 
PMA, 
thrombin, 
collagen 
Zhu et al., 2007 
TGFα C/I A17ΔZn/ΔZn MEF PMA Peschon et al., 1998 
TMEFF2 I HEK293, CHO, LNCaPs 
PMA, 
GM6001 Ali & Knäuper, 2007 
TNFα I  PMA, LPS, glutamate 
Moss et al., 1997; Black et 
al., 1997 
TRANCE/RANKL I COS-7, HEK293, KMLS-8.3.5.1  PMA Lum et al., 1999 
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ce
ll-
su
rf
ac
e 
re
ce
pt
or
s 
ACE2 I HEK-ACE cells 
PMA, TAPI, 
GM6001; 
GW, GI, 
TIMP-3 
Lambert et al., 2005 
CD30 I Karpas 299 lymphoma cells PMA Hansen et al., 2004 
CD40 I B cells α-CD40 Contin et al., 2003 
CD89 I HEK293T, CHO, RBL  
PMA, 
GM6001, 
EDTA 
Peng et al., 2010 
CD91/LRP1 C brain, CSF - - - Liu et al., 2009 
EPCR (C?)/I HUVECS, EC2-EPCR 
PMA, TIMPs, 
siRNA Qu et al., 2007 
FLT3L C/I 
COS-7, 
TACE/Mx1 
murine serum 
PMA Horiuchi et al., 2009 
GPIba (C?)/I A17
ΔZn/ΔZn 
murine platelets PMA, TAPI Bergmeier et al., 2004 
GPV I A17
ΔZn/ΔZn 
murine platelets 
PMA, CRP, 
thrombin Rabie et al., 2005 
GPVI C/I A17–/– platelets PMA, GM6001 Bender et al., 2010 
GHR C/I HEK-293 (rbGHR infected) PMA Wang et al., 2002 
HER4/ErbB4 I A17–/– MEF cells PMA Rio et al., 2000 
IL-1 receptor-II I   Reddy et al., 2000 
IL-15 receptor-α C, I Renal Cancer Cells PVN, GW, GI Kahawam et al. 2009 
IL-6 receptor C/I ADAM17
 –/– 
MEF cells PMA Althoff et al., 2000 
KDR, VEGFR2 C/I COS-7, ADAM17
 
–/– MEF cells PMA Swendeman et al., 2008 
M6P/IGF2R C HUVECs siRNA, GM6001 Leksa et al., 2011 
M-CSFR I BAC.1-2F5 PMA, LPS, EDTA Rovida et al., 2001 
Notch1 I A17
–/– 
monocytes PMA Brou et al., 2000 
NPR I Neurons, Purkinje cells TAPI2, PMA Cho et al., 2008 
p75NTR C/I A17
–/– CHO, 
A17–/– MEF PMA Weskamp et al., 2004 
PTP-LAR I ADAM17
ΔZn/ΔZn 
fibroblasts PMA Ruhe et al., 2006 
Ptprz C/I A17–/– PMA, A17 GM6001 Chow et al., 2008 
SDC1 C/I ECV304, A549 PMA Pruessmeyer et al., 2010 
SDC4 C/I ECV304, A549 PMA Pruessmeyer et al., 2010 
SORCS1 C/I transfected CHO cells PMA Hermey et al., 2006 
SORCS3 C/I transfected CHO cells PMA Hermey et al., 2006 
SORL1 I A17-/- CHO PMA Guo et al., 2002 
SORT1 I transfected CHO cells PMA Hermey et al., 2006 
TNF-RI I A17
ΔZn/ΔZn EC2 PMA Reddy et al., 2000 
TNF-RII I 
 
  Peschon et al., 1998 
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trkA (NGFA) I 
trkA transfected 
PC12 and CHO 
cells 
PMA Díaz-Rodríguez et al., 1999 
ad
he
sio
n 
m
ol
ec
ul
es
 
ALCAM C CHO/M2 cells BB-94 Bech-Serra et al., 2006 
CD44 C/I OVMz, SKOV3ip PMA, APMA Stoeck et al., 2006 
CD62L    Peschon et al., 1998 
Collagen XVII (C?)/I 
human 
keratinocytes, 
murine 
ADAM17ΔZn/ΔZn 
keratinocytes 
PMA, 
various MP 
inhibitors 
Franzke et al., 2002 
Desmoglein-2 C CHO/M2 cells BB-94 Bech-Serra et al., 2006 
EpCAM C FaDu siRNA,  Maetzel et al., 2009 
ICAM-1 C/I HEK293ICAM1 
TIMP-3, 
PMA, siRNA Tsakadze et al., 2006 
JAM-A C/I HEK293, A17
-/- 
MEFs 
PMA, GW, 
GI Koenen et al., 2009 
L1-CAM C/I A17-/- EC2 cells GW, GI, PMA Maretzky et al., 2005b 
NCAM-1 C Neuro 2a, CHO, A17-/- MEFs GM6001 Kalus et al., 2006 
Nectin-4 C/I CHO 
GM6001, 
TAPI-1, 
PMA, TIMPs 
Fabre-Lafay et al., 2005 
VCAM-1 I NIH3T3VCAM1 PMA Garton et al., 2003 
ot
he
rs
 
APLP2 C SH-SY5Y siRNA, insulin, IGF-1 Jacobsen et al., 2010 
APP I ADAM17
-/- 
MEFs PMA, IC3 Buxbaum et al., 1998  
C4.4A C MCF siRNA Esselens et al., 2008 
CA9 C/I CGL3 cells  PMA, BB-94 Zatovicova et al., 2005 
CD163 I HEK293 PMA, TIMP-3 Etzerodt et al., 2010 
GP C RK-13 cells TAPI-1,  … Dolnik et al., 2004 
Klotho C/I COS-7 Insulin, TIMP-3 Chen et al., 2007 
Meprin-β I Transfected COS-1 cells PMA Hahn et al., 2003 
MUC-1 C/I HES cells PMA Thathiah et al., 2003 
Pmel17 C B16-F0 melanoma cells 
TAPI-2, 
siRNA Kummer et al., 2009 
PrPc C A17
-/- MEFs, A17 
HEK293 - - - Vincent et al., 2001 
Vasorin C MCF-7 cells BB-94 Malapeira et al., 2010 
However, one has to keep in mind that many of the known substrates have been identified 
in a variety of different cellular systems and by different experimental approaches [Gooz, 
2010]. For instance, shedding of HB-EGF has been investigated in ADAM17 knock-out MEF 
cells in presence of PMA [Sunnarborg et al., 2002]. Semaphorin 4D has been identified as 
PMA-induced substrates in platelets derived from TACEΔZn/ΔZn mice [Zhu et al., 2007]. ACE2 
was identified as an ADAM17 substrate in ACE2-transfected HEK293 cells, treated with PMA 
and different metalloprotease inhibitors [Lambert et al., 2005]. In addition, CHO cells have 
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been transfected with human protein sequences, to elucidate ADAM17-mediated shedding 
of SORCS1 and SORCS3 in presence and absence of PMA [Hermey et al., 2006]. As an 
exception, the group of Joaquin Arribas identified several substrates of ADAM10 and 
ADAM17 on tumor-derived cell lines, treated with BB-94 or ADAM17 RNAi, renouncing the 
use of PMA [Bech-Serra et al., 2006; Esselens et al., 2008; Malapeira et al., 2010]. Moreover, 
they identified Desmoglein-2 as an ADAM substrate in a 2D-DiGE approach on cell culture 
supernatant proteins [Bech-Serra et al., 2006]. 
1.4.5 ADAM17 in health and disease 
Although ADAM10 and ADAM17 have a rather bad reputation for promoting pro-
inflammatory signaling events (e.g. shedding of TNFα,   IL-6 and IL-15R), they also exert 
protective effects in neuronal differentiation, regeneration and neurodegeneration (e.g. APP 
processing, shedding of N-cadherin and ephrins). Thus, ADAM17 can take good and bad roles 
in health and disease, depending on the substrates and their specific functions [Pruessmeyer 
and Ludwig, 2008].  
Upregulation of ADAM17 on various levels of its biosynthetic pathway has been reported to 
play an important role in a variety of diseases, especially in cancer. Thus, ADAM17 appears 
to be over-expressed on protein level in human breast cancer [Santiago-Josefat et al., 2007], 
leading to an increased maturation of proTGFα  by  increased  shedding  [Borrell-Pages et al., 
2003; Kenny and Bissell, 2007].  Thus,   increased  shedding  of  TGFα is associated with tumor 
progression and metastasis [McGowen et al., 2008]. Moreover, by upregulation of ADAM17 
in synovial cells, ADAM17 contributes to rheumatoid arthritis in association with HIF-1 
expression [Charbonneau et al., 2007]. In the case of multiple sclerosis, ADAM17 is 
upregulated in blood vessels, macrophages and astrocytes [Plumb et al., 2006]. Finally, in 
response to LDL, monocytes from diabetic patients also show increased levels of ADAM17 in 
contrast to non-diabetic control individuals [Worley et al., 2007]. 
Increased levels of ADAM17 are also associated with various inflammatory diseases. Thus, 
ADAM17 levels are elevated in whole cartilage and chondrocytes in patients with 
osteoarthritis [Patel et al., 1998; Amin, 1999] and in synovial tissues of patients with 
rheumatoid arthritis [Ohta et al., 2001]. As mentioned, ADAM17 modulates the adherence 
of leukocytes by shedding of L-Selectin [Peschon et al., 1998] in macrophages [Wang et al., 
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2009b; Condon et al., 2001]. Furthermore, ADAM17 modulates leukocyte migration, 
attachment and diapedesis by shedding of CX3CL1/Fractalkine [Garton et al., 2001], V-CAM 
[Garton et al., 2003], ICAM-1 [Tsakadze et al., 2006] and JAM-1 [Koenen et al., 2009]. The 
natural inhibitor TIMP-3 has been reported to act in a balancing manner on ADAM17 activity 
during inflammatory responses as evidenced from TIMP3–/– mice [Mahmoodi et al., 2005; 
Smookler et al., 2006; Sahebjam et al., 2007]. In contrast to these findings, ADAM17-
mediated shedding of CSF-1 from activated macrophages [Rovida et al., 2001], as well as IL-
15Rα   [Kahawam et al., 2009] and IL-6Rα   [Marin   et al., 2002] also implicate an anti-
inflammatory role of ADAM17 [Gooz, 2010].  
Regarding  Alzheimer’s  disease,  together  with  ADAM9  and  ADAM10,  ADAM17  is discussed as 
an   α-secretase on the amyloid precursor protein (APP). Thereby, the balance of the APP 
metabolism is altered to the non-amylodogenic pathway, which prevents the outcome of 
Alzheimer’s  disease  [Allinson  et al., 2003].  
In addition, ADAM17 has also been reported to contribute in a variety of other diseases 
including sepsis [Horiuchi et al., 2007], inflammatory bowel disease [Cesaro et al., 2009], 
psoriasis [Moriyama et al., 2004; Kawaguchi et al., 2005; Guinea-Viniegra et al., 2009], 
multiple sclerosis [Seifert et al., 2002], angiogenesis [Rundhaug, 2005], atherosclerosis 
[Canault et al., 2006a], diabetes [Togashi et al., 2002] and nephropathy [Dell et al., 2001; 
Nemo et al., 2005; Kassiri et al., 2009]. 
1.4.6 Experimental systems in ADAM17 research 
In contrast to other proteases (e.g. caspases), ADAM17 does not seem to prefer a defined 
consensus cleavage site. Although ADAM17 shows a preference for certain amino acid 
compositions of its substrates, structural aspects of both, ADAM17 and its substrates, as well 
as membrane proximity seem to have a crucial influence on shedding activity [e.g. White, 
2003]. However, these aspects preclude possibilities for identification of unknown ADAM17 
substrates that have been used in degradome studies for caspases [compare Lee et al., 2004; 
Jang et al., 2008] or matrix metalloproteases [compare Bajor et al., 2012]. This includes in 
silico approaches, targeting consensus cleavage sites and in vitro approaches like treating 
complex protein extracts with recombinant proteases. 
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Several' approaches' have' been' used' to' study' the' effects' of' different' ADAMs,' including'
knockFdown'by' siRNA'or' shRNA,' increase'or'decrease'of'ADAM'activity'by'using'different,'
more'or'less'specific'and'effective'stimuli'and'inhibitors.'However,'especially'investigations'
on' ADAM10' and' ADAM17' have' predominantly' been'made'with' in& vitro' approaches,' as' a'
knockFout'of'both'ADAM10'[Hartmann'et&al.,'2002]'and'ADAM17'[Zhao'et&al.,'2001]'is'lethal'
at'embryonic'or'perinatal'developmental'stages.''
Widely' distributed' among' ADAM' research' are' experiments' based' on' stimulating' or'
inhibiting'protease'activity'using'more'or'less'specific'compounds.'Among'these'compounds,'
the' phorbol' ester' PMA' is' a' predominant' stimulus,' although' it' is' neither' physiologic,' nor'
specific'for'ADAM17'[Gooz,'2010].'An'overview'on'the'compounds,'most'commonly'used'in'
metalloprotease'research'is'given'in'table'1.2.'
Tab.&1.2.:& Overview&on&inhibitors&and&stimuli&used&in&metalloproteases&research.&
compound'
stimulus'/'
inhibitor'
way'of'action' specificity' natural' reference'
TPA'
(=PMA)'
stimulus' PKC'activation' none'' no'
Castagna'et&al.,'
1982'
ionomycin' stimulus' Ca2+'ionophore' none' no'
e.g.'Le'Gall'et&
al.,'2009'
GI254023X' inhibitor' blocking'catalytic'site' ADAM10' no'
Hoettecke'et&
al.,'2010'
GW280264X' inhibitor' blocking'catalytic'site' ADAM10'and'ADAM17' no' '
Marimastat' inhibitor'
mimicking'natural'MMPI'
peptides'
broadFspectrum'MMP' no'
Millar'et&al.,'
1998'
Batimastat' inhibitor'
mimicking'natural'MMPI'
peptides'
broadFspectrum'MMP' no'
Steinman'et&al.,'
1998&
BzATP' stimulus'
activation'of'P2X7'
receptor'
ADAM10/17'activator' no'
Le'Gall'et&al.,'
2009'
LPS' stimulus' cell'activation'via'TLR4' none' yes' F'F'F'
TAPI' inhibitor' blocking'catalytic'site' ADAM17'and'MMPs' no'
Mohler'et&al.,'
1994'
TIMP3' inhibitor' blocking'catalytic'site'
ADAM17,'ADAM10,'
MMPs'
yes' Uria'et&al.,'1994'
However,' a' variety' of' overexpression' experiments' have' been' performed.' Interestingly,'
cloning'of'the'human'ADAM17'gene'was'not'possible'for'years'and'human'cells'have'been'
transfected'with'ADAM17'overexpression'constructs'originating'from'Mus&musculus,'Rattus&
norwegicus,'Gallus&gallus'or'Bos& tauris.'These'experiments'are'disputable,'as' the'ADAM17'
sheddomes' of' different' species' have' been' reported' to' be' similar,' but' not' identical' [e.g.'
Garbers' et& al.,' 2011].' Moreover,' transfected' ADAM17' appeared' to' be' processed'
differentially' than' its' endogenous' counterpart' [Borroto' et& al.,' 2003],' indicating' that'
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transfection experiments are also inadequate to study the endogenous situation [Gooz, 
2010].  
1.4.7 The murine hypomorphic ADAM17ex/ex model 
Previously, in the Institute for Biochemistry, a hypomorphic mouse model, showing barely 
detectable levels of ADAM17 in all tissues has been established [Chalaris et al., 2009]. 
Briefly, an additional exon, which starts with an in-frame stop codon, has been inserted into 
the ADAM17 encoding gene sequence (Fig. 1.7 A).  
 
Fig. 1.7:  The ADAM17 hypomorphic mouse model (ADAM17ex/ex). (A) Scheme for targeting the ADAM17 
gene by the Exon Induced Translational Stop (EXITS) strategy. Open arrowheads denote FLP recombinase sites, 
and LoxP sites are indicated by closed arrowheads. The altered allele contains an artificial exon starting with an 
in-frame translational stop codon placed downstream of exon 11. The artificial exon (E11a, yellow) containing 
the stop codon is flanked by noncanonical splice donor and acceptor sites. (B) ADAM10 and ADAM17 Western 
blots of tissue samples from skin and heart.  (C) Shedding of L-selectin from B cells. (D) Shedding of proTNFα 
from spleen cells. (E) Serum levels of sTNF-RII. Figures were taken and rearranged from Chalaris et al., 2010. 
The exon induced translational stop (EXITS) strategy leads to a severe decrease in ADAM17 
protein levels, as 95 % of cellular mRNA includes the additional exon, leading to a precocious 
abrogation of the translation process. Therefore, cells and tissues derived from ADAM17ex/ex 
mice only show very low ADAM17 protein levels (Fig. 1.7 B). In contrast to ADAM17-/- mice, 
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ADAM17ex/ex mice are viable and fertile, but show severe defects in a variety of tissues, 
including  heart,  eyes,  skin  and  hair,  similar  to  TGFα-/- mice [Chalaris et al., 2010]. Moreover, 
a clear reductions in ADAM17-mediated shedding of L-selectin,  TNFα  and  TNF-RII could be 
observed (Fig. 1.7 C – E) and a decrease in ADAM17-maturated amphiregulin EGF receptor 
ligands might be responsible for the reduced milk duct development in female individuals as 
well as for the increased susceptibility to DSS-induced colitis [Chalaris et al., 2010]. As 
already mentioned, the reported ADAM17 degradome was investigated using divers cellular 
systems and different experimental approaches [Gooz, 2010]. Thus, the ADAM17ex/ex 
hypomorphic mouse system might be a potent tool to study the effects of a loss of ADAM17 
activity in vivo.  
The elucidation of ADAM17-dependent, proteome-wide changes in cells and tissues of wild-
type and ADAM17ex/ex mice using an unbiased, gel-based proteomic approach was the major 
aim of this project. At initial stages of this project, murine embryonic fibroblasts (MEFs) from 
wild-type and ADAM17ex/ex mice were available and used to adapt and enhance suitable 
approaches for this proteomic study prior to the investigation of the effects of ADAM17 in 
tissue-derived cell. In case of cultured cells, ectodomain shedding leads to the accumulation 
of shed protein fragments within the supernatant of cultured cells. Thus, a variety of recent 
studies analyzed metalloprotease-dependent alterations of cell culture supernatant proteins 
by gel-based proteomic approaches, including two-dimensional difference gel 
electrophoresis (2D-DiGE). For instance, supernatant proteins of PMA-treated 
DRM ADAM17–/–enriched by lectin-mediated precipitation revealed several substrates of 
ADAM17   including   the   “macrophage   colony   stimulating   factor   1” (M-CSF-1) and the 
“interleukin-6   receptor”   (IL-6R) [Guo et al., 2002]. In addition, ADAM17-dependent 
alterations of desmoglein-2 shedding were observed in breast cancer cells, treated with 
broad-spectrum metalloprotease inhibitors by 2D-DiGE [Bech-Serra et al., 2006]. 
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2 Aim of this thesis 
The general aim of this work was the characterization of ADAM17-dependent, proteome-
wide changes in cells and tissues upon loss of ADAM17 activity in an unbiased proteomic 
approach. Specifically, the following questions were to be addressed. 
(I) Do MEF cells from wild-type and ADAM17ex/ex mice differ in their capacity to 
release cell surface proteins? 
(II) Which proteins are differentially shed or secreted in the presence or absence of 
ADAM17? 
(III) Is this model based on the analysis of murine embryonic fibroblasts suited to 
analyze the ADAM17 sheddome? 
Based on the initial analyses of culture supernatants from MEF populations, a proof of 
principle for the methodological approach was required to address whether or not the 2D-
DiGE strategy would allow the detection of known ADAM17 substrates. 
(IV) Can  one  detect  differential  processing  of  TNFα  in  wild-type and ADAM17ex/ex MEF 
cells following overexpression of an established substrate? 
Moreover, as part of the Z2 unit of the SFB877, method development was one of the major 
tasks of the project, especially regarding the enrichment of plasma membrane proteins or 
the analysis of extracellular matrix proteins by electrophoresis. 
(V) How to enrich plasma membrane-associated proteins prior to 2D-DiGE analyses? 
(VI) Could lectins be used to enrich glycosylated plasma membrane proteins? 
(VII) Which electrophoresis protocols are suited for the analysis of membrane proteins 
in combination with differential fluorescence labelling? 
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3 Materials&
3.1 Cells&
Most'experiments'were'performed'on'wildFtype'(MEF'1#3,'1#7,'2#1)'and'ADAM17ex/ex'(MEF'
1#1,'1#8,'2#8)'murine'embryonic'fibroblasts'(MEFs).'These'cells'were'generated'and'kindly'
provided' by' Dr.' Athena' Chalaris' (Institute' for' Biochemistry,' CAU' Kiel).' MEF' cells' were'
routinely' cultured' in' MEFF10' medium' (DMEM' medium,' supplemented' with' 1'%' (v/v)'
penicillin/streptomycin,'2'mM'LFglutamine,'110'mg/ml'sodium'pyruvate'and'10'%'(v/v)'FBS).'
3.2 Antibodies&
The' following' table' (Tab.'3.1)' summarizes' all' antibodies' that' have' been' used' within' this'
work.' In'addition,' information'about'working'concentrations,'epitopes,'manufacturers'and'
application'are'also'provided.'
Tab.&3.1:& &Overview&on&used&antibodies.&
antibody' clone' origin'
concentration'
[mg/ml]'
application' dilution' manufacturer'
Annexin'A2' F'F'F' rabbit' 1.00' WB' 1:1000' abcam'
Bip/GRP78' 40' mouse' 0.25' WB' 1:250' BD'
BMPF1' F'F'F' rabbit' 0.20' WB' 1:500' Santa'Cruz'
Cathepsin'B' F'F'F' rat' 1.0' WB' 1:1000' R&D'
Cofilin' D3F9' rabbit' 1.0' WB' 1:1000' CellSignaling'
COL1α1'(CFPro)' LFF41' rabbit' 1.00' WB' 1:1000' Fisher'et&al.,'1989a'
COL1α1'(CFtelo)' LFF68' rabbit' 1.00' WB' 1:1000' Bernstein'et&al.,'1995b'
COX'IV' FF8' mouse' 0.20' WB' 1:1000' Santa'Cruz'
ECMF1' HF300' rabbit' 0.20' WB' 1:250' Santa'Cruz'
Fibronectin' ISTF9' mouse' 0.20' WB' 1:500' Santa'Cruz'
FlotilinF2' 29' mouse' 0.25' WB' 1:1000' BD'
GalectinF3' 9C4' mouse' 0.20' WB' 1:500' SantaCruz'
GAPDH' 6C5' rabbit' 0.25' WB' 1:2000' Trevigen'
HtrA1' F'F'F' rabbit' 0.25' WB' 1:500' biorbyt'
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Integrin  α2 H-293 rabbit 0.20 WB 1:500 Santa Cruz 
LAMP-1 25 mouse 0.25 WB 1:500 BD 
mADAM10 10.2 rabbit 1.00 WB 1:1000 AG Chalaris 
mADAM17 18.2 rabbit 1.00 WB, CLSM 1:1000 AG Chalaris 
mADAM17 10.1 rabbit 1.00 WB, CLSM 1:1000 AG Chalaris 
MMP-2  rabbit 0.20 WB 1:500 Santa Cruz 
Mouse IgG2a, HRP-
linked IgG2a rabbit 1.00 WB 1:10000 Cell Signaling 
Nucleolin - - - rabbit 1.00 WB 1:1000 Abcam 
Nucleophosmin EP1848Y rabbit 1.00 WB 1:1000 Abcam 
pCofilin S3 rabbit 1.00 WB 1:1000 CellSignaling 
pCofilin (Ser3) S3 rabbit 1.00 WB 1:1000 Cell Signaling 
PCPE-1 7A11/1 mouse 0.20 WB 1:250 Santa Cruz 
Periostin H-300 rabbit 0.20 WB 1:250 Santa Cruz 
Perlecan  rat 0.20 WB 1:500 Santa Cruz 
Pro-COL1A1 A-17 goat 0.20 WB 1:500 Santa Cruz 
Rabbit IgG, HRP-
linked IgG mouse 1.00 WB 1:5000 Cell Signaling 
Rat IgG, HRP-linked IgG rabbit 1.00 WB 1:5000 Cell Signaling 
Vimentin RV202  1.00 WB 1:1000 Abcam 
Vinculin SPM227 mouse 0.20 WB 1:1000 Abcam 
β-actin - - - rabbit 0.25 WB 1:1000 Cell Signaling 
3.3 Reagents, buffers and media 
3.3.1 Cell biology 
DMEM medium           Biochrom AG, Berlin, GER 
L-glutamine (200 mM)         Biochrom AG, Berlin, GER 
FBS (heat-inactivated and sterilized by filtration)  Invitrogen, Carlsbad, USA 
penicillin/streptomycin (104 U / 104 µg/ml)    Biochrom AG, Berlin, GER 
Trypsin/EDTA (0.5 % / 0.2 % (w/v))      Biochrom AG, Berlin, GER 
PBS              Biochrom AG, Berlin, GER 
sodium pyruvate (110 mg/l)        Sigma-Aldrich, St. Luis, USA 
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3.3.2 Immunofluorescence 
Poly-L-lysine solution: 
 100 µg/ml Poly-L lysine in PBS      Sigma-Aldrich, München, GER 
2x PEM buffer (pH 6.95, 0.22 µm filter-sterilized): 
 200 mM PIPES           Merck KGaA, Darmstadt, GER 
 2 mM MgCl2           Merck KGaA, Darmstadt, GER 
 2 mM EGTA           Merck KGaA, Darmstadt, GER 
2x Borate buffer (pH 11.0, 0.22 µm filter-sterilized): 
 200 mM Na2B4O7          Merck KGaA, Darmstadt, GER 
 2 mM MgCl2           Merck KGaA, Darmstadt, GER 
6 % (w/v) PFA (pH 7.0): 
 6 % (w/v) PFA in PBS         Merck KGaA, Darmstadt, GER 
 mix 1:1 with 2x borate buffer 
permeabilization buffer: 
 1 % (v/v) Triton X-100 in PBS       Merck KGaA, Darmstadt, GER 
reducing agent: 
 0.1 % (w/v) NaBH4         Carl Roth, Karlsruhe, GER 
blocking buffer: 
 0.2 % (w/v) BSA          Serva, Heidelberg, GER 
0.01 % (v/v) Triton X-100        Merck KGaA, Darmstadt, GER 
Gold Prolong Antifade Reagent Mounting Medium  Life Technologies,,GER 
3.3.3 ELISA 
ELISA coating buffer: 
 1x PBS 
1 % (w/v) BSA           Serva, Heidelberg, GER 
ELISA wash buffer: 
 0.2 % (w/v) BSA          Serva, Heidelberg, GER 
0.01 % (v/v) Triton X-100        Merck KGaA, Darmstadt, GER 
Substrate Reagent Pack         R&D Systems, USA 
Mouse TNF-alpha DuoSet        R&D Systems, USA 
Mouse TNF-Receptor I DuoSet       R&D Systems, USA 
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3.3.4 Molecular biology 
polymerase chain reaction: 
 DreamTaq polymerase        Thermo Scientific, Karlsruhe, GER  
 dNTPs             Thermo Scientific, Karlsruhe, GER 
 customized oligonucleotides       MWG Biotech, Ebersberg, GER 
agarose electrophoresis: 
 agarose            Invitrogen, Carlsbad, USA 
 ethidium bromide          Carl Roth, Karlsruhe, GER 
 50x TAE buffer 
  242 g/l Tris          Merck KGaA, Darmstadt, GER 
  5.7 % (v/v) glacial acetic acid      Carl Roth, Karlsruhe, GER 
  50 mM EDTA, pH 8.0        Merck KGaA, Darmstadt, GER 
 1 kb DNA ladder          New England Biolabs, Ipswich, USA 
3.3.5 Cell lysis buffers 
NP40 lysis buffer: 
 1 % (v/v) Nonidet® P40        Sigma-Aldrich, St. Luis, USA 
 20 mM tris base          Merck KGaA, Darmstadt, GER  
150 mM NaCl           Merck KGaA, Darmstadt, GER 
 2 µg/ml aprotinin          Sigma-Aldrich, St. Luis, USA 
 2 µg/ml leupeptin          Sigma-Aldrich, St. Luis, USA 
 1 mM PMSF           Sigma-Aldrich, St. Luis, USA 
 1 mM Na3VO4           Merck KGaA, Darmstadt, GER 
10 mM NaF           Sigma-Aldrich, St. Luis, USA 
1 mM Na2P2O7          Sigma-Aldrich, St. Luis, USA 
 2 µg/ml pepstatin A         Sigma-Aldrich, St. Luis, USA 
RIPA Lysis Buffer: 
 1 % (v/v) Nonidet® 40         Sigma-Aldrich, St. Luis, USA 
 50 mM tris base          Merck KGaA, Darmstadt, GER 
 150 mM NaCl           Merck KGaA, Darmstadt, GER 
 1 % (w/v) DOC           Sigma-Aldrich, St. Luis, USA 
 2 % (w/v) SDS           Sigma-Aldrich, St. Luis, USA 
2 µg/ml aprotinin          Sigma-Aldrich, St. Luis, USA 
 2 µg/ml leupeptin          Sigma-Aldrich, St. Luis, USA 
 1 mM PMSF           Sigma-Aldrich, St. Luis, USA 
 1 mM Na3VO4           Merck KGaA, Darmstadt, GER 
10 mM NaF           Sigma-Aldrich, St. Luis, USA 
1 mM Na2P2O7          Sigma-Aldrich, St. Luis, USA 
 2 µg/ml pepstatin A         Sigma-Aldrich, St. Luis, USA 
DOC Lysis Buffer: 
2 % (v/v) DOC           Sigma-Aldrich, St. Luis, USA 
 20 mM tris base          Merck KGaA, Darmstadt, GER 
 2 mM EDTA           Merck KGaA, Darmstadt, GER 
Chapter 3: Materials 25 
 2 mM iodoacetamide         GE Healthcare, Uppsala, SWE 
 2 µg/ml aprotinin          Sigma-Aldrich, St. Luis, USA 
 2 µg/ml leupeptin          Sigma-Aldrich, St. Luis, USA 
 1 mM PMSF           Sigma-Aldrich, St. Luis, USA 
 1 mM Na3VO4           Merck KGaA, Darmstadt, GER 
10 mM NaF           Sigma-Aldrich, St. Luis, USA 
1 mM Na2P2O7          Sigma-Aldrich, St. Luis, USA 
 2 µg/ml pepstatin A         Sigma-Aldrich, St. Luis, USA 
2D lysis buffer: 
7 M urea            GE Healthcare, Uppsala, SWE 
 2 M thiourea           GE Healthcare, Uppsala, SWE 
 4 % (w/v) CHAPS          Merck KGaA, Darmstadt, GER 
 30 mM tris base          Merck KGaA, Darmstadt, GER 
Solution adjusted to pH 8.5 prior to supplement of CHAPS. Buffer was stored at -20 °C until 
use and was supplemented with Roche Complete Protease Inhibitor. 
3.3.6 Protein biochemistry 
Bradford reagent           Thermo Scientific, Karlsruhe, GER 
3x reducing sample buffer (Protean II system): 
 6 % (w/v) SDS           Merck KGaA, Darmstadt, GER 
 30 % (v/v) glycerol         Merck KGaA, Darmstadt, GER 
 200 mM tris base, pH 6.8        Merck KGaA, Darmstadt, GER 
 2 % (v/v) 2-mercaptoethanol       Merck KGaA, Darmstadt, GER 
 0.005 % (w/v) bromophenol blue     Merck KGaA, Darmstadt, GER 
15 % SDS running gel (Protean II system): 
 15.0 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 11.2 ml 1 M tris base, pH 8.8       Merck KGaA, Darmstadt, GER 
 0.3 ml 10 % (w/v) SDS        SERVA, Heidelberg, GER 
 3.7 ml aqua ad injectabilia        Braun, Meslungen, GER 
 0.1 ml 20 % (w/v) APS        Merck KGaA, Darmstadt 
 0.02 ml TEMED          GE Healthcare, Uppsala, SWE 
12.5 % SDS running gel (Protean II system): 
 12.5 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 11.2 ml 1 M tris base, pH 8.8       Merck KGaA, Darmstadt, GER 
 0.3 ml 10 % (w/v) SDS        SERVA, HEIDELBERG, GER 
 6.2 ml aqua ad injectabilia       Braun, Meslungen, GER 
 0.1 ml 20 % (w/v) APS        Merck KGaA, Darmstadt 
 0.02 ml TEMED          GE Healthcare, Uppsala, SWE 
10 % SDS running gel (Protean II system): 
 10.0 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 11.2 ml 1 M tris base, pH 8.8       Merck KGaA, Darmstadt, GER 
 0.3 ml 10 % (w/v) SDS        SERVA, Heidelberg, GER 
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 8.7 ml aqua ad injectabilia       Braun, Meslungen, GER 
 0.1 ml 20 % (w/v) APS        Merck KGaA, Darmstadt 
 0.02 ml TEMED          GE Healthcare, Uppsala, SWE 
4 % SDS stacking gel (Protean II system): 
 1.67 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 1.25 ml 1 M tris base, pH 6.8       Merck KGaA, Darmstadt, GER 
 0.1 ml 10 % (w/v) SDS        SERVA, Heidelberg, GER 
 7.0 ml aqua ad injectabilia       Braun, Meslungen, GER 
 0.05 ml 20 % (w/v) APS        Merck KGaA, Darmstadt 
 0.01 ml TEMED          GE Healthcare, Uppsala, SWE 
10x SDS running buffer (Protean II system): 
 30.3 g/l tris base          Merck KGaA, Darmstadt, GER 
 144.0 g/l glycine          Carl Roth, Karlsruhe, GER 
1.0 g/l SDS            Merck KGaA, Darmstadt, GER 
Low-Range Standard          Bio-Rad, Hercules, USA 
Precision Plus Protein All Blue Standard     Bio-Rad, Hercules, USA 
NuPAGE® LDS sample buffer (4x)       Invitrogen, Carlsbad, USA 
NuPAGE® MES SDS running buffer (20x)     Invitrogen, Carlsbad, USA 
DTT (0.85 M in sterile water)        Serva, Heidelberg, GER 
Coomassie staining solution: 
 100.0 g/l NH4Cl          Carl Roth, Karlsruhe, GER  
 10 % (v/v) H3PO4           Carl Roth, Karlsruhe, GER    
 20 % (v/v) methanol         Carl Roth, Karlsruhe, GER 
1.2 g/l Coomassie Brilliant Blue (G-250)    Sigma-Aldrich, St. Luis, USA 
Coomassie destaining solution: 
 10 % (v/v) ethanol (96 %)        Carl Roth, Karlsruhe, GER  
2 % (v/v) H3PO4           Carl Roth, Karlsruhe, GER  
Western transfer buffer: 
 25 mM tris base          Merck KGaA, Darmstadt, GER 
192 mM glycine           Merck KGaA, Darmstadt, GER 
20 % (v/v) methanol         Carl Roth, Karlsruhe, GER 
0.015 % (w/v) SDS         Merck KGaA, Darmstadt, GER 
Ponceau S staining solution        Sigma-Aldrich, St. Luis, USA 
TBS (pH 7.5): 
 10 mM tris base          Merck KGaA, Darmstadt, GER 
150 mM NaCl            Carl Roth, Karlsruhe, GER  
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TBS-T: 
 10 mM tris base          Merck KGaA, Darmstadt, GER 
150 mM NaCl            Carl Roth, Karlsruhe, GER  
 0.05 % (v/v) Tween-20        Merck KGaA, Darmstadt, GER 
Western blocking solution A: 
 100 mM tris base          Merck KGaA, Darmstadt, GER 
2.2 % (w/v) NaCl           Carl Roth, Karlsruhe, GER  
0.01 % (w/v) NaN3         Merck KGaA, Darmstadt, GER 
5 % (w/v) BSA           Serva, Heidelberg, GER 
Western blocking solution B: 
 10 mM tris base          Merck KGaA, Darmstadt, GER 
150 mM NaCl            Carl Roth, Karlsruhe, GER  
 0.05 % (v/v) Tween-20        Merck KGaA, Darmstadt, GER 
 5 % (w/v) dry milk          Granovita, Lüneburg, GER 
Stripping solution: 
 62.5 mM tris base, pH 8.8       Merck KGaA, Darmstadt, GER 
2 % (v/v) 2-mercaptoethanol       Merck KGaA, Darmstadt, GER 
6.9 % (w/v) SDS          Serva, Heidelberg, GER 
ECLTM detection reagent         GE Healthcare, Buckinghamshire, UK 
Zymography buffer I: 
 2.5 % (v/v) Triton X-100        Merck KGaA, Darmstadt, GER 
Aqua iniectabilia          Braun, Meslungen, GER 
Zymograpyh buffer II: 
 50 mM tris base          Merck KGaA, Darmstadt, GER 
150 mM NaCl           Carl Roth, Karlsruhe, GER  
10 mM CaCl2           Carl Roth, Karlsruhe, GER  
5 mM NaN3           Carl Roth, Karlsruhe, GER  
Aqua iniectabilia          Braun, Meslungen, GER 
Adjust pH to 7.8 by addition of concentrated hydrochloric acid. 
 
3.3.7 Two-dimensional gel electrophoresis (2D-IEF/SDS-PAGE) 
10 % SDS runnung gel (2nd dimension): 
 15.0 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 11.2 ml 1.5 M tris base, pH 8.8      Merck KGaA, Darmstadt, GER 
 0.3 ml 10 % (w/v) SDS        SERVA, Heidelberg, GER 
 3.7 ml aqua ad injectabilia       Braun, Meslungen, GER 
 0.1 ml 20 % (w/v) APS        Merck KGaA, Darmstadt 
 0.02 ml TEMED          GE Healthcare, Uppsala, SWE 
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12.5 % SDS running gels (2nd dimension): 
 15.0 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 11.2 ml 1.5 M tris base, pH 8.8      Merck KGaA, Darmstadt, GER 
 0.3 ml 10 % (w/v) SDS        SERVA, Heidelberg, GER 
 3.7 ml aqua ad injectabilia       Braun, Meslungen, GER 
 0.1 ml 20 % (w/v) APS        Merck KGaA, Darmstadt 
 0.02 ml TEMED          GE Healthcare, Uppsala, SWE 
 
 
2D lysis buffer: 
7 M urea            GE Healthcare, Uppsala, SWE 
 2 M thiourea           GE Healthcare, Uppsala, SWE 
 4 % (w/v) CHAPS          Merck KGaA, Darmstadt, GER 
 30 mM tris base          Merck KGaA, Darmstadt, GER 
Solution adjusted to pH 8.5 prior to supplement of CHAPS. Buffer was stored at -20 °C until 
use and was supplemented with Roche Complete Protease Inhibitor. 
2D-DiGE Sample Buffer: 
7 M urea            GE Healthcare, Uppsala, SWE 
 2 M thiourea           GE Healthcare, Uppsala, SWE 
 4 % (w/v) CHAPS          Merck KGaA, Darmstadt, GER 
Solution was stored at -20 °C until use and supplemented with: 
2 % (w/v) DTT           Serva, Heidelberg, GER 
2 % /v/v) IPG buffer         GE Healthcare, Uppsala, SWE 
2D-SDS Running Buffer (10-fold solution): 
250 mM tris base          Merck KGaA, Darmstadt, GER 
1.92 M glycine          Merck KGaA, Darmstadt, GER 
0.1 % (w/v) SDS          Merck KGaA, Darmstadt, GER 
APS solution: 
ammonium persulfate        Merck KGaA, Darmstadt, GER 
Aqua iniectabilia          Braun, Meslungen, GER 
Solution is stored as 1 ml aliquots at -20 °C until use. 
Displacing Solution: 
 25 % (v/v) tris base (1.5 M, pH 8.8)     Merck KGaA, Darmstadt, GER 
 50 % (v/v) glycerol (98 %)        Carl Roth, Karlsruhe, GER 
 0.005 % (w/v) bromophenol blue     GE Healthcare, Uppsala, SWE 
25 % (v/v) aqua ad injectabilia      Braun, Meslungen, GER 
 This solution is stored at 4°C until use. 
Equilibration Solution: 
 5 % (v/v) tris base (1.5 M, pH 8.8)     Merck KGaA, Darmstadt, GER 
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 6 M urea            Carl Roth, Karlsruhe, GER 
30 % (v/v) glycerol (98 %)        Carl Roth, Karlsruhe, GER 
2 % (w/v) SDS           SERVA, Heidelberg, GER 
0.005 % (w/v) bromophenol blue     GE Healthcare, Uppsala, SWE 
ad 100 ml aqua ad injectabilia      Braun, Meslungen, GER 
This solution is stored as 10 ml aliquots at 4 °C. Prior to use, two aliquots are 
supplemented with 100 mg dithiotreitol or 250 mg iodoacetamide, respectively. 
FlamingoTM fixation buffer: 
 40 % (v/v) ethanol (99 %, undenatured)    Carl Roth, Karlsruhe, GER Roth 
 10 % (v/v) acetic acid (100 %)      Carl Roth, Karlsruhe, GER 
 50 % (v/v) aqua ad injectabilia       Braun, Meslungen, GER  
FlamingoTM staining solution: 
 10 % (v/v) FlamingoTM Fluorescent Gel Stain (10x) Bio-Rad, Hercules, USA 
90 % (v/v) aqua ad injectabilia       Braun, Meslungern, GER 
Lower Chamber Buffer (LBC buffer): 
25 mM tris base          Merck KGaA, Darmstadt, GER 
0.192 M glycine          Merck KGaA, Darmstadt, GER 
0.01 % (w/v) SDS          Merck KGaA, Darmstadt, GER 
LBC buffer is made from 10x 2D-SDS running buffer by dilution in a one to ten ratio. 
Low-melting agarose: 
0.5 % (w/v) low-melting agarose      Thermo Scientific 
0.005 % (w/v) bromophenol blue     GE Healthcare, Uppsala, SWE  
Components are suspended in UCB-buffer, brought to a final volume of 20 ml and heated 
in a microwave oven until agarose is completely solved. Low-melting agarose mixture is 
stored at 4 °C until use. 
Lysin Solution: 
L-lysin             SERVA, Heidelberg, GER 
1.5 M Tris Solution: 
1.5 M tris base          Merck KGaA, Darmstadt, GER 
Tris base is solved in 700 ml of Aqua iniectabilia and pH is adjusted to 8.8 by addition of 
an appropriate amount of 37 % hydrochloric acid solution. Finally, volume is adjusted to 
1000 ml and the solution is stored at 4 °C until use. 
Upper Chamber Buffer (UBC buffer): 
50 mM tris base          Merck KGaA, Darmstadt, GER 
0.384 M glycine          Merck KGaA, Darmstadt, GER 
0.02 % (w/v) SDS          Merck KGaA, Darmstadt, GER 
UBC buffer is made from 10x 2D-SDS running buffer by dilution in a one to five ratio. 
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3.3.8 2D-CTAB/SDS-PAGE 
CTAB Gel Buffer I: 
300 mM KH2PO4          Carl Roth, Karlsruhe, GER 
Substance is dissolved in 350 ml Aqua iniectabilia and pH is adjusted to 2.1 by adding an 
appropriate amount of phosphoric acid (85 %). 
CTAB Gel Buffer II: 
500 mM KH2PO4          Carl Roth, Karlsruhe, GER 
Substance is dissolved in 350 ml Aqua iniectabilia and pH is adjusted to 4.1 by adding an 
appropriate amount of phosphoric acid. 
CTAB Running Buffer: 
0.192 M glycine          Merck KGaA, Darmstadt, GER 
50 mM H3PO4           Carl Roth, Karlsruhe, GER 
0.25 % CTAB           Carl Roth, Karlsruhe, GER 
CTAB Sample Buffer: 
4.5 M urea           Carl Roth, Karlsruhe, GER 
10 % CTAB           Carl Roth, Karlsruhe, GER  
15 % (v/v) glycerol (98 %)        Carl Roth, Karlsruhe, GER  
0.005 % (w/v) Pyronine Y        Sigma-Aldrich, St. Luis, USA 
Mix urea, CTAB and glycerole with 4 ml of Aqua iniectabilia. Carefully heat the paste-like 
mixture in a microwave oven, until it is completely dissolved. Add DTT and Pyronin Y and 
bring the solution to a final volume of 10 ml. Store this 2-fold sample buffer at 60 °C until 
use.  
CTAB/SDS-Equilibration Buffer: 
2 % (w/v) SDS           Serva, Heidelberg, GER 
1 M tris, pH 6.8          Merck KGaA, Darmstadt, GER 
10 % (v/v) glycerol (98 %)        Carl Roth, Karlsruhe, GER 
0.005 % (w/v) bromophenol blue     Sigma-Aldrich, St. Luis, USA 
CTAB stacking gel (4 %): 
 1 g urea            Carl Roth, Karlsruhe, GER 
1.76 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 1.1 ml Gel B (2 % bisacrylamide)      Carl Roth, Karlsruhe, GER 
2.5 ml CTAB gel buffer II         
 0.7 ml 25 mM CTAB         Carl Roth, Karlsruhe, GER 
 1.0 ml 80 mM L-ascorbic acid      Carl Roth, Karlsruhe, GER 
80 µl 10 mM iron (II) sulfate       Carl Roth, Karlsruhe, GER  
 aqua ad injectabilia ad 10 ml       Braun, Meslungen, GER 
 5 µl 37 % hydrogen peroxide       Carl Roth, Karlsruhe, GER 
CTAB separation gel (8 %): 
7.2 g urea            Carl Roth, Karlsruhe, GER 
10.0 ml 30 % acrylamide/0.8 % bisacrylamide  Carl Roth, Karlsruhe, GER    
 1.0 ml Gel B (2 % bisacrylamide)      Carl Roth, Karlsruhe, GER 
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10.0 ml CTAB gel buffer II        
 5.0 ml 25 mM CTAB         Carl Roth, Karlsruhe, GER 
2.5 ml 80 mM L-ascorbic acid      Carl Roth, Karlsruhe, GER 
80 µl 10 mM iron (II) sulfate       Carl Roth, Karlsruhe, GER  
 aqua ad injectabilia ad 40 ml       Braun, Meslungen, GER 
 5 µl 37 % hydrogen peroxide       Carl Roth, Karlsruhe, GER 
3.3.9 MALDI-ToF/ToF 
1 M ABC Stock Solution: 
 1 M (NH4)HCO3          Carl Roth, Karlsruhe, GER 
 water (HPLC Gradient Grade)       Carl Roth, Karlsruhe, GER 
250 mM ABC Stock Solution: 
 250 mM (NH4)HCO3         Carl Roth, Karlsruhe, GER 
 water (HPLC Gradient Grade)       Carl Roth, Karlsruhe, GER 
Digester Solution 1: 
 50 % (v/v) methanol         Carl Roth, Karlsruhe, GER 
 50 mM (NH4)HCO3 (from 1 M stock)     Carl Roth, Karlsruhe, GER 
50 % (v/v) water (HPLC Gradient Grade)    Carl Roth, Karlsruhe, GER 
Digester Solution 2: 
 50 % (v/v) acetonitrile (with 0.1 % TFA)    Carl Roth, Karlsruhe, GER 
 50 % (v/v) water (HPLC Gradient Grade)    Carl Roth, Karlsruhe, GER 
Solvent A:    
 65 % (v/v) acetonitrile (with 0.1 % TFA)    Carl Roth, Karlsruhe, GER 
 35 % (v/v) water (with 0.1 % TFA)     Carl Roth, Karlsruhe, GER 
Lyophyilized CHCA MALDI Matrix (LaserBio Labs, Sophia-Antipolis Cedex, FRA) is solved in 
1.66 ml of Solvent A. 
Trypsin solution: 
 10 µg/ml trypsin          Serva, Heidelberg, GER 
 25 mM (NH4)HCO3 (from 250 mM stock)    Carl Roth, Karlsruhe, GER    
Lyophilized trypsin is dissolved in 2.5 ml of a 25 mM ABC solution, sonicated within a 
waterbath and immediately used for sample processing. 
3.3.10 Buffers and reagents for Preparations of ECM Proteins 
T-ECM-1 (Low-Salt ECM Buffer): 
0.5 M sodium chloride        Carl Roth, Karlsruhe, GER  
10 mM tris base          Carl Roth, Karlsruhe, GER 
Dissolve components in 200 ml Aqua iniectabilia, adjust pH to 7.5 and bring the solution 
to a final volume of 250 ml. Solution has to be stored at 4 °C until use. Prior to use, 
protease inhibitors were freshly added. 
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T-ECM-2 (Decellularization Buffer): 
137 mM sodium chloride        Carl Roth, Karlsruhe, GER 
2.7 mM potassium chloride       Carl Roth, Karlsruhe, GER 
10 mM disodium hydrogen phosphate    Carl Roth, Karlsruhe, GER 
1.8 mM potassium dihydrogen phosphate   Carl Roth, Karlsruhe, GER 
1 % (w/v) sodium dodecyl sulphate     SERVA, Heidelberg, GER 
Dissolve components in 450 ml Aqua iniectabilia, adjust pH to 7.4 with hydrochloric acid, 
add appropriate amount of SDS and adjust volume to 500 ml. Solution has to be stored 
at room temperature to prevent precipitation of SDS. Prior to use, protease inhibitors 
have to be added freshly. 
T-ECM-3 (ECM Solubilisation Buffer): 
4 M guanidine hydrochloride       Carl Roth, Karlsruhe, GER 
50 mM sodium acetate        Carl Roth, Karlsruhe, GER 
Dissolve components in 200 ml Aqua iniectabilia, adjust pH to 5.8 and bring the solution 
to a final volume of 250 ml. Solution has to be stored at 4 °C until use. Prior to use, 
protease inhibitors were freshly added. 
3.3.11 Lectin-mediated precipitation of proteins 
Agarose-bound Wheat Germ Agglutinin     Vector Labs, Burlingame, USA 
WGA wash buffer: 
 10 mM HEPES, pH 7.5         Carl Roth, Karlsruhe, GER 
 150 mM NaCl           Carl Roth, Karlsruhe, GER 
WGA elution buffer: 
 10 mM HEPES, pH 7.5         Carl Roth, Karlsruhe, GER 
 150 mM NaCl           Carl Roth, Karlsruhe, GER 
 0.5 M N-Acetyl-D-Glucosamine      Carl Roth, Karlsruhe, GER 
WGA storage buffer: 
 10 mM HEPES, pH 7.5         Carl Roth, Karlsruhe, GER 
 150 mM NaCl           Carl Roth, Karlsruhe, GER 
 20 mM N-Acetyl-D-Glucosamine      Carl Roth, Karlsruhe, GER 
ConA binding buffer: 
 10 mM HEPES, pH 7.5         Carl Roth, Karlsruhe, GER 
 150 mM NaCl           Carl Roth, Karlsruhe, GER 
 0.01 mM MnCl2          Carl Roth, Karlsruhe, GER 
 0.1 mM CaCl2           Carl Roth, Karlsruhe, GER 
ConA elution buffer: 
 10 mM HEPES, pH 7.5         Carl Roth, Karlsruhe, GER 
 150 mM NaCl           Carl Roth, Karlsruhe, GER 
 0.01 mM MnCl2          Carl Roth, Karlsruhe, GER 
 0.1 mM CaCl2           Carl Roth, Karlsruhe, GER 
 200 mM α-methyl mannoside      Merck KGaA, Darmstadt, GER 
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3.4 Consumables 
3.4.1 General laboratory consumables 
 
Agarose-bound Wheat Germ Agglutinin     Vector Labs, Burlingame, USA 
Amicon® Filter Unit (20 ml, 100 kDa MWCO)   Millipore, Darmstadt, GER  
cell culture dish, 10 cm         Becton Dickinson, Heidelberg, GER 
cell culture dish, 20 mm         NUNC, Roskilde, DK 
cell culture plate (6-, 12-, 24-, 96-wells)     Sarstedt, Nümbrecht, GER 
cell scraper            Sarstedt, Nümbrecht, GER 
centrifugation tube (15 ml, 50 ml)      Sarstedt, Nümbrecht, GER 
colibri tips             Kisker Biotech, Steinfurt, GER 
Concanavalin A (biotinylated)       Sigma-Aldrich, München, GER 
coverslips             Carl Roth, Karlsruhe, GER 
CryoTubeTM            NUNC, Roskilde, DK 
Falcon Tubes (15, 50 ml)         Greiner, Frickenhausen, GER 
Feather® scalpels           Feather, Osaka, JPN 
glass slide              Carl Roth, Karlsruhe, GER 
HyperfilmTM ECL chemiluminescence film    GE Healthcare, Buckinghamshire, UK 
Microlance® syringe          Becton Dickinson, Heidelberg, GER 
Microlance® syringe needles (20-gauge)     Becton Dickinson, Rutherford, USA 
Micropipette filter tips (10, 100, 200, 1000 µl)   Sarstedt AG, Nümbrecht, GER 
Micropipettes (2.5, 10, 20, 100, 200, 1000 µl)   Eppendorf, Hamburg, GER 
Multichannel Pipette Tips        Mettler-Toledo, Gießen, GER 
NuPAGETM 4-12% Bis-Tris (10 well, 1.5 mm)    Life Technologies 
NuPAGETM 4-12% Bis-Tris (15 well, 1.5 mm)    Life Technologies 
object slide            Carl Roth, Karlsruhe, GER 
Optitran® (0.2 µm)          GE Healthcare, Uppsala, SWE 
Optitran® (0.45 µm)          GE Healthcare, Uppsala, SWE 
Parafilm®             Pechiney Plastic Packaging, USA 
Pasteur pipet            Hecht, Sondheim, GER 
PMA (10 ng/ml)           Sigma-Aldrich, München, GER 
reaction tubes (0.5 ml, 1.5 ml, 2.0 ml)     Sarstedt, Nümbrecht, GER 
Reaction Tubes (250, 500, 1500, 2000 µl)    Sarstedt AG, Nümbrecht, GER 
Serologic Pipettes (5, 10, 25, 50 ml)      Greiner, Frickenhausen, GER 
spectroscopic cuvettes          Sarstedt, Nümbrecht, GER 
sterile filter (0.22 µm, 0.445 µm)       GE Healthcare, Uppsala, SWE 
sterile filter (0.22 µm, 500 ml)       Millipore, Billerica, USA 
Streptavidin magnetic beads        Sigma-Aldrich, München, GER 
syringe filters (0.22 and 0.45 µm)      Sartorius, Göttingen, GER 
syringes (1 ml, 10 ml, 50 ml)        Braun, Meslungen, GER 
Ultra-ClearTM centrifugation tubes, 11-60 mm   Beckman Coulter, Krefeld, GER 
Ultra-ClearTM centrifugation tubes, 16-102 mm   Beckman Coulter, Krefeld, GER 
VivaSpin® 20 (3 kDa MWCO)        GE Healthcare, Buckinghamshire, UK 
VivaSpin® 500 (3 kDa MWCO)       GE Healthcare, Buckinghamshire, UK 
Whatman paper           Millipor, Billerica, USA 
Zeba Desalting Columns (500 µl, 7 kDa MWCO)   Thermo Scientific, Schwerte, GER 
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3.4.2 Kits 
2D CleanUp Kit           GE Healthcare, Uppsala, SWE 
Amersham ECL Western Blotting Detection Reagents GE Healthcare, Buckinghamshire, UK 
CyDyeTM DIGE Fluor Labeling Kit (5 nM)     GE Healthcare, Uppsala, SWE 
DeStreak Rehydration Solution       GE Healthcare, Uppsala, SWE 
Membrane Protein Extraction Kit      PromoKine, Heidelberg, GER 
MycoProbe® Mycoplasm detection kit     R&D, Wiesbaden, GER 
NE-PERTM Nuclear & Cytoplasmic Extraction Reagent Thermo Scientific, Schwerte, GER 
3.5 Laboratory equipment 
3.5.1 General laboratory equipment 
Avanti J-25.1 ultracentrifuge        Beckman Coulter, Fullerton, USA 
Axioskop             Carl Zeiss, Jena, GER 
Axiovert 10            Carl Zeiss, Jena, GER 
Biofuge 15R            Heraeus, Osterrode, GER 
Branson Sonifier 450          Branson, Danbury, USA 
calibrated densitometric gel scanner GS-800   Bio-Rad, Hercules, USA 
CO2-humidified, water jacketed incubator    Forma Scientific, Marietta, USA 
Confocal FL-1000           Olympus, Hamburg, GER 
Cryo preservation tank         Cryotherm, Euteneuen, GER 
Devloping machine Curix60        Agfa, Mortael, BE 
Dounce homogenizators         Braun, Meslungen, GER 
Eppendorf® Centrifuge 5415C       Eppendorf, Hamburg, GER 
Eppendorf® Centrifuge 5417R       Eppendorf, Hamburg, GER 
film cassetetes           GE Healthcare, Buckinghamshire, UK 
Fridge/freezer combination (+4 °C / -20 °C)    Liebherr, Bieberach, GER   
heating block            Techne, Wertheim, GER 
Infinite® M200 Microplate Reader      Tecan, Durham, USA 
inverse light microscope         Carl Zeiss, Jena, GER 
LaminAir® - Laminar flow hoods       Heraeus, Osterrode, GER 
Laser scanning microscope LSM 510 Meta    Carl Zeiss, Jena, GER 
Megafuge 10            Heraeus, Osterrode, GER 
microwave oven           Bosch, Gerlingen, GER 
Minifold-II SlotBlot system        Schleicher & Schüll, Dassel, GER 
NanoDropTM ND-1000         Thermo Scientific, Schwerte, GER 
Neubauer hemocytometer        Fischer, Frankfurt, GER 
pH meter             WTW, Weilheim, GER 
Pipetting Aid accu-jet pro         Brand, Wertheim, GER 
Power Supply 200/300         Bio-Rad, Hercules, USA 
Protean® II electrophoresis chamber      Bio-Rad, Hercules, USA 
rocking device            Fröbel, Lindau, GER 
shaking incubator           GFL, Burgwedel, GER 
shaking water bath          GFL, Burgwedel, GER 
SmartSpecTM 3000 spectrophotometer     Bio-Rad, Hercules, USA 
Chapter 3: Materials 35 
ThermoMixer®           Eppendorf, Hamburg, GER 
Trans-Blot® Transfer Tank         Bio-Rad, Hercules, GER 
Ultracentrifuge TLA-100         Beckman Coulter, Hrefeld, GER  
Ultracentrifuge XL-100         Beckman Coulter, Krefeld, GER 
UV documentation system        INTAS, Göttingen, GER 
Varifuge 3.0R            Heraeus, Osterrode, GER 
Vortex-Genie 2           Scientific Industries, Bohemia, USA 
Weighing machine          Sartorius, Göttingen, GER 
Weighing machine (special accuracy)     Sartorius, Göttingen, GER 
3.5.2 Gel-based proteomics and mass spectrometry 
4800 Plus MALDI-ToF/ToFTM Analyzer     AB Sciex, Framingham, USA 
automatic multichannel pipette (250 µl)     Mettler-Toledo, Gießen, GER 
equilibration chamber         GE Healthcare, Uppsala, SWE 
Ettan Dalt six            GE Healthcare, Uppsala, SWE 
Ettan Digester            GE Healthcare, Uppsala, SWE 
Ettan IPGphor            GE Healthcare, Uppsala, SWE 
Ettan Spotpicker           GE Healthcare, Uppsala, SWE 
gel caster (for six gels)          GE Healthcare, Uppsala, SWE 
OPTI-TOF 384 MALDI grid         AB Sciex, Framingham, USA 
rehydration chamber          GE Healthcare, Uppsala, SWE 
TyphoonTRIO laser scanner        GE Healthcare, Uppsala, SWE 
Ultrasonic bath           Branson, Danbury, USA 
3.6 Software and Web Services 
3.6.1 Software 
DeCyderTM 2D software 7.2        GE Healthcare, Uppsala, SWE 
Ettan Digester control software       GE Healthcare, Uppsala, SWE 
Ettan Spot Picker control software          GE Healthcare, Uppsala, SWE 
ImageMaster 2D Platinum 7.0        GE Healthcare, Uppsala, SWE 
ImageQuant TL 7.0          GE Healthcare, Uppsala, SWE 
Infinite® 200 PRO           Tecan, Durham, USA 
IPGphor 3 control software        GE Healthcare, Uppsala, SWE 
MS Office 2011 (Word, Excel, PowerPoint)    Microsoft, Redmond, USA 
TyphoonTRIO control software       GE Healthcare, Uppsala, SWE 
3.6.2 Web Services 
ExPASy pI/MW tool          http://web.expasy.org/compute_pi/  
National Center for Biotechnology Information   http://ncbi.nlm.nih.gov/  
SMART domain prediction tool       http://smart.embl-heidelberg.de/  
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STRING 9.1            http://string-db.org  
UniProt Protein Knowledgebase       http://uniprot.org 
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4 Methods 
4.1 Cell culture 
4.1.1 Cultivation of mammalian cells 
Cells were routinely cultured at 37 °C in a humidified atmosphere with 5 % carbon dioxide. 
Cell culture media, used for different cell lines are listed in table 4.1. 
Tab. 4.1: Cell culture media  
cell line medium composition used  for  … substance amount 
murine  
embryonic 
fibroblasts 
(MEF) 
MEF-10 
DMEM 
sodium pyruvate 
L-glutamine 
FBS 
Penicillin/Streptomycin 
 
110 mg/ml 
2 mM 
10 % (v/v) 
1 % (v/v) 
cultivation 
MEF-0 
DMEM 
sodium pyruvate 
L-glutamine 
Penicillin/Streptomycin 
 
110 mg/ml 
2 mM 
1 % (v/v) 
washing, 
supernatant 
analyses 
MEF-ECM 
DMEM 
ascorbic acid 
sodium pyruvate 
L-glutamine 
FBS 
Penicillin/Streptomycin 
 
10 nM 
110 mg/ml 
2 mM 
10 % (v/v) 
1 % (v/v) 
cultivation 
macrophages 
(MΦ) 
MΦ-10 
DMEM 
sodium pyruvate 
L-glutamine 
FBS 
Penicillin/Streptomycin 
HEPES 
rm m-CSF 
 
110 mg/ml 
2 mM 
10 % (v/v) 
1 % (v/v) 
10 mM 
40 ng/ml 
differentiation, 
cultivation 
MΦ-0 
DMEM 
sodium pyruvate 
L-glutamine 
Penicillin/Streptomycin 
HEPES 
rm m-CSF 
 
110 mg/ml 
2 mM 
1 % (v/v) 
10 mM 
40 ng/ml 
washing, 
supernatant 
analyses 
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For standard cultivation of murine embryonic fibroblasts (MEFs), cells were detached by 
trypsin-containing PBS for 5 min at room temperature. Cells were transferred into fresh 
medium and harvested by centrifugation for 5 min at 500 xg and room temperature. The 
pelleted cells were resuspended in 1 ml of fresh culture medium and passaged in a 1:10 or 
1:5 ratio. Possible contaminations by mycoplasms were excluded periodically using a PCR-
based mycoplasma detection kit. 
4.1.2 Cryopreservation of cells 
Long-term storage of stable cell lines (e.g. murine embryonic fibroblasts) was carried out by 
cryopreservation in liquid nitrogen. Prior to cryopreservation, cells were harvested, counted 
and washed with fresh culture medium. Afterwards, cells were pelleted by centrifugation for 
5 min at 500 xg and room temperature and re-suspended in an appropriate volume of cryo-
medium, which is normal growth medium containing additional 20 % (v/v) of FBS and 10 % 
(v/v) DMSO. Immediately, cells were transferred into 1 ml cryo tubes and stored at -80 °C for 
short periods before transfer into liquid nitrogen. 
4.1.3 Determinating cell number and viability of cultured cells 
Cells were counted using standard Neubauer hemocytometer. Thereto, 10 µl of the cell 
suspension was mixed with 90 µl of trypan blue or eosin red before counting. 
4.2 Sample preparation techniques 
4.2.1 Preparation of murine, bone marrow –derived macrophages 
Anesthetized mice were killed by cervical dislocation and Os femoris and Os tibia from both 
legs were prepared by dissection. Bones were cleaned from remaining tissues and kept on 
ice in culture medium on ice. Bone marrow was obtained after cutting the joint ends and the 
sockets of the bones, respectively. The red bone marrow was rinsed into a sterile sieve using 
a 20-gauge needle and fresh MΦ-0 medium to obtain a single cell suspension. The cells were 
then pelleted by centrifugation for 10 min at 300 xg and  4  °C,  resuspended  in  7  ml  MΦ-10 
medium, transferred into a coated cell culture plate and incubated for 24 h at standard 
culture conditions. 
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Then, the monocyte-containing culture supernatant was removed and discarded. The 
adherent cells were detached with 10 ml of fresh MΦ-0 medium, centrifuged for 10 min at 
300 xg and 4 °C, resuspended   in  1  ml  of   fresh  MΦ-10 medium and counted. 1 x 107 cells 
were transferred into a coated cell culture plate with 7 ml of MΦ-10 medium.  
Differentiation of macrophages was performed for 48 h under standard culture conditions, 
followed   by   additional   72   h   after   supplementing   7   ml   of   fresh   MΦ-10 medium. 
Differentiated macrophages were harvested by accutase and used for respective 
experiments. 
4.2.2 Preparation of whole cell lysates 
In order to analyze proteins from whole cell lysates by SDS-PAGE and subsequent Western 
blot analyses, 2.5 x 106 cells were harvested and washed three times with PBS. Cells were 
centrifuged for 5 min at 500 xg and room temperature, re-suspended in an appropriate 
volume of NP40 or RIPA lysis buffer and kept on ice for 20 minutes. Cellular debris was 
removed by centrifugation for 10 min at 15.000 xg and 4 °C and the supernatant was 
collected for further processing or storage at -20 °C. In case of 2D-DiGE analyses, whole cell 
lysates were produced using 2D Lysis Buffer. 
4.2.3 Enrichment of proteins from cell culture supernatants 
4.2.3.1   Enrichment of proteins using centrifugal filter units 
In a first series of experiments, proteins from cell culture supernatants were enriched by 
reduction of the sample volume, using Vivaspin 500 centrifugal filter units with a 3 kDa 
molecular weight cut-off (GE Healthcare). Briefly,  2·∙108 cells per cell line were seeded on ten 
20 cm cell culture dishes and incubated overnight at standard culture conditions. 
Afterwards, the supernatants were removed and the cells were washed three times with 
MEF-0 medium before adding fresh MEF-0 medium for another 48 h of incubation. Two 
hours before harvesting the cell culture supernatant, 10 nM of the phorbolester PMA was 
added. The cell culture supernatants were harvested and detached cells were removed by 
centrifugation for 10 min at 1,500 xg and 4 °C. Cleared supernatants were supplemented 
with protease inhibitors and the volume was reduced by centrifugal filter units (3 kDa 
MWCO). For subsequent 2D-DiGE analyses, remaining medium was exchanged against 2D 
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lysis buffer, using Zeba Spin Desalting Columns (7 kDa MWCO, Thermo Scientific) following 
the  manufacturer’s  instructions. 
4.2.3.2 Precipitation of glycosylated proteins by wheat germ agglutinin 
In order to enrich secreted or shed membrane proteins from cell culture supernatants, 
proteins were precipitated using WGA-agarose beads. This procedure was introduced as a 
means for the identification of shed cell-surface proteins by metalloproteases [Guo et al., 
2002] and, more specifically for the identification of Desmoglein-2 as a substrate of ADAM10 
[Bech-Serra et al., 2010]. This approach is based on the fact that most cell-surface proteins 
contain one or more carbohydrate groups and released cell-surface proteins are thus likely 
to be highly glycosylated. WGA is a lectin from Triticum vulgaris and binds N-acetyl-D-
glycosamines and sialic acids that are common to many secreted and membrane 
glycoproteins of mammalian cells. 
For the preparation of proteins from cell culture supernatants of MEF cells from wild-type or 
ADAM17ex/ex mice, 2x108 cells per cell line were placed in ten cell culture dishes (20 cm). 
After incubation for 12 h at 37 °C and 5 % CO2, cells were washed twice with MEF-0 medium 
and finally covered with 15 ml of MEF-0 medium. After incubation for 46 h at 37 °C and 5 % 
CO2, cells were exposed to 10 nM PMA and for additional two hours. Subsequently, cell 
culture supernatants were harvested and centrifuged at 1000 xg and 4 °C for 10 min to 
remove cellular debris. Supernatants were carefully transferred into fresh tubes with 
protease inhibitors and stored on ice. Washed WGA-agarose beads were added to the 
supernatants (200 µl to 100 ml supernatant) and incubated for 16 h at 4 °C. WGA-agarose 
beads were centrifuged at 4,000 xg and 4 °C and transferred to a fresh 1.5 ml reaction tube. 
Precipitated proteins were eluted with WGA elution buffer for 2 h, rotating at 4 °C. Finally, 
WGA-agarose beads were collected by centrifugation at 15,000 xg and 4 °C for 5 minutes. 
The supernatant contained the eluted proteins and the volume was reduced to 100 µl using 
VivaSpin 500 centrifugal filter units (3 kDa MWCO). Proteins were cleaned up using the 2D 
CleanUp Kit and subjected to two-dimensional differential gel electrophoresis. In case of 
Western blot analyses, respective aliquots for separation of proteins by SDS-PAGE were 
taken from the concentrated sample. 
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4.2.4 Preparation of plasma membrane proteins 
4.2.4.1  Preparation of plasma membrane proteins by a “two-phase system” 
In order to address a potential regulation of membrane proteins, plasma membrane proteins 
were enriched using the Plasma Membrane Extraction Kit (PromoKine). The extraction was 
performed   according   to   manufacturer’s   instructions. Putative membrane fractions were 
resuspended in 2D lysis buffer for subjection to 2D-CTAB/SDS-DiGE or in DOC lysis buffer for 
subjection to WGA-mediated precipitation. 
4.2.4.2 Formation of Giant Plasma Membrane Vesicles (GPMVs) 
For the formation of GPMVs, 107 MEF cells were seeded into 20 cm cell culture plate and 
incubated overnight at standard conditions. Cell culture medium was discarded and cells 
were washed with pre-warmed GPMV wash buffer, twice. Cells were covered with 10 ml 
pre-warmed, TPA-containing GPMV blebbing buffer and incubated for 2 h at 37 °C and 
gentle agitation. Supernatant was harvested, transferred to a 50 ml reaction tube and 
underlayed with GPMV sucrose buffer. After centrifugation for 30 min at 500 xg and 4 °C, 
the upper phase was transferred into Ultra-Clear® centrifugation tubes and centrifuged for 
one hour at 100,000 xg and 4 °C. GPMVs were resuspended in PBS and sonicated. After 
centrifugation for 30 min at 25,000 xg and 4 °C, GPMV debris was resuspended in 2D lysis 
buffer and subjected to further proteomic analysis. 
4.2.4.3 Combination of a  “two-phase system“ and ConA-mediated precipitation 
Another strategy for plasma membrane protein enrichment was a combined approach of the 
two-phase system and Concanavalin A-mediated lectin precipitation. Thus, putative 
membrane fractions were generated as described before (see section 4.2.4.1) and were 
resuspended in ConA binding buffer. Biotinylated ConA was linked to streptavidine-magnetic 
beads as described elsewhere [Lee et al., 2008] and transferred to the sample. After 
incubation for 16 h at 4 °C, Con A-bound proteins were harvested by magnets and eluted by 
incubation in ConA elution buffer for 2 h at 4 °C. Con A-magnetic beads were removed and 
proteins were precipitated using the 2D CleanUp Kit. Precipitated proteins were re-
solubilized in 2D lysis buffer overnight at 4 °C and subjected to 2D-CTAB/SDS-DiGE. 
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4.2.5 Enrichment of ECM proteins from cells and tissues 
4.2.5.1  Preparation of ECM proteins from cultured cells 
In order to identify and verify potential differences in the extracellular matrix (ECM) 
composition of wild-type and ADAM17ex/ex MEF cells, enrichment of ECM from these cells 
was performed as described elsewhere [Cukierman et al., 2001]. Briefly, 3 x 106 MEF cells 
were seeded into four 20-cm cell culture dishes. Cells were cultured for 17 days under 
standard culture condition, changing MEF-ECM medium every third day. Afterwards, the 
medium was removed and discarded. Cells were twice rinsed with 5 ml pre-warmed PBS, 
covered with 5 ml of pre-warmed ECM extraction buffer (C-ECM) and incubated for 5 to 10 
minutes at 37 °C to lyse the cells. After addition of 10 ml ice-cold PBS, supernatant was 
removed and cell culture plates were washed two times with cold PBS. Finally, supernatant 
was removed completely and the remaining ECM was harvested in 2D lysis buffer using a cell 
scraper. After desalting, the sample was immediately subjected to 2D-DiGE analysis. 
4.2.5.2 Adapted protocol for the preparation of ECM proteins from cultured cells 
In order to optimize the enrichment of ECM proteins from cultured MEF cells, 
decellularization was linked to WGA-mediated precipitation. Thus, ECM enrichment was 
performed as described before. Putative ECM proteins were transferred into WGA wash 
buffer and supplemented with WGA-agarose beads. Proteins were harvested and processed 
as described in section 4.2.3.2. 
4.2.5.3 Preparation of ECM Proteins from Murine Tissues 
In order to verify potential differences in extracellular matrix composition between wild-type 
and ADAM17ex/ex phenotype in vivo, different organs were dissected from wild-type and 
ADAM17ex/ex mice. Several protocols have been published for enrichment of ECM proteins 
from different tissues. The procedure used here combines protocols for cartilage matrix 
preparation for 2D-DiGE analyses [Wilson and Bateman, 2008] and for preparation of cardiac 
ECM for subsequent mass spectrometrical analyses [de Castro Brás et al., 2013]. Therefore, 
mice were sacrificed by cervical dislocation and dissected immediately. Heart, lung, spleen, 
kidneys, liver, colon, intestine and parts of the skin were removed, washed three times in 
sterile and ice-cold PBS and were stored at -80 °C for 24 h. For preparation of ECM, organs 
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were thawed and cut into smaller pieces. Organs were incubated in high-salt extraction 
buffer (T-ECM-1) for 40 h at 4 °C. Afterwards, the solution was aspirated, tissues were 
washed once with isosmotic decellularization buffer (T-ECM-2) and incubated in fresh T-
ECM-2 for 24 to 48 h at room temperature. After removing the liquid from each sample, the 
remaining tissues were carefully washed with deionized water and further incubated in 
guanidine extraction buffer (T-ECM-3) for 48 h at 4 °C and 800 rpm. For further sample 
processing, tissue debris was removed by centrifugation for 15 min at 10,000 xg and 4 °C. 
The supernatants were transferred into centrifugal filter units with 3 kDa MWCO and sample 
volume was reduced to 200 µl by centrifugation at 15,000 xg and 4 °C. Finally, proteins were 
precipitated using the 2D CleanUp Kit (GE Healthcare), resuspended in 2D lysis buffer and 
subjected to 2D-DiGE analysis or Western blot analysis, respectively. 
4.2.5.4 Adapteded protocol for the enrichment of ECM proteins 
In order to increase the amount of extracted ECM components by the previous described 
decellularization protocol, this procedure was amended by enrichment of glycosylated 
proteins, using WGA-agarose beads. Therefore, decellularization and ECM enrichment was 
performed as described in section 4.2.5.3 and ethanol-precipitated proteins were dissolved 
in WGA Wash Buffer. The samples were then supplemented with 50 µl of stirred WGA-
agarose bead solution and incubated for 16 h at 4 °C on an over-head incubator. Afterwards, 
WGA-agarose beads were harvested and bound proteins were eluted as described 
previously (see section 4.2.3.2). Again, the sample volume was reduced by centrifugal filter 
units (3 kDa MWCO) to a final volume of 100 µl and proteins were precipitated using the 2D 
CleanUp Kit. Finally, proteins were re-suspended in 2D Lysis Buffer for subsequent 
measurement of protein concentration. 
4.2.6 Biotinylation 
Enrichment of putative membrane fractions for screening analyses was also performed by 
biotinylation. Thus, the Pierce Cell Surface Protein Isolation Kit (Thermo Scientific) was used, 
following manufacturers instructions. Eluted proteins were precipitated using the 2D 
CleanUp Kit and resuspended in 2D lysis buffer for further analysis. 
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4.2.7 Cell-surface labeling by fluorescent dyes 
Similar to biotinylation, cell-surface proteins in some cases can also be labeled by 
fluorescent  dyes  (e.g.  CyDye’s). Cell-surface labeling was performed as described elsewhere 
[Mayrhofer et a., 2006].  
4.2.8 Preparation of nuclear proteins from cultured cells 
Nuclear proteins were enriched using the NE-PER Nuclear Protein Extraction Kit (Pierce), 
following  the  manufacturer’s  instructions.  Prior  to  subsequent  analyses  by  2D-DiGE or SDS-
PAGE, the enrichment of nuclear proteins was analyzed by Western blot analyses.  
4.2.9 Determination of protein content 
Protein concentrations were determined using a Bradford Assay (Thermo Scientific), 
following   the  manufacturer’s   instructions [Bradford, 1976]. Briefly, 5 µl of protein sample 
were supplemented with 995 µl of Coomassie (Bradford) Protein Assay Reagent (Thermo 
Scientific) and incubated for 15 min at room temperature. Absorbance was measured with a 
SmartSpecTM 3000 spectrophotometer (Bio-Rad) and protein concentration was calculated in 
silico using a straight calibration line.  
4.3 Enzyme-linked immunosorbent assay (ELISA) 
In order to measure the concentration of shed fragments of known ADAM17 substrates 
(sTNFα,  sTNF-RI and sTNF-RII) in the supernatant of wild-type and ADAM17ex/ex MEF cells, the 
colorimetric enzyme-linked immunosorbent assay (ELISA) was. For each soluble fragment, a 
specific DuoSet ELISA Development Kit (R&D Systems, Minneapolis, USA) was used according 
to  manufacturer’s   instructions. Finally, absorption of the samples was detected using the 
Tecan® ELISA plate reader. 
4.4 Confocal laser scanning microscopy (CLSM) 
Cover slips were incubated for 15 min in concentrated hydrochloric acid at room 
temperature. Hydrochloric acid was removed and cover slips were washed twice with ultra 
pure water and once with 70 % ethanol. Finally, cover slips were dried over night at 180 °C 
Chapter 4: Methods 45 
and sterilized. For confocal imaging of MEF cells, cover slips were transferred into sterile 12-
well plates and labeled with poly-L-lysine for 30 min at 37 °C. Coated cover slips were 
washed three times with sterile PBS and 105 MEF cells were seeded per well and cultured 
overnight. After stimulation with TPA for two hours, cell culture medium was removed and 
cells were washed twice with sterile PBS. Cells were fixed with 3 % PFA/PEM buffer for 5 min 
at room temperature, followed by 10 min of incubation in 3 % PFA/borate buffer. For 
staining of intracellular proteins, cells were permeabilized by incubation in 1 % Triton X-100 
in PBS for 15 min. Cells were washed three times with PBS and free aldehyde groups were 
reduced by incubating the cells twice for 10 min in sodium borohydride solution. Again, cells 
were washed three times with PBS, followed by blocking of unspecific binding sites by 1 % 
BAS/PBS for one hour at room temperature. Primary antibodies were diluted in 60 µl of 
blocking solution and spotted on a piece of Parafilm®. The cells on the cover slip were placed 
in the antibody solution and incubated over night at 4 °C. Subsequently, cells were washed 
twice with PBS and incubated with the secondary antibody for one hour at room 
temperature. Finally, cells were washed with ultra pure water and were placed on an object 
slide containing 14 µl mounting medium with DAPI. After one hour of incubation at room 
temperature, samples were stored at 4 °C until imaging using the Olympus FV-1000 confocal 
microscope. Images were processed using the FluoView Viewer software. 
4.5 Gel-based proteomic approaches 
4.5.1 SDS-PAGE 
The sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is an 
electrophoretic separation technique for the analysis and separation of protein mixtures 
according to their molecular masses. As the migration of a protein within an electric field 
(mobile phase) and a polyacrylamide gel (stationary phase) does not only depend on the 
molecular weight, but also on intramolecular charge distributions, the anionic detergence 
sodium dodecyl sulfate (SDS) is used to circumvent inhomogeneous charge distribution. In 
an SDS solution, proteins are covered by a homogeneous negative charge and 
electrophoretic separation solely depends on the molecular weight. In addition, reduction of 
disulfide bonds by DTT or  β-mercaptoethanol can lead to enhanced protein separation. In 
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the context of this work, SDS-PAGE was performed in three different systems: (I) NuPAGE®, 
(II) Protean II and (III) Ettan DALTsix. 
NuPAGE®: 
This system includes preformed 4 – 12 % gradient gels and a MES buffer system. Prior to 
separation, 8 – 10 µg of a protein mixture were supplemented with a corresponding volume 
of 4-fold NuPAGE® LDS Sample Buffer and DTT. Finally, the sample volume was brought to 
30 µl and the protein mixture was denatured for 5 min at 95 °C. The electrophoretic 
separation was performed by applying a current of 200 V until the dye front reached the 
bottom of the gel. 
Protean II: 
In contrast to the NuPAGE® system, the Protean II system allows the adaption of the 
acrylamide concentration to the particular needs of the analysis. In the context of this work, 
this system has been used for a variety of analyses, including (I) one-dimensional separation 
of proteins prior to subsequent Western blot analyses, (II) separation of proteins upon 
isoelectric focusing and (III) separation of proteins upon CTAB-PAGE in the first dimension.  
Ettan DALTsix system: 
In order to achieve a higher degree of comparability of different separations of protein 
samples by 2D-DIGE, the Ettan DALTsix system was used for second dimension separation of 
proteins in 2D-IEF/SDS approaches. In contrast to the Protean II system six different gels 
were made in a row by using the DALTsix Gel Caster (GE Healthcare). Glass plates were 
cleaned with an aqueous solution of 2 % SDS and ultrapure water. In addition, dry plates 
were cleaned with a duster to remove particles of dust and placed in the gel caster. Finally, 
the gel solution was poured into the gel caster and displacing solution was added. A film of 
ultrapure water on top of the gels was used to create a smooth surface. Gel composition is 
summarized in section 3.3.7. 
4.5.2 MMP zymography 
In order to investigate changes in MMP activity in ADAM17ex/ex MEF cells a zymography 
assay was performed, as described by previously [Toth et al., 2012] with slight modifications. 
Briefly, a 12.5 % SDS separation, containing 0.2 mg/ml gelatin (for MMP-2 and MMP-9) or 
casein (for MMP-3) was prepared. Protein samples from cell culture were combined with 
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SDS sample buffer without reducing agents and boiling of the sample. The samples were 
separate by SDS-PAGE, until the bromophenol blue front reached the end of the gel. SDS was 
removed from the zymography gels by incubation in zymography buffer I for 45 min at room 
temperature. Digestion of the incorporated MMP substrates was performed by incubation in 
zymography buffer II for 20 h at 37 °C. Finally, MMP activity was detected by staining the gel 
with Coomassie staining solution and subsequent destaining. 
4.5.3 2D-IEF/SDS-PAGE 
In the context of unbiased, gel-based proteomic approaches, the resolution of separated 
protein mixtures can be increased by two-dimensional techniques. In case of the 2D-IEF/SDS-
PAGE, the electrophoretic separation of protein mixtures is performed by isoelectric focusing 
according to the isoelectric point (pI) of a given protein within a preformed pH gradient, 
followed by a separation via SDS-PAGE  [O’Farrell,  1979].  Despite the increased resolution of 
this two-dimensional technique, the comparability of two different proteomes separated in 
different gels was often problematic. An increase in resolution and comparability was 
achieved by the 2D-DiGE technique [Ünlü et al., 1997]. This approach uses different weight-
matched fluorochromes (CyDyesTM) for covalent fluorescent labeling of protein mixtures 
prior to two-dimensional separation. Differentially labeled protein mixtures can then be 
combined and separated in a single gel (Fig. 4.1). 
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Fig. 4.1:   Overview on 2D-IEF/SDS-DiGE workflow. (A) Sample Labelling: Prepared protein samples, which 
have to be compared are differentially labelled by fluorescent dyes (Cy3 and Cy5). In addition, a 
mixture of both samples is labelled by Cy2 for subsequent statistic evaluations. After stopping the 
labelling, all three samples mixtures are combined. (B) First Dimension: After rehydration of the 
IPG strip, the prepared sample is applied to the IPG strip and separation of proteins by isoelectric 
focussing is performed. The IPG strip is equilibrated to SDS-PAGE conditions and proteins are 
reduced and alkylated. (C) Second Dimension: The equilibrated IPG strip is transferred on top of 
SDS gel and proteins are separated according to their molecular weight by SDS-PAGE. (D) Data 
Acquisition: Fluorescence of differentially labelled and separated proteins is detected by Typhoon 
TRIO laser scanner. (E) Data Analyses: Differences in protein levels between both samples are 
calculated by DeCyder 6.5 software. (F) Protein Identification: Finally, Proteins of interest are 
selected and processed for subsequent identification by MALDI-ToF/ToF. 
4.5.3.1 Isoelectric focusing (first dimension) 
Rehydrated DryStrips were placed on the ceramic tray of an IPGphor device and a cup was 
placed onto the acidic part of the strip. Both, the acidic and the alkaline ends were covered 
Chapter 4: Methods 49 
with wet paper wicks on which the electrodes were placed. In order to prevent dehydration 
of the DryStrip, the strips and the whole ceramic tray were covered with DryStrip Cover 
Fluid. Separation of proteins was performed according to a standard program reaching up to 
65 kVh by limiting the amperage to 75 µA per strip (see Fig. 4.2). 
step mode voltage time [hh:mm] 
 
1 step 100 V 2:00 
2 step 300 V 3:00 
3 grad 500 V 3:00 
4 grad 1000 V 5:00 
5 grad 10,000 V 4:00 
6 step 10,000 V 2:00 
Fig. 4.2: Parameters and progression curve of both, voltage and amparage, during isoelectric focussing of 
proteins on an 24-cm IPGstrip (3-11 NL), using the Ettan IPGphor3 device. 
4.5.3.2 SDS-PAGE (second dimension) 
Second dimension separation of isoelectrically focused proteins was routinely performed 
using the Ettan DALTsix system. Briefly, strips were equilibrated to SDS-PAGE conditions with 
concurrent reduction and alkylation of proteins at room temperature for 15 minutes with 
DTT and iodoacetamide, respectively. Strips were washed with 2-fold running buffer, 
transferred on top of a SDS-PAGE gel and fixed with 0.5% low melting agarose in 2-fold 
running buffer. Separation by molecular weight was performed at 24 mA per gel until the 
bromophenol blue front reached the bottom end of the gel. 
4.5.3.3 Visualization of CyDye-labelled proteins 
In order to detect and quantify differences in protein levels of proteins separated by 2D-
DIGE, glass plates were cleaned with ultrapure water. The glass plates were placed on 
Typhoon Trio laser scanner, using appropriate spacers. As the DeCyder 2D Analysis Software 
(GE Healthcare) requires fluorescence data that do not exceed 100,000 relative fluorescent 
units, prescans were performed with a resolution of 1000 microns for adaption of correct 
PMT values. Finally, different CyDyeTM fluorescence’s were scanned with a resolution of 
100 microns according to the settings depicted in table 4.2. 
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Tab. 4.2.: Overview on Typhoon TRIO laser  settings  for  the  detection  of  protein,  labeled  by  CyDye’s. 
CyDyeTM emission filter laser 
Cy5 670 BP 30 red (633 nm) 
Cy3 580 BP 30 green (532 nm) 
Cy2 520 BP 40 blue (488 nm) 
 
In principle, the detected fluorescence intensities can dynamically be correlated to the 
amount   of   proteins.   Individual   scan   images   of   different   fluorescence’s   (Cy5,   Cy3   and   Cy2)  
were opened with the Differential In-gel Analysis (DIA) program of the DeCyder 2D Analysis 
Software package (GE Healthcare). Different criteria, e.g. fluorescence intensity, slope and 
area were used for selection of spots for subsequent in silico analysis of protein abundances. 
Different fold-change values of individual protein spots were used to calculate a threshold, 
which indicates certain protein spots to be differentially regulated.  
4.5.3.4 Selection of proteins of interest for subsequent MS analysis  
Proteins that appeared to be differentially abundant were selected for subsequent 
identification by MALDI-ToF/ToF analysis. As the in-gel migration of labelled proteins might 
slightly differ from that of non-labelled proteins [REF], gels were fixed with FlamingoTM Fixing 
Solution for at least 3 hours at room temperature, followed by an additional 12 hours of 
incubation within FlamingoTM staining solution (Bio-Rad). After removal of the staining 
solution, gels were washed twice with ultrapure water for 20 minutes at room temperature 
and gels were placed on a cellulose membrane. Prior to imaging of proteins using the 
TyphoonTRIO Variable Mode Imager (GE Healthcare) with the Cy3 emission filter settings, 
the cellulose membrane was dried on paper towels for at least 30 minutes in the dark. 
Fluorescence data were processed using the ImageQuant TL 7.0 software and proteins of 
interest were marked within a pick list that was created by selecting spots of interest within 
the ImageMaster 2D Platinum 7.0 software (GE Healthcare). Finally, the gel was placed into 
the EttanPicker unit and selected proteins were picked automatically and transferred into 
96-well plates.  
4.5.4 2D-CTAB/SDS-PAGE 
Conventional 2D-IEF/SDS-PAGE combines isoelectric focusing of proteins according to their 
isoelectric point and a subsequent, mass-related separation by SDS-PAGE. Due to their 
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increased hydrophobicity, integral membrane proteins, especially those containing more 
than one transmembrane domain, can only hardly be separated by this approach. 
Alternative two-dimensional electrophoretic approaches for analytical and semi-preparative 
separations of membrane proteins therefore use cationic detergents such as 
benzyldimethyl-n-hexadecylammoniumchloride (16-BAC) [Harbingers et al., 1996] or 
cethyltriammoniumbromide (CTAB) [Macfarlane et al., 1989] to increase the resolution of 
membrane proteins. In contrast to 2D-IEF/SDS-PAGE, 2D-CTAB/SDS-PAGE combines two 
mass-related separations within two different gels using two different buffer systems and 
detergents. First, proteins are separated by a cationic CTAB polyacrylamide gel 
electrophoresis (CTAB-PAGE) at low pH. Second, proteins are transferred to an anionic SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) at alkaline pH. In both cases, the particular 
detergent covers intramolecular charge distributions and protein separated is carried out 
according to their molecular weight (see Fig. 4.3). The approach that was used in the present 
work was recently published for the characterization of membrane components of 
Plasmodium falciparum-infected erythrocytes [Philipp et al., 2012]. Related to the 2D-DiGE 
approach [Ünlü et al., 1997], separation of different protein samples within one gel is also 
possible, as the usage of CyDyesTM is compatible with the 2D-CTAB/SDS system [Helling et 
al., 2006]. Within this thesis, 2D-CTAB/SDS-DiGE was used to separate membrane proteins 
enriched from both wild-type and ADAM17ex/ex MEF cell surfaces by different approaches. 
At the beginning of this project, separation of proteins by 2D-CTAB/SDS-PAGE was shown to 
be compatible with a variety of different lysis buffers for protein sample preparation, 
including NP40 and 2D lysis buffer (data not shown). If performed as a 2D-CTAB/SDS-DiGE, 
protein samples were cleaned up with the 2D CleanUp-Kit and were solubilized in 2D lysis 
buffer. Differential labelling of proteins was performed as described before. 
The separation gel of the first dimension is prepared at least twelve hours before separation 
of proteins. All components, except CTAB and hydrogen peroxide are mixed vigorously until 
the urea is completely dissolved. Then, CTAB and hydrogen peroxide are added and the 
solution is mixed vigorously, again. The stacking gel is poured into a prepared gel caster, 
using 1 mm spacers, and overlayed with 2 ml of pure ethanol. After 15 min, ethanol is 
removed, gels are flushed with pure water and covered with CTAB Storage Solution for 
overnight storage at 4 °C. For proper polymerization of the stacking gel, the solution has to 
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be vortexed vigorously for 30 seconds. Finally, the solution can be poured on top of the 
separation gel, using a 10-well comb for formation of sample pockets. 
 
 
Fig. 4.3.: Schematic overview on 2D-CTAB/SDS-PAGE. Proteins, denatured by an CTAB-containg sample 
buffer are separated by CTAB-PAGE at 30 °C. Sample lanes are excised and equilibrated to SDS-
PAGE conditions by incubation in CTAB/SDS equilibration buffer. In addtion, disulfide bonds are 
reduced and alkylated by DTT and iodoacetamide, respectively. Finally, equilibrated sample lane is 
transferred onto an SDS gel and proteins are separated at room temperature.  
For second dimension separation, sample lanes were excised and equilibrated in 20 ml 
of CTAB/SDS equilibration buffer for 15 min, followed by two additional incubation steps in 
the presence of 100 mM DTT (15 minutes) and 250 mM iodoacetamide (15 minutes). 
For the SDS-PAGE in the second dimension, a 12.5 % gel was used, which was overlayed with 
a 1 cm stacking gel. The equilibrated gel strips were placed on top of the SDS stacking gel 
and fixed with 0.5 % Gel Fixing Solution. In addition, protein markers were placed next to the 
fixed gel strips. Separation of proteins was performed at 125 V per gel, until the 
bromophenol blue front reached the bottom end of the gel. 
4.5.5 Western blot 
Following in-gel electrophoresis, proteins were transferred to nitrocellulose membranes. 
Transfers were performed as wet blots in Western blot transfer buffer for 2 h at 150 V and 
4 °C (Protean II system) or for 1 h at 100 V and 4 °C (NuPAGE® system). A schematic overview 
on the assembly of a Western blot cassette is shown in figure 4.4. 
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Fig. 4.4: Assembly of a Western blot cassette. Transfer of proteins from SDS gel onto a nitrocellulose 
membrane is performed by electrophoresis within transfer buffer at 4 °C with proteins migrating 
from anode to catode due to covering by SDS. Between the Western blot clip, the SDS gel, which is 
in close contact to the nitrocellulose membrane, is surrounded by two layers of Whatman® paper 
and a sponge. Formation of air bubbles between all layers has to be avoided for proper transfer of 
proteins. 
After blotting of proteins, transfer was monitored by Ponceau S staining for 5 min at room 
temperature. Afterwards, destaining was performed by incubation in TBS for 5 min at room 
temperature. Nitrocellulose membranes were blocked by WB Blocking Buffer I or WB 
Blocking Buffer II for one hour at room temperature. Membranes were washed with WB 
Wash Buffer and incubated with a primary antibody against a protein of interest over night 
at 4 °C. Afterwards, membranes were washed with WB Wash Buffer for 10 min and the HRP-
tagged secondary antibody, which is directed against the Fc part of the primary antibody, 
was applied for 45 min at room temperature. The membrane was washed three times with 
WB Wash Buffer for 10 min, each, and chemiluminescence substrate (ECL) was applied for 
one minute. Finally, the chemiluminescence was detected using Amersham Hyperfilms ECL 
(GE Healthcare), which were developed in a Curix 60 device (Agfa). 
4.5.6 SlotBlot 
SlotBlot analysis was performed for proteins enriched from cell culture supernatants by 
centrifugal filter units and whole-cell lysates. Protein samples were transferred onto 
nitrocellulose membranes by vacuum using the Minifold II Slot Blot System (Schleicher & 
Schüll). Immunodetection of transferred proteins was performed as described for Western 
blot analyses (see section 4.5.5). 
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4.6 Mass Spectrometry 
In case of top-down proteomic approaches, proteins of interest that were separated by 2D-
DiGE were analyzed by mass spectrometry. This analytical approach records molecular 
weights of sample molecules that have been converted into electrically charged particles by 
ionization. The molecular weight of ionized sample molecules is determined upon their 
migration within an electromagnetic field according to their mass:charge ratio (m/z). All 
protein identifications of proteins separated by 2D-DiGE were performed by MALDI-ToF/ToF 
analysis by Bart van den Berg and Tomas Koudelka at the laboratory of Prof. Dr. Andreas 
Tholey (Institute for Experimental Medicine, UK S-H Kiel), using a 4800 Plus MALDI-
ToF/ToFTM Analyzer from AB Sciex. 
 
Fig. 4.5.: Schematic overview on the inside structure and particle flow of an MALDI-ToF/ToF device. For 
further information, refer to the text below. 
Briefly, peptides are embedded into a MALDI-compatible   matrix   (e.g.   α-cyano-4-
hydroxycinnamic acid) and placed onto a MALDI spot grid. By applying a high-energy laser 
beam to the sample, ionized peptides are produced. These ionized peptides fly through the 
highly evacuated MALDI chamber and its magnetic field. Finally, peptides are detected at the 
linear detector and linked to a measured time of flight (ToF). In case of tandem mass 
spectrometry, specific ionized peptides are selected for reflection by a magnetic reflector. 
The single peptides within this generated MS/MS particle beam can be detected at the 
reflector detector. Again, the detected peptides are linked to a time of flight value. The 
combination of the MS- and MS/MS-derived ToF-values leads to an enhanced accuracy for 
peptide identification. Identification of detected peptides is performed in silico by linking the 
measured  ToF  values  to  theoretical  ToF  values,  derived  from  protein  databases  [compare  …]. 
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4.6.1.1  Sample preparation 
Picked protein spots were washed according to the following settings by the EttanDigester 
(GE Healthcare; see Tab. 4.6). Afterwards, washed gel pieces were processed immediately or 
covered with acetonitrile for storage at -80 °C. 
Prior to in-gel tryptic digestion, gel pieces were washed two times with pure water and three 
times with 50 mM ammonium bicarbonate in 50 % methanol for 20 min, each. Finally, gel 
spots were dehydrated with 70 % acetonitrile for 20 min. 
For preparation of 384 protein spots for analysis by MALDI-ToF/ToF 50 µg of trypsin, were 
solved in 5 ml of a 25 mM ammonium bicarbonate solution. 10 µl of this trypsin solution was 
added to each picked protein spot and incubated for 10 minutes at 4 °C. Then, another 10 µl 
of the 25 mM ammonium bicarbonate solution were added to each protein spot and tryptic 
digestion was performed for 12 h at 37 °C. 
Digestion was stopped by addition of 20 µl of acetonitrile containing 0.1 % (v/v) 
trifluoroacetic acid. After 15 minutes of incubation in an ultrasonic bath, supernatants were 
transferred into a clean, U-shaped 96-well plate and the remaining protein spots were 
covered with 20 µl of acetonitrile containing 0.1 % (v/v) trifluoroacetic acid. After additional 
15 minutes of incubation at room temperature, the supernatants were combined. 
Evaporation of the collected supernatants was performed in a SpeedVac® concentrator 
under medium heat conditions for approximately 45 minutes. 
Lyophilized α-cyano-4-hydroxycinnamic acid (CHCA, LaserBio Labs) was solved in Solvent A 
to reach a final concentration of 5 mg/ml. Each protein spot was solved within 0.8 µl of the 
CHCA matrix solution and was transferred onto a MALDI spot grid for subsequent analysis.  
4.6.1.2 MALDI-ToF/ToF analytical parameters  
In case of identifying proteins that were selected from 2D gels, MALDI-TOF/TOF was 
performed at the group of Prof. Dr. Andreas Tholey at the Institute for Experimental 
Medicine by Bart van den Berg and Tomas Koudelka. Briefly, spectra were acquired on an AB 
SCIEX MALDI-TOF/TOF 5800 (AB SCIEX) mass spectrometer in positive ion mode. For MS 
measurements 1600 to 2000 shots were accumulated in the mass range of 800 - 4000 m/z. 
Default calibration was performed using 4800 Proteomics Analyzer Standards Kit, while MS 
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measurements were calibrated internally using trypsin, matrix and contaminant peaks 
(842.509, 877.034 and 2807.315 Da) and smoothed using a FFT Poison-Denoise algorithm. 
Precursor selection for MS/MS analysis was achieved using the 4000 Series Explorer 
Software (AB SCIEX) with acquisition of the 20 most intense precursors (S/N > 20) beginning 
with the strongest first. All MS/MS spectra were acquired with 1 kV collision energy at 
ambient air pressure (CID medium: 1.25 x 10-6 Torr) using 3000 laser shots. MS/MS post 
processing involved smoothing using the Savitsky-Golay algorithm with 7 points across the 
peak and a polynomial order of 4.  
For peptide identification, MALDI-TOF/TOF MS/MS raw files were searched using AB SCIEX 
GPS software (Version 3.6, build 332) with the following pre-filter settings: only peaks within 
a mass range from 60 Da to the precursor mass minus 35 Da and S/N ratio above 10 were 
used.  Spectra were searched with Mascot (version 2.2.04, Matrix Science, London, U.K) 
against the Swissprot database using either Mus musculus (16 345 sequences) or Homo 
sapiens as a taxonomy filter (20 254 sequences) and the following parameter settings: 
precursor tolerance, 30 to 50 ppm; MSMS tol, 0.3 to 0.5 Da; max missed cleavages 2. 
Oxidation (M) was set as a variable modification, while carbamidiomethylation (C) was set as 
a fixed modification. Proteins were considered identified when either 2 peptides were 
identified  with  a  confidence  interval  ≥  99%  (p  <  0.01)  or  3  peptides  ≥  95%  (p  <  0.05) [Tomas 
Koudelka, personal communication].  
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5 Results 
This section summarizes the observed changes in ADAM17-dependent proteome and sub-
proteome compositions that were identified by gel-based approaches. The presented 
differentially regulated proteins only represent a small portion of the overall identified 
proteins. All indicated 2D-DiGE images are included in the addendum of this thesis. The 
information on individual protein spots (e.g. MALDI-ToF/ToF data and fold-change values 
when using differential electrophoresis) are available in separated files on the enclosed 
digital data carrier. 
5.1 Decreased shedding activity in ADAM17ex/ex MEF cells 
At the beginning of this thesis, a hypomorphic mouse model (ADAM17ex/ex) was introduced 
as a putative tool for the analysis of the effects of reduced ADAM17 activity in vivo [Chalaris 
et al., 2010]. Murine embryonic fibroblasts (MEFs) from wild-type (MEF 1#3) and 
ADAM17ex/ex (MEF 1#1) mice and were provided by Athena Chalaris (Institute for 
Biochemistry, CAU Kiel) for initial proteomic analysis. For further experiments (section 5.7), 
two additional pairs of wild-type (MEF 1#7 and MEF 2#1) and ADAM17ex/ex (MEF 1#8 and 
MEF 2#8) MEF cells became available. 
The ADAM17 status in the provided MEF cells was routinely monitored by Western blotting 
for ADAM17. Immunodetection of ADAM17 in different MEF cell lysates confirmed the 
ADAM17ex/ex-dependent reduction of both, the ADAM17 pro-form (130 kDa) (Fig. 5.1 A) and 
the mature form (100 kDa, Fig. 5.1 B). In contrast, ADAM10 protein levels were not affected 
(Fig. 5.1 C). Shedding activity of wild-type and ADAM17ex/ex MEF cells was monitored by 
ELISA, targeting the soluble and shed fragments  of  TNFα  (Fig. 5.1 D) and TNF-RI (Fig. 5.1 E). 
The loss of ADAM17 activity led to decreased shedding of both substrates from all tested 
ADAM17ex/ex MEF cell lines. In addition, shedding activity was enhanced upon treatment 
with the phorbolester TPA (Fig. 5.1 D and E, dark blue bars) in contrast to non-stimulated 
MEF cells (Fig. 5.1 D and E, light blue bars). Of note, because the addition of ionomycin 
resulted in significant cell death, only TPA was used for MEF cell stimulation. 
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Fig. 5.1:  Reduced ADAM17 levels in ADAM17ex/ex MEF cells lead to reduced shedding activity. Protein 
levels of both, (A) ADAM17 and (B) ADAM10 were checked routinely by immunodetection in whole-cell lysates 
of TPA-treated MEF cells. Proteins were separated by 12.5 SDS-PAGE prior to transfer to a nitrocellulose 
membrane. Shedding activity was monitored by detection of soluble TNFα (C) and TNF-RI (D) in cell culture 
supernatants of unstimulated and TPA-treated MEF cells.  
In addition, the subcellular localization of ADAM17 in wild-type and ADAM17ex/ex MEF cells 
was monitored by confocal microscopy, using the available anti-mADAM17 antibody clone 
18.2 (Fig. 5.2). In ADAM17ex/ex MEF cells, decreased levels of ADAM17 were seen at the cell-
surface and within the cell. Interestingly, the majority of the cellular ADAM17 content was 
not located at the plasma membrane, but within a perinuclear compartment. In addition, 
specific fluorescent signals were also detected within the nuclei of both, wild-type and 
ADAM17ex/ex MEF cells. 
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Fig. 5.2:  Reduced intracellular and cell-surface ADAM17 levels in ADAM17ex/ex MEF cells. Wild-type and 
ADAM17ex/ex MEF cells were grown on poly-L-lysine coated coverslip and immunostained for ADAM17 using 
the 18.2 antibody against the extracellular region of ADAM17. Images show ADAM17 staining (ADAM17), the 
nucleus (DAPI), an overlay of both pictures (merge) and a staining with the secondary antibody alone.  
5.2 Proteomic analyses of MEF cell culture supernatants 
5.2.1 Proof of principle – Analysis of shedding by 2D-DiGE 
Based on the assumption that ADAM17 primarily acts as a plasma membrane-located 
sheddase, the starting point of this project was the characterization of the ADAM17-
dependent MEF cell sheddome. To this end, proteins from cell culture supernatants of MEF 
cells had to be enriched for a subsequent separation by 2D-DiGE.  
 
Fig. 5.3:  Different resolution of enriched supernatant samples by two-dimensional electrophoresis. 
Proteins from MEF cell culture supernatants were enriched by precipitation with 85 % ammonium sulfate 
(A) or using centrifugal filter units (B). Proteins were separated by two-dimensional gel electrophoresis on a 
24 cm 3-11NL IPG strip, followed by SDS-PAGE. Proteins were stained by FlamingoTM fluorescent gel stain. 
Images were captured by the TyphoonTRIO device. 
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Initially, proteins from conditioned cell culture media were thus enriched by protein 
ammonium sulfate precipitation. Although sufficient amounts of protein were precipitated, 
re-solubilization was mostly incomplete and led to impaired protein separation by two-
dimensional gel electrophoresis (Fig. 5.3 A). In contrast, the enrichment of supernatant 
proteins using centrifugal filter unit, resulted in a decent resolution on 2D (Fig. 5.3 B). 
 
Fig. 5.4:  Reduced levels of sTNFα in supernatants of TNFα-overexpressing ADAM17ex/ex MEF cells. 
(A) Pseudo-colored 2D-DiGE image of separated proteins from cell culture supernatants of TNFα-
overexpressing wild-type (Cy5, red) and ADAM17ex/ex (Cy3, green) MEF cells. Proteins were separated on 24 cm 
3-11NL IPG strips, followed by a SDS-PAGE. The white box indicates protein spots, identified as TNFα. 
(B) Enlarged, single-colored section of the boxed area (part A) and 3D fluorescence histograms of the putative 
TNFα spots in wild-type (upper panel) and ADAM17ex/ex MEF cell supernatants (lower panel) as integrated by 
the DeCyder 2D software. (C) The protein sequence of the full-length TNFα molecule comprises an intracellular 
domain (gray), a transmembrane region (red) and an extracellular region (black and light blue). Light blue 
sequence represents the soluble TNFα form. Bold and underlined letters indicate high confident MALDI-
ToF/ToF-derived sequence coverage. 
Unfortunately, the initial supernatant-based sheddome analyses did not reveal indications 
for major changes in ADAM17-mediated ectodomain shedding. Therefore, a proof-of-
principle experiment needed to be performed,  using  TNFα-transfected variants of the wild-
type (MEF 1#3mTNFα) and ADAM17ex/ex (MEF 1#1mTNFα) MEF cells. As before, proteins were 
enriched by centrifugation and analyzed by 2D-DiGE. As detailed in figure 5.4, at a molecular 
weight of approximately 17 kDa and an isoelectric point of 4.5 (Fig. 5.4 A, white box), a 
group of protein spots was drastically (14.9-fold) reduced in ADAM17ex/ex MEF cell 
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supernatants (Fig. 5.4 B). The subsequent analysis of these differentially regulated protein 
spots by MALDI-ToF/ToF identified them as TNFα.  Of note, the observed reduction of the 
molecular weight of the 25 kDa  proTNFα and the sequence coverage in mass spectrometry 
confirmed the reduced TNFα shedding in ADAM17ex/ex MEF cells. All detected peptides were 
located within the soluble TNFα  region (Fig. 5.4 C). This result clearly demonstrated that 2D-
DiGE experiments are suited for the analysis of alterations in ectodomain shedding. 
5.2.2 Improved protein enrichment by WGA-mediated precipitation 
According to the proof-of-principle experiment, 2D-DiGE appeared to be a suitable approach 
for the analysis of cell culture supernatants and for the detection of ADAM17-mediated 
changes in ectodomain shedding. Nevertheless, 2D-DiGE analyses of samples enriched by 
centrifugal filter units revealed changes in protein cleavage and secretion (see below), but 
did not point to evident ADAM17-mediated shedding events. Moreover, the identification of 
the enriched proteins only revealed a rather low abundance of secreted or cell-surface 
proteins. In order to increase the enrichment of cell-surface, shed and secreted proteins 
from cell culture supernatants, agarose-bound wheat germ agglutinin (WGA) was chosen for 
lectin-mediated protein enrichment. Wheat germ agglutinin contains a variety of closely 
related isolectins that specifically bind to N-acetyl-D-glucosamine and to sialic acid.  
 
Fig. 5.5:  Reduced sample complexity of supernatant samples, derived by WGA-mediated precipitation. 
Proteins were either enriched by centrifugal filter units (A) or by WGA-mediated precipitation (B). Proteins 
were separated on 24 cm 3-11NL IPG strip, followed by SDS-PAGE. Proteins were stained with FlamingoTM 
fluorescent gel stain. 
As the majority of cell-surface and secreted proteins of mammalian cells are highly 
glycosylated by sialic acid or terminal N-acetyl-D-glucosamine [e.g. reviewed by Gahmberg 
and Tolvanen, 1996], WGA was chosen for purification of cell culture supernatant proteins. 
An initial experiment using cell culture supernatants of TPA-treated wild-type (MEF 1#3) and 
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ADAM17ex/ex (MEF 1#1) MEF cells led to a decrease of sample complexity in comparison to 
samples enriched by centrifugal size exclusion and indicated a reduced number of 
detectable protein spots (Fig. 5.5). More importantly, WGA-mediated protein precipitation 
also led to an increased enrichment of surface or secreted proteins. 
Notably, two-dimensional separation of WGA-enriched supernatant proteins in many cases 
led to reduced protein resolution of high molecular proteins at lower isoelectric points. This 
could be circumvented by deglycosylation of the enriched proteins, unfortunately 
accompanied by decreased protein information following mass spectrometry. 
5.3 Changes in MEF cell supernatants 
Overall, seven 2D-DiGE analyses of wild-type (MEF 1#3) and ADAM17ex/ex (MEF 1#1) MEF cell 
supernatant proteins were performed. These analyses revealed that several protein 
fragments and full-length proteins differed in their abundance upon reduced ADAM17 
activity.  
5.3.1 Altered levels of protein fragments in MEF 1#1 cell supernatants 
Overall, fourteen protein fragments were identified that showed reduced or increased 
protein levels in 2D-DiGE analyses of MEF cell supernatants (Tab. 5.1).  
The 30 kDa fragments of the type-I  collagen  α1 (CO1A1) and α2 chains (CO1A2) and a 25 kDa 
fragment of perlecan (PGBM) were identified in several independent experiments. Further 
results on these proteins will be presented separately (sections 5.3.1.1 and 5.3.1.2).  
In addition, decreased protein levels were seen for the C-terminal propeptide of the type-III 
collagen  chain  α1 (CO3A1)   in  supernatants  of  TNFα-overexpressing ADAM17ex/ex MEF cells. 
As observed for the type-I collagen propeptides, MALDI-ToF/ToF-derived sequence coverage 
revealed three peptides with high confidency that were located within the C-terminal 
propeptide of CO3A1. 
The 151 kDa proteoglycan lubricin (PRG4) was identified from a protein spot with a 
molecular weight of 11 kDa and an isoelectric point of 9. Elevated lubricin fragment levels 
were found in supernatants of untransfected and   TNFα-overexpressing ADAM17ex/ex MEF 
cells. This protein fragment was identified in three independent analyses and showed 
increased protein levels (1.5-fold to 1.9-fold) in   TNFα-overexpressing MEF cells. In 
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supernatants of untransfected ADAM17ex/ex MEF cells, the fragment was increased by 3.85-
fold. Here, the protein was identified with four peptides, located between aa956 and 
aa1033, which represents the “proteoglycan-4 C-terminal part” 
(http://uniprot.org/uniprot/Q9JM99). 
Tab. 5.1: Differentially regulated proteins identified by 2D-DiGE analyses of MEF cell culture supernatant 
proteins, enriched by centrifugal filter units (CFU) and WGA-mediated precipitation (WGA). Protein fold-
change values are baseed on DeCyder 2D software calculations. Results from seven independent experiments 
are summarized. Underlined fold-change values indicate spots that were not identified by MS analyses in a 
given experiment, but showed the same in-gel localization as identified spots from other experiments. 
Theoretical protein data (pILit and MWLit) are listed according to the ExPASy pI/MW tool web service 
(http://web.expasy.org/compute_pi/). Observed protein data (pIObs and MWObs) were estimated by 
approximation. Information about subcellular distribution was searched from http://uniprot.org and according 
to the corresponding accession number. Subcellular distribution is indicated as follows: secreted (S), 
extracellular matrix (EM), basal membrane (BM), plasma membrane (M). Please note: samples separated in 
DiGE150 were proteins from TNFα-overexpressing MEF cells. 
 
The differential analyses of culture supernatants also revealed several proteases and 
protease interacting proteins to be altered in ADAM17ex/ex MEF cell supernatants (see 
section 5.4). Reduced protein levels of the extracellular serine protease C1 subcomponents 
C1r-A and C1s-A were observed in WGA-enriched ADAM17ex/ex MEF cell supernatants. Thee 
fragments showed a  2.7- and 3.3-fold lower abundance in ADAM17ex/ex MEF cells. All 
peptides detected by MALDI-ToF/ToF are located between aa463 and aa767 (C1r-A; 
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http://www.uniprot.org/uniprot/Q8CG16) and aa438 and aa636 (C1s-A; 
http://www.uniprot.org/uniprot/Q8CG14), representing the light chains of these proteins. 
Moreover, in supernatants  of  TNFα-overexpressing ADAM17ex/ex MEF cells lower amounts of 
a 15 kDa form of the cystein protease cystatin-C were detected. In contrast, the 20 kDa form 
was slightly elevated (compare Tab. 5.2). Finally, the 50 kDa procollagen C-endopeptidase 
enhancer (PCOC-1) was identified in one single experiment as a 30 kDa fragment. MALDI-
ToF/ToF-derived sequence coverage was located within the 35 kDa CUB1-CUB2-region 
(http://uniprot.org/uniprot/Q61398).  
Only a few proteins that were identified as protein fragments contain transmembrane 
domains that seem to be a crucial characteristic of ADAM substrates [White, 2003]. This 
includes TNFα that was only identified from TNFα-overexpressing MEF cells. The 99 kDa 
cadherin-2 is a known substrate of the metalloprotease ADAM10 [Reiss et al., 2005] and was 
decreased in a 15 to 20 kDa fragment with peptides at aa69 to aa91 and aa68 to aa91. 
According to the available protein domain information for cadherin-2 
(http://uniprot.org/uniprot/P15116), these peptides are located within the N-terminal 
propeptide. In addition, several supernatant analyses revealed an increased release of the 
interleukin-1 receptor-like protein 1 (IL1RL1). This 65 kDa transmembrane protein was 
identified in several indpendent experiments as a 40 kDa fragment. Finally, the 120 kDa 
transmembrane neural cellular adhesion molecule 1 (NCAM-1) was already mentioned as a 
known ADAM17 substrate. The 2D-DiGE analysis of deglycosylated supernatant proteins, 
enriched by WGA-mediated precipitation revealed a 100 kDa fragment to be reduced by 
1.69-fold in ADAM17ex/ex MEF cell supernatants. 
5.3.1.1 Reduced levels of the type-I collagen C-terminal propeptides 
As already mentioned, fragments of the type-I collagen  α1 and  α2 chains were reproducibly 
reduced in ADAM17ex/ex MEF cell supernatants. Figure 5.6 A depicts the C-terminal 
propeptide spots in a 2D-DiGE image of WGA-enriched cell culture supernatant proteins 
(DIGE169). The protein spots with a molecular weight of approximately 30 kDa were 
identified as the 138 kDa collagen alpha-1 (I) chain (Fig. 5.6 A, red arrow) and the 130 kDa 
collagen alpha-2 (I) chain (Fig. 5.6 A, white arrow), respectively. Calculation of the changes in 
protein levels revealed a decrease by approximately 2.5-fold (Fig. 5.6 B), but these values 
varied between different 2D-DiGE analyses (compare Tab. 5.1). Interestingly, the impaired 
release of these protein   fragments   from   TNFα-overexpressing ADAM17ex/ex MEF cells was 
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even more prominent, showing a decrease by approximately 6-fold (compare Tab. 5.1, 
DIGE150).  
 
Fig. 5.6:  Reduceded release of the type-I collagen C-terminal propeptides from ADAM17ex/ex MEF cells. 
(A) Pseudo-colored 2D-DiGE image of MEF cell culture supernatant proteins enriched from wild-type (Cy3, 
green) and ADAM17ex/ex MEF cells (Cy5, red) by WGA-mediated precipitation. Proteins were separated on a 
24 cm 3-11NL IPG strip, followed by SDS-PAGE. The image was recorded using a TyphoonTRIO device and 
processed with ImageQuant TL software. Protein spots, identified as the type-I collagen chains α1 (red arrow) 
and α2 (white arrow) C-terminal propeptides are indicated in the enlarged section below. (B) Fluorescence 
intensities of the observed protein spots in wild-type (left panel) and ADAM17ex/ex MEF cells (right panel), as 
calculated by DeCyder 2D software (Version 7.2). (C) Schematic overview on localization of the MALDI-
ToF/ToF-identified peptide sequences within the full-length type-I collagen α1 and α2 chain sequence. Numbers 
indicate starting and ending amino acid (compare http://uniprot.org/uniprot/P11087 and 
http://uniprot.org/uniprot/Q01149). Peptide sequences are presented by the one letter code. 
(D) Immunodetection of type-I collagen α1 chain fragments in whole-cell lysates (WCL) and supernatant 
samples, enriched by centrifugal filter units (CFU) and WGA-mediated precipitation (WGA).  
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The MALDI-ToF/ToF-derived sequence coverage clearly demonstrated that the indicated 
collagen molecules represent the C-terminal propeptide regions (Fig. 5.6 C).  
Immunodetection of the C-terminal propeptide in samples enriched by centrifugal filter 
units yielded a very intense signal at low exposure times (Fig. 5.6 D, center panel). However, 
this was not seen in WGA-precipitated samples (Fig. 5.6 D, right panel). 
In summary, the Western blot analyses confirmed the reduced levels of the C-terminal 
propeptide of the collagen alpha-1 (I) chain in ADAM17ex/ex MEF cell culture supernatants. In 
contrast, a high molecular form of the type-I collagen (>250 kDa) was increased in 
ADAM17ex/ex MEF cell whole-cell lysates (Fig. 5.6 D, left panel). Interestingly, 
immunodetection of type-I collagen via the C-terminal propeptide also revealed a variety of 
collagen fragments which were increased in wild-type MEF cell supernatants. 
5.3.1.2 Reduced levels of the LG3 peptide of perlecan in ADAM17ex/ex 
supernatants 
Another protein fragment with a molecular weight of approximately 25 kDa and an 
isoelectric point of 5 was identified as the 405 kDa basement heparane sulfate proteoglycan 
core protein (perlecan, Fig. 5.7 A, white arrow). Protein levels of this protein fragment 
appeared to be reduced in cell culture supernatants of ADAM17ex/ex MEF cells by 2.89-fold 
(Fig. 5.7 B).  This protein was identified by MALDI-ToF/ToF with two highly confident peptide 
sequences (aa3514 to aa3707 of the full-length perlecan molecule), which indicates the LG3 
peptide (compare http://uniprot.org/uniprot/Q05793). Unfortunately, Western blot analysis 
targeting the perlecan C-terminal region of MEF cell-derived protein samples did not deliver 
any additional information. Thus, the protein samples were further fractionated using 
centrifugal filter units (100 kDa MWCO) into a <100 kDa and a >100 kDa fraction and 
subjected to SlotBlot analysis (Fig. 5.7 C). As depicted, the SlotBlot analysis confirmed the 
reduced perlecan levels within the <100 kDa fraction of ADAM17ex/ex MEF cell-derived 
supernatants (Fig. 5.7 C, SN, <100kDa). In contrast, whole-cell lysates showed increased 
perlecan levels within the >100 kDa fraction derived from ADAM17ex/ex MEF cell lysates 
(Fig. 5.7 C, WCL, >100kDa). Interestingly, small amounts of a shorter perlecan fragment were 
also observed in whole-cell lysates of MEF 1#1. 
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Fig. 5.7:  Reduced generation of the perlecan LG3 peptide in ADAM17ex/ex MEF cells. (A) Pseudo-colored 
2D-DiGE image section of wild-type (Cy3, green) and ADAM17ex/ex (Cy5; red) MEF cell-derived cell culture 
supernatant proteins, enriched by centrifugal filter units. Proteins were separated on a 24 cm 3-11NL IPG strip, 
followed by SDS-PAGE. The image was recorded using the TyphoonTRIO laser scanner and processed by the 
ImageQuant TL software. The protein spot identified as the perlcan LG3 peptide is indicated (white arrow). 
(B) Fluorescence intensities of the observed protein spot in wild-type (left panel) and ADAM17ex/ex MEF cells, as 
calculated by DeCyder 2D software (Version 7.2). (C) Immunodetection of the C-terminal region of perlecan by 
SlotBlot analysis of fractionized (<100 kDa and >100 kDa) cell culture supernatants (SN) and whole-cell lysates. 
(D) Equal protein amount loading was monitored by Ponceau S staining. 
5.3.2 Altered protein secretion from ADAM17ex/ex MEF cells 
The analyses of MEF cell-derived cell culture supernatants not only revealed a variety of 
differentially abundant protein fragments, but also changes in the representation of several 
full-length proteins. Out of approximately 400 different identified proteins, around 70 
proteins were supposed to be secreted into the cell culture supenatant. Fold-change values 
of differentially regulated secreted proteins, derived from seven independent 2D-DiGE 
analyses are summarized in table 5.2. Of note, the proteins included in the table only 
represent a selection from all identified proteins. 
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Tab. 5.2: Differentially regulated proteins within MEF cell culture supernatants, enriched by centrifugal 
filter units (CFU) or WGA-mediated precipitation (WGA). Fold-change values based on DeCyder 2D software 
(Version 7.2) calculations as given. Results from seven independent approaches are summarized. Underlined 
fold-change values indicate spots that were not identified by MS analyses in the given experiment, but were 
annotated according to the localization in other experiments. Information about the subcellular distribution 
were taken from http://uniprot.org based on the corresponding accession number and are indicated as 
follows: secreted (S), extracellular matrix (ECM), basal membrane (BM), plasma membrane (M). Please note: 
samples separated in DiGE150 were proteins from TNFα-overexpressing MEF cells. 
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Although a large number of differentially abbundant proteins were identified from analyses 
of MEF cell culture supernatants, individual analyses did not deliver consistent data sets. 
Some proteins were only identified from samples enriched by centrifugal filter units (e.g. 
cystatin-C) or WGA-mediated precipitation (e.g. ECM-1), respectively. Although, several 
secreted proteins showed altered protein levels in ADAM17ex/ex MEF cell culture 
supernatants, there was no common direction of the alterations. Whereas some proteins 
(e.g. ECM-1 and Fstl-1) were increased within ADAM17ex/ex MEF cell supernatants, others 
were decreased (e.g. Olfl-1). Notably, the rather prominent group of ECM proteins, mainly 
represented by various types of collagens, showed reduced protein levels in ADAM17ex/ex 
MEF cell supernatants.  
In summary, the analyses of cell culture supernatants by 2D-DiGE pointed to a variety of 
changes in protein secretion, but also delivered incomplete data sets. 
5.3.2.1 Reduced levels of full-length type-I collagen molecules in ADAM17ex/ex 
supernatants 
Reduced levels of the type-I collagen C-terminal propeptides in ADAM17ex/ex MEF cell 
supernatants were highlighted in section 5.3.1.1. However, the analyses of MEF cell culture 
supernatants also revealed changed protein levels for various full-length collagen chains, 
which were mostly reduced within ADAM17ex/ex MEF cell supernatants. As summarized in 
table 5.2, this not only includes type-I collagen molecules, but also type-IV, type-V and type-
VI collagen chains. Unfortunately, antibodies for verification of these findings were not 
available (except for the already mentioned type-I  collagen  α1 chain antibody). Reduced full-
length type-I collagen protein spots were observed at two different molecular masses of 
about 150 and 120 kDa (compare Fig. 5.8 A and the corresponding fold-change values in 
Tab. 5.2). 
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Fig. 5.8:  Reduced levels of type-I collagen α1 protein bands in ADAM17
ex/ex MEF cell supernatants. Cell 
culture supernatant proteins, enriched by WGA-mediated precipitation were separated by SDS-PAGE (12.5 %) 
and transferred onto a nitrocellulose membrane. Type-I collagen α1 chain was targeted via its C-terminal pro-
peptide (CO1A1 CPP) and its C-terminal telo-peptide (CO1A1 C-telo) by antibodies LF-41 and LF-68, 
respectively.  
At least for the type-I   collagen   α1 chain, these findings were confirmed by Western blot 
analyses via the C-terminal propeptide (Fig. 5.8 B; left panel) and the C-terminal telo-peptide 
(Fig. 5.8 B, right panel). In addition to the 30 kDa CO1A1 C-terminal propeptide (Fig. 5.8, 
CO1A1 CPP, purple arrow) also a high molecular weight form of type-I collagen of 
approximately 250 kDa was decreased in ADAM17ex/ex MEF cell supernatants (Fig. 5.8, 
CO1A1 CPP, red arrow). Moreover, type-I  collagen  α1 chain molecules, targeted via their C-
terminal telo-peptide (Fig. 5.8 B, CO1A1 C-telo), revealed decreased levels of two protein 
bands with molecular weights of approximately 200 kDa (Fig. 5.8 B, black arrow) and of 
130 kDa (Fig. 5.8 B; blue arrow). The cell culture supernatant of wild-type MEF cells 
contained a variety of further protein fragments that were specifically detected by the used 
antibodies. 
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5.4 ADAM17 – A modulator of the protease web? 
Tab. 5.3: Differentially regulated proteases, protease inhibitors and protease enhancers identified by 2D-
DiGE analyses from MEF cell culture supernatant proteins, enriched by centrifugal filter units (CFU) or WGA-
mediated precipitation (WGA). Protein fold-change values base on DeCyder 2D software (Version 7.2) 
calculations. Results from seven independent experiments are summarized. Information upon subcellular 
distribution was taken from http://uniprot.org and the corresponding accession number and are indicated as 
follows: secreted (S), extracellular matrix (ECM), basal membrane (BM), plasma membrane (M). Please note: 
samples separated in DiGE150 were proteins from TNFα-overexpressing MEF cells. 
 
A third group of differentially abundant proteins, identified from MEF cell culture 
supernatants is represented by proteases and protease interacting proteins. As summarized 
in table 5.3, these protease-associated proteins included matrix metalloproteases (MMPs), 
tissue inhibitors of metalloproteases (TIMPs), serpin family proteins (e.g. serpin H1, glia-
derived nexin 1) and cystein protease inhibitors (cystatins). 
5.4.1 Reduced BMP-1 protein levels in ADAM17ex/ex MEF cell supernatants 
Within two analyses of supernatant proteins, enriched by WGA-mediated precipitation, the 
procollagen C-proteinase BMP-1 showed reduced protein levels in ADAM17ex/ex MEF cell 
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supernatants. Western blot analysis of wild-type and ADAM17ex/ex MEF cell-derived 
supernatant proteins confirmed these findings (Fig. 5.9, left panel). In contrast, 
immunodetection of BMP-1 within MEF cell-derived whole-cell lyates showed increased 
protein levels within the wild-type MEF cell samples (Fig. 5.9, right panel). Of note, another 
pro-collagenase, Meprin β,  was  not  detectable in MEF cell samples by various anti-mMeprin-
β  antibodies.  
 
Fig. 5.9:  Altered protein levels of the procollagen C-proteinase BMP-1. Whole-cell lysates (WCL) and 
WGA-precipitated supernatant proteins (WGA) were separated by SDS-PAGE, using a 4-12% pre-cast gradient 
gel. Separated proteins were transferred onto a nitrocellulose membrane and stained for BMP-1. 
5.4.2 ADAM17 – A putative modulator of MEF cell MMP activity? 
The matrix metalloproteases MMP-2 and MMP-3 showed elevated protein levels in 
ADAM17ex/ex MEF cell supernatants (Tab. 5.3, MMP2 and MMP3). Unfortunately, suitable 
antibodies were not available for further analyses. Thus, putative changes in MMP activity 
were assayed by gelatin and casein zymography using cell culture supernatant proteins 
enriched by centrifugal filter units without protease inhibitor treatment.  
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5.4.2.1 Impaired gelatinolytic activity of ADAM17ex/ex MEF cell supernatants 
 
Fig. 5.10: Impaired gelatinolytic activity of ADAM17ex/ex MEF cell culture supernatants. (A) Pseudo-colored 
image section of MEF cell culture supernatants proteins, separated by 2D-DiGE. Proteins from MEF cells were 
enriched by WGA- precipitation and differentially labeled by Cy3 (MEF 1#3, green) and Cy5 (MEF 1#1, red). 
Proteins were separated on a 24 cm 3-11NL IPG strip, followed by SDS-PAGE. (B) Fluorescence intensities of 
MMP-2 protein levels in wild-type and ADAM17ex/ex MEF cells. (C) MALDI-ToF/ToF-derived sequence coverage 
of the full-length proMMP-2 sequence consisting of the signal peptide (black), a propeptide (light blue) and the 
MMP-2 region (red). Underlined regions indicate peptides identified by MALDI-ToF/ToF. (D) Gelatinolytic 
activity at approximately 92 kDa (black arrow) and 63 kDa (blue arrow) within wild-type and ADAM17ex/ex MEF 
cell culture supernatants. Proteins were separated on a 12.5 % polyacrylamide gel, containing 2 mg/ml gelatin. 
Cleared protein bands represent gelatin degradation after 20 h of incubation. 
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As indicated in figure 5.10, high confident peptides, identified by MALDI-ToF/ToF analysis 
were also located within the MMP-2 propeptide (Fig. 5.10 C). However, the gelatin 
zymogram of wild-type MEF cell culture supernatants revealed two distinct and clear protein 
bands at approximately 92 kDa (Fig. 5.10 D, black arrow) and at approximately 63 kDa 
(Fig. 5.10 D, blue arrow). In both cases, gelatinolytic activity was reduced in ADAM17ex/ex 
MEF cell culture supernatants. 
5.4.2.2 Impaired caseinolytic activity within ADAM17ex/ex MEF cell supernatants 
In addition to MMP-2, one 2D-DiGE analysis also revealed increased protein levels of matrix 
metalloprotease 3 (MMP-3) in supernatants of  TNFα-overexpressing ADAM17ex/ex MEF cells. 
As indicated in figure 5.11 A, the observed protein spot was elevated by approximately 3.8-
fold (Fig. 5.11 B). Moreover, the localization of MMP-3 above the 50 kDa marker implicated 
that this protein spot represents the immature proMMP-3 form. This was supported by the 
MALDI-ToF/ToF derived sequence coverage, as some peptides within the MMP-3 pro-
domain were identified (Fig. 5.11 C). Although less sensitive, casein zymography is more 
suitable for the detection of MMP-3 activity, compared to gelatin zymography.  
As shown in figure 5.11, the casein zymogram of wild-type MEF cell culture supernatants 
revealed two distinct and clear protein bands below (Fig. 5.11 D, blue arrow) and above the 
50 kDa marker (Fig. 5.11 D, black arrow). Wheras the <50 kDa form is increased in wild-type 
samples, the >50 kDa signal appeared to be slightly increased within ADAM17ex/ex MEF cell 
supernatants.  
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Fig. 5.11: Impaired MMP-3 caseinolytic activity of ADAM17ex/ex MEF cell supernatants. (A) Pseudo-colored 
image section of MEF cell culture supernatants proteins, separated by 2D-DiGE. Proteins from TNFα-
overexpressing MEF cells were enriched by centrifugal filter units and differentially labeled by Cy5 (MEF 1#3) 
and Cy3 (MEF 1#1). Proteins were separated on a 24 cm 3-11NL IPG strip, followed by SDS-PAGE. (B) 
Fluorescence intensities of MMP-3 protein levels in wild-type and ADAM17ex/ex MEF cells. (C) MALDI-ToF/ToF-
derived sequence coverage of the full-length proMMP-3 sequence consisting of the signal peptide (black), a 
propeptide (light blue) and the MMP-3 region (red). Underlined regions indicate peptides identified by MALDI-
ToF/ToF. (D) Caseinolytic activity above (black arrow) and below the 50 kDa marker (blue arrow) within wild-
type and ADAM17ex/ex MEF cell culture supernatants. Proteins were separated on a 12.5 % polyacrylamide gel, 
containing 2 mg/ml casein. Cleared protein bands represent casein degradation after 20 h of incubation. 
5.4.3 ADAM17 affects protease interacting proteins 
As mentioned before, analyzed cell culture supernatants not only showed altered protein 
levels for different protease, but also for protease interacting proteins, including protease 
inhibitors and protease enhancer molecules. 
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5.4.3.1 Reduced TIMP-1 and TIMP-2 levels within ADAM17ex/ex MEF cells 
Tissue inhibitors of metalloproteases (TIMP) proteins are physiological inhibitors of matrix 
metalloproteases and other metalloproteases via their characteristic netrin-like (NTR) 
domain [Williamson et al., 2008]. Analyses of supernatants from TNFα-overexpressing 
ADAM17ex/ex MEF cells showed reduced levels of TIMP-1 (Fig. 5.12 A, white arrow and B, 
upper panel) and TIMP-2 (Fig. 5.12 A, red arrow and B, lower panel).  
 
Fig. 5.12: Reduced cellular and extracellular TIMP-1 and TIMP-2 protein levels in ADAM17ex/ex MEF cells. 
(A) Pseudo-colored 2D-DiGE image section of separated TNFα-overexpressing MEF cell culture supernatant 
proteins, enriched by centrifugal filter units. Samples were differentially labeled by Cy3 (ADAM17ex/ex, green) 
and Cy5 (wild-type, red) and separated on a 24 cm 3-11NL IPG strip, followed by SDS-PAGE. (B) Fluorescence 
intensities of TIMP-1 (upper panel) and TIMP-2 (lower panel) in the supernatant of wild-type (left panel) and 
ADAM17ex/ex MEF cells (right panel). (C) SlotBlot analyses of TIMP-1, TIMP-2 and TIMP-3 in whole-cell lysates 
(WCL) and concentrated cell culture supernatants (SN). Equal protein amount loading was monitored by 
Ponceau S staining.  
Unfortunately, the available antibodies yielded poor results in case of Western blot analyses. 
Thus, supernatants and whole-cell lysates were subjected to immunodetection of TIMP-1, 
TIMP-2, and TIMP-3 by SlotBlot analyses. As shown, SlotBlot analyses confirmed the 
observed reduction of TIMP-1 (Fig. 5.12 C; SN) and TIMP-2 (Fig. 5.12 D; SN) in ADAM17ex/ex 
MEF cell supernatants. Moreover, ADAM17ex/ex MEF whole-cell lysates also showed reduced 
TIMP-1 (Fig. 5.12 C; WCL), and TIMP-2 (Fig. 5.12 D; WCL) protein levels. In contrast, TIMP-3 
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protein levels were comparable in wild-type and ADAM17ex/ex MEF cell supernatants and 
lysates. 
5.5 ADAM17-mediated changes of intracellular proteins 
During the analyses of cell culture supernatant proteins not only secreted and cell-surface 
proteins were identified, but also a variety of intracellular proteins. Also, the described 
alterations concerning type-I collagen levels indicated that other proteins might be affected 
by the absence of ADAM17. To address this, whole-cell lysates were analyzed for putative 
changes in relation to the ADAM17ex/ex phenotype. Whole-cell lysates were generated in five 
independent biological replicate approaches and separated in two 2D-DiGE experiments. 
Notably, the five biological replicates resulted in five very similar gels with similar overall 
resolutions and detectable protein changes. Fold-change values for selected differentially 
abundant proteins are summarized in table 5.4.  
Tab. 5.4: Differentially regulated proteins from MEF cell-derived whole-cell lysates. Protein fold-change 
values are depicted for several identified proteins, as calculated by the DeCyder 2D software after separation 
of differentially labeled whole-cell lysates proteins by 2D-DiGE. Each column represents values from one out of 
five independentl 2D-DiGE analyses. Fold-change values are indicated and highlighted by different colors. 
Underlined fold-change value indicate that this spot was observed but not identified by MALDI-ToF/ToF 
analyses from the corresponding sample, but showed the same localization as protein spots identified within 
other analyses. Information on subcellular distributions (Sub. Loc.) were taken from http://uniprot.org and the 
corresponding accession number (Acc. No.) and are indicated as follows: extracellular matrix (ECM), secreted 
(S), mitochondrium (Mi), nucleus (N), lysosome (L), plasma membrane (PM), basal membrane (BM), 
endoplasmic reticulum (ER), cytoskeleton (CS). 
Protein ID 
DIGE158 DIGE160 Acc. No. Sub. 
Loc. E1 E2 E3 E4 E5 
Argininosuccinate synthase 2,98 5,97 1,7  2,78 P16460 MI 
Collagen alpha-1 (I) chain 4,68 2,66 2,45 2,64 3,9 P11087 S/ECM 
Latexin 2,87 2,78 3,59   P70202 C 
SPARC 1,21 2,43 3,93   P07214 S, ECM 
T-complex protein subunit zeta 2,28 2,54 2,5 2,09 3,1 P80317 C 
Cartillage-associated protein 2,38 2,33 2,46   Q9CYD3 S/ECM 
Gelsolin 2,53 2,38 2,58 2,23 2,07 P13020 C; S 
Prolyl 4-hydroxylase subunit alpha-1 1,98 1,76 2,64 2,2 2,06 Q60715 ER 
Galectin-3 1,65 2,13 2,22   P16110 C; N; S 
Prelamin-A/C 1,76 1,89 1,68 1,95 2,15 P48678 N 
Vimentin 1,88  1,82 1,88 1,94 P20152 C 
Biglycan 2,28 1,47 1,64   P28653 S/ECM 
Annexin A3 1,87 1,83 1,8 1,63 1,85 O35639 M 
Vinculin 1,65 1,93 1,95  1,54 Q64727 C; M 
Serpin H1 1,66 1,66 1,68 2,09 1,74 P19324 ER 
Septin-7 1,94 1,66 1,61  1,73 O55131 C 
Protein disulfide isomerase A3 1,91 1,77   1,52 P27773 ER 
Ezrin 1,84 1,66 1,65 1,59 1,81 P26040 C;CS;PM 
PLOD-3 1,39 1,85 1,88 1,46 1,88 Q9R0E1 ER 
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Moesin  1,7 1,67 1,91 1,48 P26041 M 
Septin-11 1,66 1,66 1,64   Q8C1B7 C 
Protein disulfide isomerase 1,65 1,77 1,73 1,55 1,53 P09103 ER; M 
Follistatin-related protein 1  1,57 1,7   Q62356 S, ECM 
Destrin 1,81 1,13 1,77 1,58  Q9R0P5 C/CS 
Ras suppressor protein 1 1,78 1,45 1,71 1,38 1,15 Q01730  
Annexin A5 1,47 1,48 1,78 1,23  P48036 S, ECM 
Annexin A1 1,39 1,48 1,37 1,54 1,61 P10107 N;C;BM 
Mitogen-activated kinase 1 1,36 1,36 1,52 1,48 1,58 P63085 C/CS; N 
Annexin A2 1,48 1,34 1,63 1,58 1,26 P07356 S/BM 
PLOD-1 1,39 1,19 1,7   Q9R0E2 ER 
Calpain small subunit 1,41 1,3 1,42  1,38 O88456 C; M 
Peptidyl-prolyl cis-trans isomerase A 1,29 1,15 1,34 1,46 1,25 P17742 C; S 
SERPIN B6    1,24 1,32 Q60854 C 
Peroxiredoxin-1 1,18 1,26 1,26 1,26 1,32 P35700 C 
LIM and SH3 domains protein 1 1,36 1,1 1,4 1,14 1,18 Q61792 C/CS 
Cofilin-1 1,09 1,08 1,01 1,04 1,11 P18760 N;C;pM 
Peroxiredoxin-2 -1,36 -1,68 -1,51 -1,37 -1,44 Q61171 C 
Peroxiredoxin-6 -1,63 -1,52 -1,51 -1,45 -1,34 O08709 C; L 
Annexin A1 -1,36 -1,41 -1,51 -1,52 -1,7 P10107 N;C; BM 
ER resident protein 29 -1,61 -1,6 -1,26 0 -1,61 P57759 ER 
Stress-induced phosphoprotein 1  -1,73 -1,21 -1,63 -1,64 Q60864 C; N 
HNRP A2/B1 -1,31 -2,06 -1,38 -1,46 -1,61 P49312 N; C 
Lon protease homolog, mitochondrial  -1,69 -1,5 -1,65 -1,65 Q8CGK3 MI 
Cystatin B -3,6 -1,27 -1,32 -1,51 -1,41 Q62426 C 
Elongaftion factor 2 -1,88 -1,95  -1,95 -1,64 P58252 C 
Inorganic pyrophosphatase -1,89 -2,23 -1,79  -1,59 Q9D819 C 
T-complex  protein  ξ -2,25 -1,91 -2,09 -1,62 -1,53 P80317 C 
Destrin -1,36 -1,72 -1,31 -2,67 -3,47 Q9R0P5 C/CS 
GST omega-1 -3,22  -3,08 -2,66 -2,8 O09131 C 
pCofilin-1 -3,6 -3,87 -3,07 -4,34 -4,79 P18760 N;C; pM 
As expected, most identified proteins were annotated to be located intracellularily, e.g. 
cofilin-1 and mitogen activated kinase. However, several proteins are normally secreted or 
comprise the extracellular matrix. For example, type-I collagen was observed with increased 
protein levels in ADAM17ex/ex whole-cell lysates, in contrast to its decreased protein levels in 
ADAM17ex/ex MEF cell supernatants. Thus, to some extent, the whole-cell lysate analysis 
might be complementary to the described supernatant analysis. 
5.5.1 Increased cellular type-I collagen levels 
In contrast to reduced full-length type-I   collagen   α1 and   α2 chain protein levels in 
ADAM17ex/ex MEF cell supernatants, ADAM17ex/ex MEF cell whole-cell lysates revealed 
increased levels of both type-I collagens with molecular weights of 200 and 130 kDa 
(Fig. 5.13 A). When MEF cell-derived whole-cell lysates were subjected to Western blot 
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analysis, detection of the type-I   collagen  α1 chain via its C-terminal propeptide confirmed 
increased protein levels of a 250 kDa form of type-I collagen within ADAM17ex/ex MEF cell 
lysates (Fig. 5.13 B, CO1A1_CPP; red arrow). In addition, immunodetection of the type-I 
collagen   α1 chain via its C-terminal telo-peptide (Fig. 5.13 B, CO1A1_C-telo) also showed 
increased protein levels of the 250 kDa collagen (Fig. 5.13 B, CO1A1_C-telo, red arrow). In 
contrast, increased levels of a 200 kDa and 130 kDa fragment were seen in wild-type whole-
cell lysates (Fig. 5.13 B, CO1A1_C-telo, black and blue arrow). 
 
Fig. 5.13: Reduced type-I collagen α1 chain fragment levels in ADAM17
ex/ex MEF cell whole-cell lysates. 
(A) Pseudo-colored 2D-DiGE image of differentially labeled wild-type (Cy5, red) and ADAM17ex/ex MEF cell (Cy3, 
green) whole-cell. Proteins were separated on a 24 cm 3-11NL IPG strip followed by SDS-PAGE. Identified type-I 
collagen α1 chain molecules is indicated (white arrow). (B) Immunodetection of the type-I collagen α1 chain in 
wild-type (1#3) and ADAM17ex/ex MEF cell whole-cell lysates via the C-terminal propeptide (CO1A1_CPP) and 
the C-terminal telo-peptide, respectively. Specific collagen signals at 250 kDa (red arrow), 200 kDa (black 
arrow) and 130 kDa (blue arrow) are indicated. 
5.5.2 ADAM17 affects members of the Cofilin/ADF-family 
5.5.2.1 Altered Cofilin-1 phosphorylation in ADAM17ex/ex MEF cells 
Among the various intracellular proteins, the 2D-DiGE analyses of whole-cell lysates of 
revealed two different protein spots that were identified as cofilin-1. Both cofilin-1 protein 
spots were located at a molecular of approximately 20 kDa, and were segregated during 
isoelectric focusing (compare Fig. 5.13 A). In addition, the spots were inversely regulated 
(Fig. 5.14 B). Whereas the cofilin-1 protein spot with at pI8 (Fig. 5.14 A, white arrow) showed 
equal or slightly increased protein levels in wild-type and ADAM17ex/ex MEF cells (Fig. 5.14 A, 
white arrow), the cofilin-1 spot pI6.5 (Fig. 5.14 A, red arrow) was clearly reduced in 
Chapter 5: Results 81 
ADAM17ex/ex cells. Two-dimensional Western blot analysis using a pan-cofilin-1 antibody 
confirmed both spots to be cofilin-1 (Fig. 5.14 C and D). The analysis also confirmed the 
reduced cofilin-1 levels at pI6.5.  
 
Fig. 5.14: Reduced cofilin-1 phosphorylation in ADAM17ex/ex MEF cells. (A) Pseudo-colored 2D-DiGE image 
of differentially labeled wild-type (Cy5, red) and ADAM17ex/ex MEF cell (Cy3, green) whole-cell lysate proteins. 
Proteins were separated on a 24 cm 3-11NL IPG strip followed by SDS-PAGE. The white dashed box indicates 
the cofilin-1 region and is enlarged in the lower panel. Protein spots, identified as phospho-cofilin-1 (red arrow) 
and non-phosphorylated cofilin-1 (white arrow) are indicated. Light blue and gray arrows indicate destrin 
protein spots (refer to section 5.5.2.2). (B) Fluorescence intensities of the phospho-cofilin-1 (upper panel) and 
the non-phosphorylated cofilin-1 spot (lower panel) in wild-type (MEF 1#3, left panel) and ADAM17ex/ex MEF 
cells (MEF 1#1, right panel) were calculated using the DeCyder 2D software. Cofilin-1 protein identity was 
confirmed by immunodetection of two-dimensionally separated (C) wild-type and (D) ADAM17ex/ex MEF cell 
lysates by a general anti-cofilin-1 antibody. Cofilin-1 spots at pI6.5 (black arrow) and pI8 (white arrow) are 
indicated. (E) Immunodetection of MEF cell lysates, separated by a 12.5 % SDS-PAGE and subsequent transfer 
onto a nitrocellulose membrane via a general anti-cofilin-1 antibody (right panel) and a anti-phospho-cofilin-1 
specific antibody (left panel). 
In addition, detection of cofilin-1 via a Ser3 phospho-specific antibody (Fig. 5.14 E, left panel) 
confirmed reduced phospho-cofilin-1 protein levels in ADAM17ex/ex MEF cells. In contrast, 
immunodetection of cofilin-1 by the general antibody showed no differences between wild-
type and ADAM17ex/ex MEF cells. 
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5.5.2.2 Inverse regulation of two different destrin protein spots 
In proximity to the observed cofilin-1 protein spots, two protein spots were identified as 
destrin, another member of the cofilin/ADF protein family. As observed for cofilin-1, the 
destrin spot at pI8 (Fig. 5.14 A, light blue arrow) appeared to be slightly increased or not 
altered, whereas the destrin spot at pI6.5 was lower upon reduction of ADAM17 activity 
(Fig. 5.14 A, grey arrow). 
5.5.3  Increased Annexin levels in ADAM17ex/ex MEF cells 
The annexin family of Ca2+-dependent membrane/phospholipid binding proteins was 
represented by four different members: Anxa1, Anxa2, Anxa3 and Anxa5.  
 
Fig. 5.15: Increased cellular protein levels of various annexin family members in ADAM17ex/ex MEF cells. 
(A) Pseudo-colored 2D-DiGE image of differentially labeled wild-type (Cy5, red) and ADAM17ex/ex MEF cell (Cy3, 
green) whole-cell lysate proteins. Proteins were separated on a 24 cm 3-11NL IPG strip followed by SDS-PAGE. 
Numbered arrows indicated positions of (1) annexin A1, (2) annexin A2, (3) annexin A3 and (5) annexin A4. 
Fluorescence intensities for (B) annexin A1, (C) annexin A3, (D) annexin A5 and (E) annexin A2 were calculated 
using the DeCyder 2D software. (F) Immunodetection of annexin A2 in wild-type (1#3) and ADAM17ex/ex MEF 
cell lysates by SlotBlot analysis. Sampling of equal protein amounts was monitored by Ponceau S staining 
(lower panel). Equal protein amount loading was monitored by Ponceau S staining. 
All proteins were elevated in whole-cell lysates of ADAM17ex/ex MEF cells by approximately 
1.5-fold in average (see table 5.4 for details). Figure 5.15 A summarizes information about 
the protein spots that were identified as annexins in representative 2D-DiGE image of 
separated proteins from MEF whole-cell lysates. Fluorescence intensities are shown for 
Annexin A1 (Fig. 5.15 B), Annexin A2 (Fig. 5.15 E), Annexin A3 (Fig. 5.15 C) and Annexin A5 
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(Fig. 5.15 D). The increased protein levels of Annexin A2 were verified by SlotBlot analyses of 
whole-cell lysates, derived from three independent experiments (Fig. 5.15 F). 
5.6 Network analysis 
The performed analyses revealed a variety of differentially affected proteins upon loss of 
ADAM17 proteolytic activity. In order to identify putative protein interactions, that might 
give insights into the role of ADAM17 on the affected proteins, an in silico network analysis 
was performed. To this end, selected proteins were analysed for putative and known protein 
interactions using the STRING 9.1 web service (http://string-db.org) at medium confidence 
settings. 
5.6.1 “The extracellular network“ of identified proteins 
First, differentially regulated proteins identified from cell culture supernatants were 
included into the network analysis, which is shown in figure 5.16. The predicted network 
revealed two major clusters that are comprised by the majority of proteins, included in the 
analysis: (I) metalloproteases and tissue inhibitors of metalloproteases and (II) members of 
the collagen protein family. As a metalloprotease, ADAM17 was placed into the first cluster 
and showed interactions with TIMP-3   and   its   main   substrate   TNFα.   Interestingly,   TNFα  
shows a confident interaction with the over-expressed glia-derived nexin (Serpine-2). In 
addition, slight interactions with TIMP-2 and matrix metalloproteases MMP-2, MMP-3, 
MMP-9 and MMP-14 were predicted. However, the predominant interactions within this 
cluster were observed between the different MMP family members and the TIMP proteins. 
These proteins also showed weak interactions with cathepsin B and ECM-1. The matrix 
metalloprotease 2 (MMP-2) represents a linkage knot between the two major clusters and 
showed interactions with various collagen molecules. All included proteins showed high 
confident protein interaction with each other. In addition, type-I and type-III collagens were 
predicted to interact with serpin H1 and BMP-1, but were also linked to a smaller third 
cluster that contained a variety of intracellular collagen modifying proteins (e.g. PLOD-1 and 
PLOD-3). The basement heparan sulfate proteoglycan core protein was also placed into this 
third cluster and showed weak interactions with BMP-1. In contrast, other observed proteins 
(e.g. IL1RL1 and proteoglycan-4) showed no direct interactions with one of the three 
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observed clusters. In summary, except for some tissue inhibitors of metalloproteases and 
matrix metalloproteases, there is no predicted protein interaction with ADAM17. 
 
Fig. 5.16: Known and predicted interactions of proteins, differentially regulated in ADAM17ex/ex MEF cell 
supernatants. This in silico analysis was performed using the STRING 9.1 web service (http://string-db.org; 
Snel et al., 2000). Position of ADAM17 is highlighted. 
5.6.2 The extended network analysis 
The performed analyses also revealed a variety of intracellular changes. Thus, these 
intracellular proteins were introduced into the network analysis. The confidence view of the 
predicted protein interactions is shown in figure 5.17. Including the intracellular proteins 
into this analysis, only slightly changed the complete network. Matrix metalloproteases and 
TIMPs and collagens still comprised two major clusters of this network. In addition, a third 
big cluster, including the annexin proteins and cytoskeletal proteins (e.g. ezrin and vimentin) 
appeared.  
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Fig. 5.17: Known and predicted protein interactions of proteins, differentially regulated in ADAM17ex/ex 
MEF cell supernatants and whole-cell lysates. This in silico analysis was performed using the STRING 9.1 web 
service (http://string-db.org; Snel et al., 2000). Poition of ADAM17 is highlighted. 
This cluster is linked to the small cluster, including perlecan and the collagen modifying 
proteins via gelsolin and to the MMP and TIMP cluster via cadherin-2. Thus, the extended 
network analysis did not provoke major changes if compared to the first predicted network, 
but elucidated another, intracellular network cluster. Especially direct interactions of these 
proteins with ADAM17 were not shown. 
5.7 MEF cells and alternative cellular systems 
5.7.1 Differences between different MEF cell lines 
Unfortunately, murine embryonic fibroblasts, derived from wild-type and ADAM17ex/ex mice 
were the only cellular samples of the ADAM17ex/ex system, available for the performed 
proteomic analysis. As already mentioned, at later stages, two additional sets of wild-type 
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(MEF 1#7 and MEF 2#1) and ADAM17ex/ex MEF cells (MEF 1#8 and MEF 2#8) were generated 
and included in the sheddome/secretome analysis. According to the Western blot analysis 
for ADAM17 protein levels and to the ELISA analysis for alterations in TNFα and TNF-RI 
shedding, these cells did not differ from the MEF cell pair used for the experiments 
described so far (Fig. 5.1 A, D and E). However, the analysis of cell culture supernatants, 
derived from wild-type and ADAM17ex/ex MEF cells by WGA precipitation revealed major 
differences between the different MEF cell pairs (compare Tab. 5.5). 
Tab. 5.5: Differences in protein levels of differentially regulated cell culture supernatant proteins of three 
different sets of wild-type and ADAM17ex/ex MEF cell. Proteins of wild-type (MEF 1#3, 1#7 and 2#1) and 
ADAM17ex/ex MEF cells (MEF 1#1, 1#8 and 2#8) were enriched by WGA-mediated precipitation and separated 
by 2D-DiGE using a sample mix, labeled with Cy2 as an internal standard. Indicated protein intensities were 
calculated by the DeCyder 2D software. Underlined values indicate fold-changes for proteins that were not 
identified by MALDI-ToF/ToF from the corresponding gel, but were matched with protein spots from one of the 
other gels by the DyCyder 2D software. Information regarding subcellular distribution was taken from 
http://uniprot.org and the corresponding accession number. 
Protein ID Accession No Subc. Loc 
DIGE169 
68572 
1#3 vs. 1#1 
68573 
1#7 vs. 1#8 
68574 
2#1 vs. 2#8 
Antithrombin III P32261 S 1,23 -1,64 -1,21 
B4GT1 P15535 G; S 2,05 -1,51 1,62 
BGAL P23780 L -4,36   
C1s-A  Q8CG16 S -1,17 1,03 1,99 
C1s-A  Q8CG14 S -1,23 2,49 -1,14 
C3 P01027 S -1,44 -6,35 1,3 
CO1A1_CPP P11087 S/ECM -1,85 2,02 -1,42 
CO1A1_FL P11087 S/ECM -1,55 1,17 -1,96 
CO1A2_FL Q01149 S/ECM -3,59  -1,96 
CO1A2_CPP Q01149 S/ECM -1,57 4,14 -2,78 
Cathepsin B P10605 L; S 1,71 2,46 -2,5 
Cystatin-B Q26426 C 4,4 -2,34  
ECM-1 Q61508 S/ECM 1,86 3,38 1,38 
Fascin Q61553 C -2,84 -1,01 1,41 
Fibulin1 Q08879 S/ECM -1,14 4,43 -2,43 
Fibulin3 Q8BPB5 S/ECM 3,3 19,5 -2,92 
fibronectin   1,36 1,06  
FSTL-1 P32261 S 3,78 2,16 -3,29 
GDN Q07235 S 6,76  -8,34 
GDN Q07235 S 9,84   
GST A4 P24472 C -2,67 -1,44  
GST Ω1 O09131 C -8,66  1,85 
HSP7C P63017 C; N; M -1,49 -1,4 4,18 
HtrA1 Q9R118 C; S -1,09 1,15 -1,01 
Galectin-1 P16045 S/ECM -3,24 1,09 2,7 
Galectin-3 P16110 C; N; S -2,45 2,29 2,85 
MMP-2 P33434 S/ECM; C; N 2,65 -1,88 -1,61 
Neogenin P97798 M -2,02 -4,15 3,06 
PCOC-1 Q61398 S 1,24 1,37 2,18 
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PEDF P97298 S 4,06 1,27  
Perlecan_LG3 Q05793 S/BM -2,89 -2,97  
PLOD-1 Q9R0E2 ER 1,57 4,79 1,38 
Phospholipid transfer protein P55065 S 2,87 -1,1 -1,07 
Phospholipid transfer protein P55065 S 2,65  -1,61 
Phospholipid transfer protein P55065 S 4,48 14,77 -1,71 
Periostin Q62009 G; S/ECM -1,64  -3,89 
PPIA P17742 C; S -2,84 -2,6 5,23 
PPIC P30412 C -1,3   
Peroxiredoxin-1 P35700 C  -2,4  
Peroxiredoxin-2 Q61171 C -2,71 -2,51 2,89 
Peroxiredoxin-6 O08709 C -3,81 -3,73  
Sulfhydryl oxidase 1 Q8BND5 M; S 1,83 4,13 1,17 
Renin receptor Q9CYN9 M -2,55   
Sulfated glycoprotein 1 Q61207 S 3,99  -2,59 
Serpin H1 P19324 ER 1,21 1,73 -4,28 
sFRP2 P97299 S 5,25 4,82 -5,9 
sFRP2 P97299 S 11,06 5,17 -1,83 
Translationally-controlled 
tumor protein P63028 C -2,87 -4,83 4,01 
TIMP-2 P25785 S 1,17 -4,69 1,14 
Vasorin Q9CZT5 M 1,93  -1,34 
As indicated by the color-coding, only a few proteins, such as ECM-1 and FSTL-1 showed a 
consitent regulation in all three sets of cells. For many other proteins, at least one set 
yielded no or an inverted pattern of regulation. 
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Fig. 5.18: Different type-I collagen C-terminal propeptide levels in supernatants of ADAM17ex/ex MEF cell 
line MEF 1#1, MEF 1#8 and MEF 2#8. (A) Pseudo-colored 2D-DiGE image sections of differentially labeled MEF 
cell culture supernatant proteins, enriched by WGA-mediated precipitation. Proteins were separated on a 
24 cm 3-11NL IPG strip, followed by SDS-PAGE. Protein spots identified as the type-I collagen α1 (red arrow) 
and α2 (white arrow) chain C-terminal propeptides are indicated. (B) Fluorescence intensities of the identified 
type-I collagen C-terminal propeptides from each cell line, as calculated by the DeCyder 2D software. 
As an example the full-length forms and C-terminal propeptides of both type-I collagen 
chains  α1 and  α2 are shown in figure 5.18. Whereas the fluorescence intensities of the two 
fragments showed reduced levels in supernatants of the ADAM17ex/ex cell lines MEF 1#1 
(Fig. 5.18 B, left panel) and MEF 2#8 (Fig. 5.18 B, right panel), the ADAM17ex/ex MEF cell line 
MEF 1#8 showed elevated levels of these protein fragments (Fig. 5.18 B, center panel) at the 
same position.  
 
Fig. 5.19: Immunodetection of full-length type-I collagen α1 chain via the C-terminal propeptide. MEF cell-
derived whole-cell lysates were generated in three independent approaches and separated by SDS-PAGE. After 
protein transfer onto a nitrocellulose membrane, the type-I collagen α1 chain was targeted via a specific 
antibody against its C-terminal propeptide.  
In addition, detection of the type-I collagen α1 chain via ist C-terminal propeptide in MEF 
cell-derived whole-cell lysates also revealed inverted levels of the full-length, cell-bound 
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type-I collagen. As shown (Fig. 5.19), increased collagen levels could be observed in 
ADAM17ex/ex MEF cell lines MEF 1#1 and MEF 2#8, but were decreased in MEF 1#8 cells. 
However, so far, only two analyses of supernatant proteins included these additional cell 
lines. Notably, further verifications of these findings by Western blot analyses led to 
contradictory results. For instance, detection of the type-I collagen C-terminal propeptide 
showed reduced levels in MEF 1#8 (ADAM17ex/ex) and MEF 2#1 (wild-type) cells. Merely, the 
MEF 1#1 (ADAM17ex/ex) and MEF 1#3 (wild-type) always showed the same picture in 
subsequent analyses. 
5.7.2 Murine embryonic fibroblasts 
Besides the observed discrepancies between the different analyzed MEF cell pairs, the use 
of these MEF cells also impeded several efforts to verify the observed protein level 
altertions by Western blot analyses. Several antibodies, although recomended and verified 
for the use with murine samples did not deliver any results if applied to MEF cell-derived 
samples. For example, the use of an anti-Meprin-β that has been successfully applied by the 
group of Prof. Dr. Becker-Pauly for different murine tissue samples, did not deliver any 
signals in MEF cell-derived samples. In addition, an anti-MMP-2 that apperently worked in 
NIH3T3 cells did not work on MEF cell-derived samples. 
5.7.3 Alternative cellular systems and approaches 
Within this project, alternative cellular systems were investigated. Besides MEF cells, bone 
marow-derived macrophages were derived from wild-type and ADAM17ex/ex mice. After 
initial studies had been performed, the low number of available macrophages could not be 
compensated by the use of additional animals, since most animals were required for other 
projects. In cooperation with Gerina Vollmers, intestinal cells were harvested and cultured, 
but these cells showed insufficient proliferative capacities. A non-small lung cell cancer cell 
line, stably transfected with ADAM17 shRNA was provided by Keisuke Yamamoto, but also 
only showed too less proliferation to reach cell numbers as regarded for the planned 
experiments. 
Finally, ECM extraction techniques from whole murine tissues were adapted, but could not 
be tested at tissues, derived from ADAM17ex/ex mice, since there were no animals provided. 
Chapter 5: Results 90 
Thus, the observed changes in MEF cell secretion, MMP activity and collagen cleavage could 
not be confirmed in other tissues or in vivo. 
5.8 Experimental gel-based proteomics 
As part of Z2 proteomics platform of the collaborative research center 877, the adaption of 
suitable methods for protomic profiling of the ADAM17ex/ex MEF cell system was also part of 
this project. This section briefly summarizes a selection of efforts to analyse the MEF cell 
subproteoms. 
5.8.1 Enrichment of extracellular matrix proteins 
According to the subcellular distribution of the observed proteins within cell culture 
supernatants, some of these proteins comprise the extracellular matrix of cells and tissues. 
 
Fig. 5.20: Separation of a putative ECM fraction by 2D-DiGE. Pseudo-colored 2D-DiGE image, of putative 
ECM fractions from wild-type (Cy5, red) and ADAM17ex/ex MEF cells (Cy3, green). Proteins were separated on a 
24 cm 3-11NL IPG strip, followed by SDS-PAGE.  
Cultured MEF cells were subjected to ECM praparation, following decellularization protocols 
as described. Subsequently, enriched ECM fractions were subjected to 2D-DiGE analysis. A 
representative 2D-DiGE image is shown in figure 5.20, demonstrating the high resolution of 
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the extracted protein fraction. However, out of 60 protein spots, differentially regulated by 
at least 1.5-fold, there was only small number of cell-surface proteins detected (compare list 
of identified proteins in section 10.7). In contrast, a variety of identified proteins originated 
from the nucleus. Among the differentially regulated proteins, the serine protease HtrA1 
appeared to be very prominent, as this protease was identified from several protein spots. 
Protein levels of both, HtrA1 forms with a molecular weight of 50 kDa and at 30 kDa were 
strongly reduced in enriched ECM samples of ADAM17ex/ex MEF cells. These findings are in 
line with reduced HtrA1 levels in ADAM17ex/ex MEF cell supernatants. In addition, members 
A1 and A5 of the already mentioned Annexin family of proteins also appeared to be 
increased within these samples.  
However, only a few known ECM proteins were identified from these experiments. 
Especially collagens were not detected from the enriched ECM fractions. Efforts for further 
purification of ECM proteins, e.g. by the use of WGA-mediated precipitation, only yielded 
insufficient amounts of protein. Thus, known protocols for the enrichment of ECM fractions 
from cultured cells did not work on MEF cells. 
5.8.2 Plasma membrane proteomics 
In case of ectodomain shedding, ADAM proteases are thought to primarily act at the plasma 
membrane. Thus, alterations in ADAM17-mediated shedding upon the ADAM17ex/ex 
phenotype could also be targeted via changes in protein levels of plasma membrane 
proteins. Unfortunately, gel-based plasma membrane proteomics is a challenging endeavor 
in terms of sample preparation and compatibility with two-dimensional gel-based 
separation techniques. Various enrichment techniques were selected for proper purification 
of plasma membrane proteins and subsequent analysis by 2D-CTAB/SDS-DiGE. This section 
summarizes the different efforts. 
5.8.2.1 The  “Two-phase system“ 
Manufacturers of commercially available kits claim to be able to enrich plasma membrane 
proteins to a high extent. Thus, the plasma membrane extraction kit (PromoKine) was 
chosen and the resulting sample was subjected to 2D-CTAB/SDS-DiGE.  
Western blot analyses targeting integrin α2 (Fig. 5.21 A) and GA3PDH (Fig. 5.21 B) that are 
commonly used for monitoring of plasma membrane protein enrichment implicated an 
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enrichment of membrane proteins.   Moreover,   integrin   α2 showed reduced levels in 
ADAM17ex/ex MEF cell membrane fractions. However, two-dimensional separation of these 
putative membrane fractions by 2D-CTAB/SDS-DiGE always led to unproper protein 
resolution (compare Fig. 5.21 C). Besides, protein identification by MALDI-ToF/ToF (see list 
of identified proteins in section 10.10) revealed cytoplasmic proteins or proteins from other 
intracellular compartments to be present within this putative membrane fraction 
(Fig. 5.21 D).  
 
Fig. 5.21: Incomplete enrichment of plasma membrane proteins by two-phase systems. Protein 
enrichment was monitored by targeting (A) integrin α2 (150 kDa) and (B) GA3PDH (37 kDa) by Western blot 
analysis in cytoplasmic (CYT) and membrane fractions (MEM). (C) Putative plasma membrane proteins from 
wild-type MEF cells were separated by 2D-CTAB/SDS-PAGE.  
5.8.2.2 GPMV-derived plasma membrane proteins 
Giant plasma membrane vesicles (GPMVs) represent a rather exotic way of plasma 
membrane protein enrichment. Originally, this system was used for the characterization of 
lipid rafts and membrane dynamics [Sezgin et al., 2012], but might also be a suitable tool for 
general plasma membrane protein enrichment. Treatment of wild-type (Fig. 5.22 A, black 
arrows) and ADAM17ex/ex MEF cells (Fig. 5.22 B, black arrows) with DTT and calcium ions 
induced the constriction of GPMVs from MEF cell plasma membranes. 
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Fig. 5.22: Constriction of giant plasma membrane vesicles (GPMVs) MEF cells. Exemplified light 
microscopy images  of wild-type (upper panel) and ADAM17ex/ex MEF cells (lower panel), prior to induction of 
GPMV formation (left panel) and after 2 h of GPMV formation (right panel, black arrows).  
Collected GPMVs were lysed and monitored for efficiency of non-plasma membrane protein 
depletion by immunodetection of the lysosomal marker LAMP-1, the mitochondrial marker 
COX IV and the plasma membrane marker flotilin-1 (Fig. 5.23). In contrast to LAMP-1 and 
COX IV, only flotilin-1 appeared in protein samples generated from harvested GPMVs 
(Fig. 5.23, pel). Thus, samples were subjected to two-dimensional separation by 2D-
CTAB/SDS-DiGE. 
 
Fig. 5.23: Monitoring of GPMV protein purity.  
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Although compatible with the 2D-CTAB/SDS-PAGE, separation of GPMV-derived always 
resulted in a poor protein resolution and showed only few differentially regulated protein 
spots (Fig. 5.24).  
Moreover, subsequent identification of separated proteins only delivered intracellular 
proteins, including actin and cofilin and peptidyl-proly cis-trans isomerases. Modifications of 
the sample preparation procedure, e.g. using sponin or digitonin treatment in combination 
with extensive washing steps, did not further increase the purity of membrane proteins. 
 
Fig. 5.24: Separation of GPMV-derived proteins by 2D-CTAB/SDS-DiGE. Pseudo-colored image of 
differentially-labeled wild-type (Cy3, green) and ADAM17ex/ex (Cy5, red) MEF cell-derived GPMV proteins. 
Proteins were separated by a 8 % CTAB-PAGE, followed by a 10 % SDS-PAGE. 
5.8.2.3 Two-phase system, linked to lectin-mediated precipitation 
Lectin-mediated precipitation of proteins has already been used to reduce undesired 
intracellular proteins from cell culture supernatant samples. Thus, another approach for the 
enrichment of plasma membrane proteins was the combined use of a two-phase separation 
system and subsequent lectin-mediated precipitation. The putative membrane fractions 
were differentially labeled and subjected to 2D-CTAB/SDS-DiGE. In contrast to previous 
separations, a higher protein resolution was achieved (compare Fig. 5.25). 
However, although several analyses were performed, objectively there was no significantly 
increased enrichment of membrane proteins as most proteins were annotated as 
cytoplasmic (e.g. actin and heat shock proteins), endoplasmic reticulum-derived (e.g. 
calnexin) or cytoskeletal (e.g. tubulin and vimentin) origin. 
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Fig. 5.25: 2D-CTAB/SDS-DiGE separation of putative membrane fractions derived from wild-type and 
ADAM17ex/ex MEF cell by combination of a two-phase system and ConA-mediated precipitation. Samples 
were differentially labeled by Cy3 (wild-type, green) and Cy5 (ADAM17ex/ex, red), respectively. Proteins were 
separated by an 8 % CTAB-PAGE , followed by a 12.5 % SDS-PAGE.  
In summary, although different approaches were used for enrichment of plasma membrane 
proteins from wild-type and ADAM17ex/ex MEF cells, none of the used experimental settings 
generated a protein sample that led to a significant increase of the plasma membrane 
fraction. Thus, the effect of the ADAM17 knock-down on the MEF cell membrane proteome 
remains unknown.  
5.8.3 Cell-surface labeling strategies 
Besides extraction of membrane or extracellular matrix by subcellular fractionation, 
alternative techniques use directed labeling of cell-surface proteins and subsequent 
separation of a whole-cell lysate-like sample. Two different approaches were also applied on 
MEF cell samples and are presented below. 
5.8.3.1 Biotinylation of cell-surface proteins 
Biotinylation is a common approach for enrichment of cell-surface proteins and is mostly for 
subsequent one-dimensional in-gel separation. However, wild-type MEF cells (MEF 1#3) 
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were used for biotinylation of cell-surface proteins using a commercially available kit. 
Subsequently, proteins were extracted by 2D lysis buffer and separated by 2D-CTAB/SDS-
PAGE (Fig. 5.26 A). In addition, whole-cell lysates were generated using 2D lysis buffer and 
subjected to 2D-CTAB/SDS-PAGE, too (Fig. 5.26 B). Unfortunately, both gels show no clear 
differences between biotinylated samples and whole-cell lysates. Apperently, the employed 
biotinylation protocol did not lead to an enrichment of cell-surface proteins for subsequent 
two-dimensional analysis. 
 
Fig. 5.26: Cell-surface biotinylation of wild-type (MEF 1#3) MEF cells. Two-dimensional gelelectrophoresis 
of putative cell-surface proteins enriched by biotinylation (left panel) and whole-cell lysates (rigth panel). 
Samples were separated on seprate gels using 13 cm 3-11NL IPG strips prior to SDS-PAGE. Proteins were 
visualized via FlamingoTM Fluorescent Gel stain solution. 
5.8.3.2 Cell-surface labeling using fluorescent dyes 
An alternate approach uses fluorescent dyes for directed labeling of cell-surface proteins. 
The general protocol of cell-surface-labeling using fluorescent dyes is also based on an 
expected limitation of endocytosis at 4 °C. In addition, CyDyesTM also bind to lysyl residues 
via a NHS ester connection. 
Cultured wild-type MEF cells (MEF 1#3) were labeled by Cy3 and subsequently lysed in 2D 
lysis buffer. In addition, a second set of MEF 1#3 cells was lysed in 2D lysis buffer and the 
generated whole-cell lysate was labeled by Cy5. Finally, both samples were combined and 
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subjected to 2D-CTAB/SDS-PAGE. Again, there was no apparent difference between both 
samples regarding the visualized sample complexity, indicating that the CyDyes penetrated 
the MEF cell membrane and also stained intracellular proteins (Fig. 5.27). 
 
Fig. 5.27: Cell-surface labeling of wild-type (MEF 1#3) MEF cells using fluorescent dyes. MEF cells were 
labeled prior to generation of MEF cell-whole lysates by Cy5 (left panel) or after generation of a whole-cell 
lysate by Cy3 (right panel). Both samples were combined and separated by 2D-CTAB/SDS-PAGE. 
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6 Discussion 
Based on a large number of in vitro and in vivo studies, it became apparent that ADAM17 is 
implicated in the irreversible processing of numerous growth factors, cytokines, adhesion 
proteins and their corresponding receptors. If the shedding of one or the other substrate is 
impaired or altered, this might be associated with pathological disturbances of cell or tissue 
homeostasis [e.g. Arribas and Esselens, 2009; Gooz, 2010]. In this present work, we 
addressed the role of ADAM17 in the processing of known and unknown substrates in MEF 
cells isolated from ADAM17ex/ex mice as compared to wild-type MEF cells by a gel-based 
proteomic approach. To date, only a few studies were published that have addressed the 
global sheddome of ADAM17 [e.g. Guo et al., 2002; Bech-Serra et al., 2006; Kawahara et al., 
2014]. In general, proteomic approaches have been hampered by the fact that sheddome 
analyses depend of the cellular source and that the direct comparison of ADAM17 knock-out 
versus wild-type cells is rather impossible except for embryonic fibroblast, bone marrow-
derived macrophages and cancer cell lines. Thus, the usage of hypomorphic mice opened the 
way to possibly circumvent this problem. Nonetheless, it turned out that the performed 
analyses only provide few indications for ADAM17-mediated shedding. Instead, reduced 
ADAM17 activity in ADAM17ex/ex mice is associated with various protein alterations that 
point to a rather complex regulation of the protease web around ADAM17. 
6.1 Comparison of the protein content of wild-type and 
ADAM17ex/ex MEF cells 
Overall, more than seventy different substrates are supposed to be shed by ADAM17 
[Pruessmeyer and Ludwig, 2009; Saftig and Reiss, 2011; Scheller et al., 2011]. The first 
identified  substrate  was  TNFα  [Black et al., 1997; Moss et al., 1997]. Therefore, ADAM17 was 
initially   termed   TNFα-converting enzyme (TACE). Based on the broad substrate specificity, 
ADAM17 and its closest relative ADAM10 have been implicated in the regulation of 
numerous pathways during development, neurogenesis, tissue homeostasis and tumor 
formation [e.g. reviewed in Edwards et al., 2007; Pruessmeyer and Ludwig, 2009; Gooz, 
2010]. 
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In order to get insights into the substrate patterns in a given cell type in the presence or 
absence of ADAM17, the complete knock-out of ADAM17 in mice, which is associated with 
embryonic lethality, has clear limitations regarding the available cellular material [Peschon et 
al., 1998]. To circumvent this issue, ADAM17 hypomorphic (ADAM17ex/ex) mice were 
regarded as a more suitable model since these mice are viable and fertile [Chalaris et al., 
2010]. In fact, ADAM17ex/ex mice have been examined to address the effect of very low 
expression of ADAM17 in various disease models including intestinal inflammation 
[Chalaris et al., 2010] and lung cancer progression   [Stevanović,   2014]. However, the 
availability of cells and tissues from ADAM17ex/ex mice was still a major limitation for the 
outcome of this project. Thus, the prime idea was to initially investigate proteomic 
alterations in the context of murine embryonic fibroblasts (MEF cells) and to run follow-up 
experiments on various other cell types including bone marrow-derived macrophages and 
tissue-derived cells. 
Assuming that ADAM17 acts as a plasma membrane-associated sheddase, cleaved 
substrates should be enriched to some extent in cell culture supernatants. Thus, the first 
experiments were performed to enrich proteins from MEF cell culture supernatants, to 
separate them by two-dimensional gel electrophoresis and to look for differences in the 
supernatants of wild-type and ADAM17ex/ex MEF cell supernatants by applying differential 
labeling. Nonetheless, the first 2D-DiGE experiments indicated that there are differences in 
the released proteins, but there are not many putative substrates that could be identified by 
this approach. In order to prove that the 2D-DiGE approach might be suitable in general for 
this purpose, we compared supernatant proteins from wild-type and ADAM17ex/ex MEF cells 
upon   transfection   with   the   cognate   ADAM17   substrate   TNFα.   In this case, the 2D-DiGE 
analysis followed by protein identification of altered protein spots by mass spectrometry, 
clearly  revealed  an  impaired  TNFα  processing  in  ADAM17ex/ex MEF cells. Thus, the processed 
TNFα  was  detected  in  wild-type MEF cells with a 14-fold higher abundance. 
Although this experiment clearly proved that the gel-based proteomic approach is suitable 
to detect forced alterations, it also revealed that other constitutively or inducibly shed 
substrates might not be detected due to sensitivity problems. Notably, supernatants of wild-
type and ADAM17ex/ex MEF   cells   were   routinely   checked   for   TNFα   cleavage   by   ELISA   as   a  
standard procedure to verify the correct phenotype. Although these analyses indicate that 
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TNFα  is  also  processed  in  untransfected MEF cells, it did not prove that other substrates are 
also available for shedding in this cellular system. 
6.2 Indications for shedding 
Besides   identifying  TNFα  as   an  ADAM17   substrate   in  wild-type MEF cells, there were only 
few indications for an ADAM17-related shedding of other proteins. In wild-type MEF cells, 
the relative abundance of a 15 kDa   TNFα   fragment   was   increased   14-fold, whereas a 
putative 100 kDa fragment of NCAM-1 was 1.69-fold increased and a 15 kDa cadherin-2 
fragment was 2.3-fold increased (section 5.3.1; Tab. 5.1). In addition, a 25 kDa fragment of 
perlecan and 30 kDa fragments of the type-I   collagen   α1 and   α2 chains showed 
approximately 2.5-fold decreased protein levels in ADAM17ex/ex MEF cells. Light chains of the 
C1 subcomponents C1r-A and C1r-S were 3-fold increased in wild-type supernatants, as were 
15 kDa fragments of cystatin-C. A 35 kDa fragment of the procollagen C-endopeptidase 
enhancer 1 was 5.8-fold decreased in ADAM17ex/ex supernatants. In contrast, a 40 kDa 
fragment of IL1RL1 and a 11 kDa fragment of lubricin were increased in ADAM17ex/ex MEF 
cell supernatants.  
Besides the already mentioned ADAM17 substrate TNFα [Black et al., 1997], only NCAM-1 
has been reported to be a substrate of ADAM17 by Kalus and colleagues [Kalus et al., 2006]. 
In this case, the generation of the predominant soluble 110 kDa form of NCAM-1 [e.g. He et 
al., 1986; Sadoul et al., 1986] from crude membrane fractions of murine brain was 
monitored in vitro in presence and absence of chelating EDTA [Kalus et al., 2006]. Finally, the 
role of ADAM17 in NCAM-1 processing was proven in murine neuroblastoma cells (Neuro 2a) 
upon GM 6001 treatment and in ADAM17-deficient fibroblast [Kalus et al., 2006]. 
In addition, most of the identified protein fragments lack a designated transmembrane 
domain, which seems to be crucial for ADAM17-mediated substrate cleavage [White, 2003]. 
This might implicate an indirect effect of ADAM17. Indeed, all proteins that fall into this 
category might be substrates of other proteases. For example, we noted an increase of the 
type-I  collagen  α1 and  α2 chain propeptides and the perlecan LG3 peptide in wild-type MEF 
cell supernatants.  Only  recently,  however,  meprin  β  has  been  identified  as  the  prominent  C- 
and N-procollagenase for type-I and type-III collagens [Broder et al., 2013]. Interestingly, the 
astacin   family  metalloprotease   “bone  morphogenic   protein  1”   (BMP-1) was reduced 1.59-
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fold in ADAM17ex/ex MEF cell supernatants. BMP-1 also mediates type-I and type-III C-
terminal propeptide cleavage [Kessler et al., 1995]. Moreover, although perlecan contains 
several putative cleavage sites for other proteases [Farach-Carson and Carson, 2007], so far, 
the observed LG3 was only reported to be released by BMP-1 cleavage [Gonzales et al., 
2005]. In addition, we detected decreased levels of a 36 kDa fragment of the procollagen C-
endopeptidase enhancer 1 (PCOC-1) in supernatants of ADAM17ex/ex MEF cells. Apparently, 
the generation of this fragment is required for BMP-1-mediated C-procollagen maturation 
[Hulmes et al., 1997]. 
The transmembrane adhesion molecule cadherin-2 was discussed as a substrate of ADAM10, 
before [Reiss et al., 2005]. Like other cadherins, cadherin-2 is synthesized as a precursor 
protein with an N-terminal prodomain. The removal of the prodomain, which is mediated by 
intracellular furin or other proprotein convertases [Ozawa and Kemmler, 1990], is crucial for 
its adhesive function [Koch et al., 2004]. However, since we observed reduced levels of the 
propeptide in supernatants of TNFα-overexpressing ADAM17ex/ex MEF cells, an effect of 
ADAM17 on maturation of this transmembrane protein cannot be excluded. 
The cysteine protease inhibitor cystatin-C was detected as a 15 kDa fragment that was 
reduced in ADAM17ex/ex MEF cell supernatants. According to the literature, cystatin-C is 
degraded by MMP-2 and MMP-9 [Prudova et al., 2010]. Both MMPs, however showed 
reduced activity in ADAM17ex/ex MEF cell supernatants. Thus, the lower abundance of the 
cystatin-C cleavage product might be an indirect effect due to ADAM17-mediated regulation 
of MMPs. Also the light chains of the C1 subcomponents C1r-A and C1s-A were reduced 
ADAM17ex/ex MEF cell supernatants. Both serine proteases show major characteristics with 
other proteases of the complement system [Sim and Laich, 2000]. Interestingly, zymogenic 
C1s-A is maturated by active C1r-A prior to processing of C2 and C4 [Gál et al., 2002]. 
Moreover, C1r-A was recently described as another target of MMP-2 [Prudova et al. 2010].  
In contrast, an 11 kDa fragment of the 225 kDa proteoglycan lubricin (PRG4) was increased 
in supernatants of ADAM17ex/ex MEF cells. It has been reported that the removal of this C-
terminal part is mediated by a subtilisin-like proprotein convertase [Rhee et al., 2005]. Of 
note, increased protein levels were also observed for the interleukin-1-like related protein 1 
(IL1RL1). This protein is supposed to exist as a transmembrane protein or as a secreted 
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protein, which is dependent on gene expression, but not on post-translational modification 
[Rössler et al., 1995]. 
Taken together, a variety of differentially abundant proteins or protein fragments were 
detected in supernatants of ADAM17ex/ex versus wild-type MEF cells. However, in most 
cases, a direct proteolysis by ADAM17 seems unlikely, since most of these proteins are not 
classical transmembrane proteins and are documented targets of other proteases. This again 
strengthens the notion that in MEF cells ADAM17 might influence the activity of other 
proteases rather than releasing numerous substrates into the cell culture supernatant. 
6.2.1 ADAM17 – A potential regulator of collagen maturation and turnover? 
6.2.1.1 Reduced type-I collagen maturation in ADAM17ex/ex MEF cells 
Among the different protein fragments that were reduced in ADAM17ex/ex MEF cell 
supernatants, the C-terminal propeptides of the type-I   collagen   α1 and   α2 chains were 
amongst the most prominent ones. Type-I, -II and -III collagens represent the major fibrillar 
components of the extracellular matrix. Fibrillar collagens are synthesized as precursor 
proteins (procollagens) containing N- and C-terminal propeptides and are released into the 
extracellular matrix. The proteolytic removal of the propetides is a crucial step in collagen 
maturation, including collagen fiber assembly. Thus, collagen maturation is essential for its 
regulated deposition and for ECM structure and morphogenesis [Kühn, 1987; Kadler et al., 
2000; Hulmes, 2002; Canty and Kadler, 2005; Hulmes, 2008]. 
The reduced levels of the C-terminal type-I collagen propeptide might thus implicate 
impaired type-I collagen maturation in ADAM17ex/ex MEF cells. This is supported by findings 
from MEF cell-derived whole-cell lysates that showed increased levels of procollagen at 
250 kDa in ADAM17ex/ex samples. Moreover, if targeted with an antibody directed against 
the C-terminal type-I collagen telo-peptide, fragments at approximately 200 and 130 kDa 
show increased levels in wild-type MEF cell samples. These fragments are correlated with C- 
and N-terminal collagen maturation [e.g. Broder et al., 2013]. However, except for type-XIII, -
XVII, -XXIII and –XXV collagen, collagens lack a transmembrane region, implicating that the C-
terminal propeptide might not be processed by the plasma membrane-associated ADAM17. 
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It has proposed that ADAM-related proteases such as ADAMTS-2, -3 and -14 are involved in 
N-terminal procollagen maturation, whereas the C-terminal propeptide is removed by BMP-
1 and related tolloid-like proteases [Kessler et al., 1995; Sarras, 1996; Colige et al., 2002; 
Hopkins et al., 2007; Moali et al., 2005; Moali and Hulmes, 2012]. In line with the reduced C-
terminal type-I collagen maturation, ADAM17ex/ex MEF cell supernatants contained reduced 
levels of BMP-1 levels indicating that reduced C-terminal collagen maturation might be due 
to reduced C-procollagenase activity. In addition, various protease enhancer molecules 
promote BMP-1 activity in a substrate dependent manner [Vadon-Le Goff et al., 2011]. For 
instance, periostin (that was also reduced in ADAM17ex/ex MEF cell supernatants) is involved 
in BMP-1-mediated proteolytic activation of lysyl oxidase [Maruhashi et al., 2010] and the 
BMP-1 C-procollagenase activity is supported by the procollagen C-endoprotease enhancer I 
(PCOC-1) [Moali et al., 2005]. Notably, a 36 kDa fragment of PCOC-1 [Hulmes et al., 1997] 
was found to be reduced in supernatants of TNFα-overexpressing ADAM17ex/ex MEF cells. 
Here, it is already reported that the proteolytic cleavage of the PCOC-1 netrin-like (NTR) 
domain is mediated by MMP-2 [Dean and Overall, 2007], which is also reduced in 
ADAM17ex/ex MEF cell supernatants. However, it has also been suggested that the full-length 
form of PCOC-1 displays BMP-1 enhancing activity by binding to the type-I collagen C-
terminal propeptide via its two CUB domains [Ricard-Blum et al., 2002] and to BMP-1 via its 
NTR domain [Bekhouche et al., 2010]. As the full-length form of PCOC-1 only showed 
moderate protein alterations in ADAM17ex/ex supernatants, reduced BMP-1 levels might be 
more relevant for the observed reduced C-terminal collagen maturation. 
Moreover, in the postulated protease web, ADAM17 might mediate the maturation of the 
astacin family metalloprotease meprin β  by  shedding  in  a  PMA-dependent manner [Hahn et 
al., 2003]. Recently, meprin β   has   been   described   as   an   important  mediator   of   C- and N-
terminal type-I and type-III collagen maturation [Broder et al., 2013]. Unfortunately, a direct 
effect of meprin β  could  not  be  investigated in more detail, since the available antibodies did 
not yield reliable results in MEF cell samples. Moreover, there is no direct evidence for the 
presence of meprin β  in MEF cells [Prof. Dr. Becker-Pauly, personal communication].  
6.2.1.2 Reduced collagen fragmentation in ADAM17ex/ex MEF cells 
The analysis of cell culture supernatants not only revealed reduced C-terminal type-I 
collagen maturation, but also a reduced release of smaller type-I collagen fragments with 
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different molecular weights (e.g. a three-quarter fragment (90 kDa) of the type-I collagen 
molecule). In general, degradation of collagen is important for remodelling of the 
extracellular matrix and for growth and development [reviewed by Cox and Erler, 2011]. It 
has been proposed that collagen degradation can occur intra- and extracellularily [Sodek and 
Overall, 1988; Everts et al., 1996]. Fragmentation of collagens is a regulated process that is 
mainly orchestrated by matrix metalloproteases during collagen turnover [Fisher et al., 
2009]. Initial type-I collagen fragmentation into quarter and three-quarter fragments is 
mediated by MMP-1 in humans [Janecki et al., 1995; Lee et al., 2006] and by MT-MMP1 
(MMP-14) in mice [Holmbeck et al., 1999; Sounni et al., 2005]. The resulting three-quarter 
and quarter fragments can be further degraded by MMP-2, MMP3 and MMP-9 [López et al., 
2010]. In addition, collagen fragments not only indicate collagen degradation, but can also 
act as biologically active ECM fragments (matrikines). For instance, the glycyl-histidyl-lysine 
tripeptide (GHL) that is derived from type-I   collagen   α2 chains stimulates the synthesis of 
collagens [Maquart et al., 1988] and induces the expression of MMP-2 by cultured 
fibroblasts [Siméon et al., 2000]. Moreover, serum levels of the type-I C-terminal propeptide 
and the C-terminal telo-peptide are used as biomarkers for collagen degradation in cardiac 
disease [Tziakas et al., 2007; López et al., 2010]. In the present study, Western blot analyses 
of whole-cell lysates and cell culture supernatants not only pointed to a reduced C-terminal 
type-I collagen maturation, but also indicated an impaired release of this fragment into the 
supernatant of ADAM17ex/ex MEF cells. A reduced remodelling of the ADAM17ex/ex MEF cell 
ECM might contribute to the reduced release of this fragment. In this context, the C-terminal 
propeptide has been described  to  mediate  TGFβ  effects in osteoblasts [Mizuno et al., 2000]. 
In conclusion, the present results suggest that ADAM17 might indirectly influence the 
maturation and turnover of collagens via modulation of MMP activity, indicating a reduced 
extracellular matrix remodelling in ADAM17ex/ex MEF cells. Interestingly, the “secreted 
protein acidic and rich in cysteine” (SPARC) is a known mediator of extracellular matrix 
remodelling [Engel et al., 1987; Funk and Sage, 1991; Lane and Sage, 1994; Murphy-Ullrich et 
al., 1995]. This protein displayed increased protein levels in ADAM17ex/ex MEF whole-cell 
lysates and might thus contribute to the reduced ECM remodelling in ADAM17ex/ex MEF cells 
due to decreased secretion. Similar observations were recently made for ADAM17–/– MEF 
cells [Kawahara et al., 2014]. Moreover, increased collagen turnover in wild-type MEF cells 
implicates an enhanced ECM remodeling in an MMP-dependent manner. In line with this, 
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MMPs are often up-regulated in cancer, thereby leading to progressive destruction of 
normal ECM and enhanced tumor invasion [Kumar and Weaver, 2009; Cox and Erler, 2011]. 
Since ADAM17 activity apparently is also increased in various tumors in comparison to 
normal tissues [Arribas and Esselens, 2009], the comparison of wild-type and ADAM17ex/ex 
cells might reflect these phenotypic differences to a certain extent. Along this line, a 
negative effect of the ADAM17ex/ex background on tumor progression was recently 
demonstrated, as injection of Lewis lung carcinoma cells led to a reduced tumor burden in 
ADAM17ex/ex mice  [Stavanović,  2014].   
6.2.2 Perlecan – A novel ADAM17 substrate in murine cells? 
The “basement heparane-sulfate proteoglycan core protein” (perlecan) is widely expressed 
during early development and plays a role in vasculogenesis and tumor angiogenesis 
[Iozzo et al., 2001; Zhou et al., 2004]. This 400 kDa proteoglycan displays a modular 
architecture of five subdomains, with a C-terminal, 85 kDa endorepellin domain [Iozzo et al., 
1998]. Thereby, the angiostatic activity is mainly located within the laminin-like globular 
domain 3 (LG3), which forms part of this endorepellin domain [Bix et al., 2004]. In the 
present study, perlecan was identified as a 26 kDa fragment that correlates in size an 
peptide sequence to the described LG3 peptide. This fragment showed a 2.9-fold reduced 
abundance in ADAM17ex/ex MEF cell supernatants. In contrast, according to the performed 
SlotBlot analyses the perlecan full-length protein levels were increased in ADAM17ex/ex MEF 
cell whole-cell lysates, indicating a reduced perlecan cleavage in ADAM17ex/ex MEF cells.  
The cleavage of perlecan has been studied thoroughly before and several proteases were 
identified as putative processing enzymes. It was found that MMP-3, MMP-14 and 
collagenase-1 [Whitelock et al.,  1996;  d’Ortho et al., 1997], but also MMP-7 [Grindel et al., 
2014] are involved in perlecan degradation. However, the aforementioned LG3 peptide is 
known to be liberated by extracellular BMP-1/tolloid-like metalloproteases [Iozzo et al., 
2005], which also showed reduced protein levels in ADAM17ex/ex supernatants. Of note, 
MMP-2 and MMP-9 are not involved in perlecan processing [Whitelock et al., 1996]. In 
addition, the endorepellin domain of perlecan interacts with a variety of proteins, including 
ECM-1 [Mongiat et al., 2003] and α1β2 integrin [Ida-Yonemochi, 2013]. Additional protein 
interactions between the perlecan N-terminal domains and growth factors and receptors, 
suggest a dual role of perlecan as a regulator of tumor progression and tumor suppression 
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via limited proteolysis of the perlecan LG3 peptide [Whitelock et al., 2008]. Again, however, 
perlecan does not contain a transmembrane domain, suggesting that classical ADAM17 
cleavage is unlikely. 
Nonetheless, perlecan cleavage has also been found to be altered in the mass spectrometry-
based study of the ADAM17-dependent MEF cell secretome [Kawahara et al., 2014]. There 
the authors observed increased endorepellin levels in wild-type MEF cell supernatants and 
demonstrated ADAM17-dependent generation of the LG3 fragment in vitro. This in vitro 
cleavage assay was performed on recombinant human endorepellin, using recombinant 
human ADAM17 (aa271 to aa671), lacking the prodomain, the transmembrane region and 
intracellular domain [Kawahara et al., 2014]. Since, the ADAM17-mediated generation of a 
25 kDa fragment was observed, it was concluded that endorepellin might serve as a novel 
substrate of ADAM17. However, such in vitro cleavage assays do not necessarily reflect the 
in vivo situation and various parameters including the temporal and spatial localization of 
proteases and substrates [Li et al., 2004; Fortelny et al., 2014]. Noteworthy, the mass 
spectrometry data presented by Kawahara and colleagues also revealed decreased 
extracellular BMP-1 levels in ADAM17–/– MEF cell supernatants [Kawahara et al., 2014]. 
6.3 ADAM17 – A modulator of the protease web? 
6.3.1 The protease web 
“Proteases  do  not  operate  alone,  but  in  pathways  and  amplification  cascades  with  a one way 
flow of information, or in regulatory circuits where information feeds back. This complexity 
is increased because of the presence of interacting proteins, receptors, substrates, cleavage 
products  and  inhibitors.”  [Overall  and  Dean,  2006].   
It was observed that many proteases and protease inhibitors such as “secreted leukocyte 
protease inhibitor” and cystatins were found to be substrates of MMPs or to be indirectly 
modulated by MMP activity. For example, fetuin A and cystatin C are able to interact with 
MMP9 and MMP2, preventing them from autocatalytic degradation [Ray et al., 2003; Chen 
et al., 2005]. Therefore, it was considered that proteolytic pathways in vivo do not act alone, 
but are part of interconnected proteolytic systems and cascades, the protease web. The net 
activity of a protease within the protease web therefore depends on the activity of several 
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associated proteases and inhibitors. Thus, overexpression of proteases can induce 
unexpected activities of other proteases and inhibition of proteases can lead to effects on 
unrelated proteases [Overall and Dean, 2006]. 
Interactions between different proteases have been described before and are well 
characterized for proteolytic cascades of the complement [e.g. Müller-Eberhardt, 1988] and 
coagulation system [e.g. Macfarlane, 1964] and for caspase-mediated apoptosis [Thornberry 
and Lazebnik, 1998; Lincz, 1998]. However, more recent studies on matrix metalloproteases 
revealed an even higher complexity of these protease interactions. For instance, cysteine 
and serine proteases that are inhibited by cystatins or serpins remain active upon MMP-
mediated cleavage and inactivation of cystatins and serpins [Knäuper et al., 1990; Mast et 
al., 1991; Dean and Overall, 2007; Auf dem Keller et al., 2013].  
Meanwhile, the idea of the protease web has been considered in a variety of different 
publications, dealing with proteolysis and its role in pathophysiological events such as cancer 
[Mason and Joyce, 2010]. In addition, in vitro and in cellulo degradomic studies on protease 
substrates [Butler and Overall, 2009; Prudova et al., 2010], but also gene expression analysis 
under reduced or elevated protease inhibitor activities in cancer [Krüger, 2009] 
strengthened the concept of the protease web. Finally, in vivo studies on the impact of 
reduced or enhanced protease activity (e.g. based on knock-out or overexpression 
approaches) might lead to indirect effects via “proteolytic side effects” [Fortelny et al. 2014]. 
Thus, alterations of protein abundance observed within this project might not be mediated 
by ADAM17 directly, but might be affected by ADAM17 as a regulatory protease within the 
protease web. 
6.3.2 ADAM17 within the protease web 
A variety of protein fragments and proteases showed altered levels in ADAM17ex/ex MEF 
cells. Among these changes, the impaired maturation and fragmentation of the type-I 
collagen chains were rather prominent. In addition, the observed changes in protein 
secretion included components of the ECM proteome that has been renamed as the 
matrisome [Naba et al., 2013]. Thus, the observed decrease of extracellular matrix protein 
levels within a given cell culture might reflect a reduced remodeling of the extracellular 
matrix due to the reduced activity of ADAM17. Investigations regarding extracellular matrix 
remodeling in various physiological processes and tissues elucidated matrix 
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metalloproteinase (MMPs) as important mediators of matrix remodeling [e.g. Vu and Werb, 
2000; Löffek et al., 2010]. In line with this, gelatin and casein-based zymographic analyses of 
MEF cell culture supernatants revealed a reduced activity of MMP-2, MMP-3 and MMP-9. In 
case of MMP-3 and MMP-2, decreased activity of the mature protein forms in ADAM17ex/ex 
MEF cells were accompanied by increased protein levels of the correspondent proforms. 
This might reflect an impaired maturation due to reduced MT-MMP1 (MMP-14) activity, 
which is known to mediate the maturation of proMMP-2 [Deryugina et al., 2001]. On the 
other hand, decreased Mmp2 expression was reported in a model for cardiac remodelling 
upon knock-down of ADAM17 [Wang et al., 2009]. In addition, the reduced TIMP-2 protein 
levels in ADAM17ex/ex MEF cells might also affect reduced proMMP-2 maturation, since this 
physiologic inhibitor is required for MMP-2 maturation by MMP-14 [Stetler-Stevenson et al., 
1990; Deryugina et al., 2001]. Reduced MMP-2 activity thus might be modulated on the gene 
expression and the protein level.  
Similarly, impaired MMP-9 activity has also been shown to correlate with an impaired Mmp9 
expression when performing a siRNA-mediated knock-down of ADAM17 in lung epithelial 
cells [Li et al., 2013]. Again, MMP-9 activity is also regulated on the protein level due to 
reduced maturation via the MT1-MMP/MMP2 axis [Toth et al., 2003]. In a prostate cancer 
model, expression of both, MMP-2 and MMP-9 is positively up-regulated in an EGFR-MEK-
ERK dependent manner [Xiao et al., 2012]. Besides, the observed ECM-1 protein levels might 
also affect the reduced MMP-9 activity observed in ADAM17ex/ex MEF cell supernatants, 
since ECM-1 can inhibit MMP-9 by direct interaction via its C-terminal region [Fujimoto et al., 
2006]. In conclusion, the reduced ADAM17 activity in ADAM17ex/ex MEF cells might affect the 
activity of matrix metalloproteases also via altered gene expression levels. Notably, 
Kawahara and colleagues observed increased Mmp2 expression in wild-type MEF cells, but 
no effect on Mmp9 expression [Kawahara et al., 2014]. 
As   mentioned   before,   “bone morphogenic protein 1” (BMP-1) was also reduced in 
ADAM17ex/ex MEF cell supernatants. BMP-1 is an important C-procollagenase for type-I and 
type-III collagens [Kessler et al., 1986]. This protease and other members of the family of 
tolloid-like metalloproteases directly effect ECM formation [Hopkins et al., 2007] by acting 
on fibrillar and non-fibrillar collagens and non-collagenous ECM components such as 
perlecan [Gonzales et al., 2005] and mimecan [Funderburgh et al., 1997]. Notably, also 
perlecan and mimecan were found to be less abundant in ADAM17ex/ex MEF cell 
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supernatants. Moreover, BMP-1 activity is enhanced by the   “procollagen  C-endopeptidase 
enhancer 1”   (PCOC-1) [Kessler and Adar, 1989] and might be inhibited by the   “secreted  
frizzled-related   protein   2”   (sFRP2), which conversely displayed increased protein levels in 
ADAM17ex/ex MEF cell supernatants. At least, murine sFRP2 is capable to inhibit BMP1/TLD-
like proteases in Xenopus and Danio rerio [Lee et al., 2006]. 
What has been discussed so far strongly argues that studies of the ADAM17-dependent 
secretome or sheddome seem to be highly affected by “proteolytic side effects” within a 
complex protease web. This implies that studies of protease-dependent proteome 
alterations should generally be combined with gene expression profiling to get deeper 
insights into the role of a certain protease within a specific cellular system. 
6.4 ADAM17-dependent secretome 
Besides the described proteins, protein fragments, proteases and protease inhibitors, also 
other full-length proteins were altered in their abundance on reduced ADAM17 activity. 
Overall 400 different proteins were identified from MEF cell culture supernatants. However, 
according to available protein information (e.g. on http://uniprot.org) only  seventy proteins 
were expected to be present in this fraction. Recently, Naba and colleagues mentioned that 
available protein information (especially subcellular distribution) is often incomplete 
[Naba et al., 2012]. Thus, it remains unknown, whether the intracellular protein (e.g. ER 
proteins PLOD-1 and PLOD-3) are also secreted into the cell culture supernatant or whether 
this is an artificial effect due to cell death. However, whereas most proteins were rather 
reduced in ADAM17ex/ex MEF cell supernatants (e.g. various types of collagen), some proteins 
were also detected with increased levels. For example, the „follistatin-like protein 1“ (FSTL-
1) and the „extracellular matrix protein 1“ (ECM-1) were increased in ADAM17ex/ex 
supernatants, especially when enriched by WGA precipitation. Interestingly, Kawahara and 
colleagues also observed increased ECM-1 levels in ADAM17–/– MEF cell supernatants, 
whereas FSTL-1 levels were decreased [Kawahara et al., 2014]. Whether the increased levels 
of full-length FSTL-1 observed in the present study are a consequence of enhanced secretion 
or of reduced cleavage by MMP-2 [Prudova et al., 2004] remains unknown. Interestingly, 
ECM-1 is known to interact with MMP-9 in an inhibitory manner [Fujimoto et al., 2006]. 
Notably, FSTL-1 was recently mentioned to modulate expression of collagens and ECM 
proteoglycans in chondrocytes [Chaly et al., 2014]. 
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It should be stressed that several of the observations detected in ADAM17ex/ex MEF cells are 
in agreement with the findings reported by Kawahara and colleagues [Kawahara et al., 
2014]. This includes various types of collagens, periostin and cadherin-2. Among others, 
these proteins are involved in proliferation and motility. In fact, ADAM17–/– MEF cells 
showed reduced migratory capacity that could be partially restored by treatment with 
conditioned cell culture supernatants from wild-type MEF cells. The reduced proliferation of 
wild-type is supposed to be mediated by reduced ERK phosphorylation and increased FAK 
phosphorylation due to altered activity of the transcription factor PPARγ [Kawahara et al., 
2014]. 
Overall, if compared to the study of Kawahara and colleagues, the ADAM17ex/ex MEF cell 
secretome shows certain similarities to the secretome of ADAM17–/– MEF cells, but also 
revealed some inverse protein regulations. Whether these differences are due to the 
residual ADAM17 activity in ADAM17ex/ex hypomorphic MEF cells or whether they relate to 
more general problems when investigating MEF cells, remains unknown. Nonetheless, both 
studies clearly indicate a role of ADAM17 beyond direct substrate shedding. 
6.5 Intracellular effects of ADAM17 in MEF cells 
As mentioned, ADAM17 might indirectly influence protein secretion and regulate cellular 
processes via an altered „secretome“   composition. Therefore we also addressed whether 
reduced ADAM17 activity in ADAM17ex/ex MEF cells also leads to altered levels of 
intracellular proteins that might be interesting in the context of ADAM17. 
6.5.1 Increased cofilin-1 phosphorylation in wild-type MEF cells 
Cofilin-1 and destrin are members of the ADF/cofilin family of actin-binding proteins and are 
potent regulators of actin dynamics [Moon and Drubin, 1995]. Interestingly, we detected a 
reduced (Ser3) phosphorylation of cofilin-1 in ADAM17ex/ex MEF cells, which might also be 
the case for destrin. It was reported that the ability of cofilin-1 to bind and depolymerize 
actin is abolished upon Ser3 phosphorylation [Agnew et al., 1995; Moriyama et al., 1996]. 
Phosphorylation of cofilin-1 at Ser3 is mediated by „LIM kinase 1“ (LIMK1) [Arber et al., 
1998] in a Rac-mediated manner [Yang et al., 1998]. In addition, in neurons, cofilin-1 is also 
phosphorylated upon reelin signaling [Chai et al., 2009]. Since a direct correlation between 
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ADAM17 and cofilin-1 is suggested from our present data, this might indicate that ADAM17 
is somehow involved in the regulation of actin dynamics.  
6.5.2 Increased intracellular annexin levels in ADAM17ex/ex MEF cells 
Annexins comprise a family of Ca2+-regulated membrane binding proteins that were 
detected at higher levels in ADAM17ex/ex MEF cell whole-cell lysates and ECM fractions, 
whereas there were only little indications for annexins in MEF cell supernatants. 
Interestingly, the recent study on the ADAM17-dependent MEF cell secretome revealed 
decreased levels of annexins A2 and A5 in ADAM17–/– MEF cell supernatants [Kawahara et 
al., 2014] suggesting an impaired release/secretion in the absence of ADAM17 activity. Of 
note, membrane-bound annexin A2 plays a crucial role in ADAM17-mediated ectodomain 
shedding of EGFR ligands by forming a shedding platform that dictates substrate specificity 
[Nakayama et al., 2012]. In addition, direct interactions of annexins with ADAM17 were 
shown in monocytes and colon epithelial cells, where annexin A2 promoted IL-1β  and  TPA-
induced  shedding  of  TNFα,  but  not  HB-EGF and amphiregulin [Tsukamoto et al., 2013].  
6.6 Method development and limitations 
6.6.1 Sheddome and secretome analysis by 2D-DiGE 
The 2D-DiGE approach has been proven suitable for the detection of shedding events at 
early stages of this project. However,  except   for  TNFα and NCAM-1, we did not find clear 
indications for ADAM17-dependent shedding comparing samples derived from ADAM17ex/ex 
MEF cells and wild-type counterparts. Nonetheless, different gel-based proteomic studies of 
cell culture supernatants have lead to the identification of several novel metalloprotease 
substrates. 
Gou and colleagues enriched supernatant proteins from bone marrow-derived macrophages 
that were cultured in presence or absence of the broad-spectrum metalloprotease inhibitor 
IC-3 by centrifugal filter units. The samples were subjected to classical 2D separations but 
revealed no indication for metalloprotease-dependent alterations. The enrichment of 
supernatant proteins by WGA-mediated precipitation and subsequent one-dimensional 
separation led to the characterization of nine fragments of transmembrane proteins, 
including IL-6R and L-selectin [Guo et al., 2002]. In a later study, supernatant proteins of 
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ADAM17-transfected A431 breast cancer cells were analyzed. To this end, cells were 
cultured in presence or absence of the broad-spectrum metalloprotease inhibitor BB-94 and 
supernatant samples were again enriched by WGA precipitation. Subsequent analysis of 
supernatant proteins by 2D-DiGE revealed three candidates (Desmoglein-2, Transferrin 
Receptor and ALCAM) that appeared to be shed in an ADAM17- or ADAM10-dependent 
manner [Bech-Serra et al., 2006]. Finally, the analysis of supernatant samples enriched by 
size exclusion centrifugation from untreated and BB-94-treated transformed macrophages 
(Raw267.7 cells) revealed the metalloprotease-dependent shedding of M-CSFR, VIP36, 
Sema4D and  MHC   class   I   α   chains   D   and   L.   In   addition, this study pointed to differences 
between LPS- and PMA-induced shedding [Shirakabe et al., 2013]. Taken together, some 
shed proteins have been identified by gel-based proteomic approaches, but the identified 
substrates only reflect a minor portion of the published ADAM17 sheddome. 
6.6.2 General limitations of 2D GE 
Besides recent advantages like reduced gel-to-gel variation using 2D-DiGE [e.g. Gade et al., 
2003] and the possible characterization of protein isoforms [e.g. Poth et al., 2008], there 
might be a number of possible intrinsic limitations of 2D-based approaches [Chevalier, 
2010]. These include the reduced separation capacity for membrane proteins [Luche et al., 
2003; Santoni et al., 2000], the separation of high molecular weight proteins [Yokoyama et 
al., 2009], but also the impaired visualization of low abundant proteins. Low abundant 
proteins are only rarely seen on 2D-GE images, as their detection is masked by large 
amounts of (highly) abundant soluble proteins [Patton, 2002; Yamada et al., 2004; Ahmed 
and Rice, 2005]. In fact, most identified proteins from 2D-based analyses represent highly 
abundant polypeptides although the low abundant proteins are often considered the more 
important factors that dictate a given analyzed phenotype [Chevalier, 2010]. Also shed 
proteins might represent only a minor fraction within cell culture supernatants, if compared 
to the overall secreted proteins or to intracellular proteins released from dead cells. This 
notion is supported by the fact that shed TNFα was observed by ELISA in wild-type MEF cell 
supernatants, but could only be detected in supernatants by the gel-based proteomic 
analysis of TNFα-overexpressing MEF cells. Therefore, more general limitations of the gel-
based approach might be one important reason for the low number of identified shed 
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proteins in various gel-based analyses [Guo et a., 2002; Bech-Serra et al., 2006; Shirakabe et 
al., 2013].  
6.6.3 Secretome and shedding analyses by MS approaches 
As mentioned, the quantification of protein ratios by 2D-DiGE is one of the major advantages 
of this technique [e.g. Chevalier, 2010]. Thus, this is also valuable for degradomic studies, 
where differences in protein levels, including protein levels of protease substrates can be 
quantified. Meanwhile, quantitative proteomics is no longer limited to gel-based analyses, 
but also available for gel-free, LC-based proteomic approaches [Butler and Overall, 2009]. 
Degradome samples can be labeled by various mass tags prior to subsequent MS analysis. 
This includes stable isotope labeling by amino acids in cell culture (SILAC) [Mann, 2006], 
metabolic 18O labeling, but also isotope-coded affinity tags (ICAT) [Shiio and Aebersold, 
2006] and isobaric tags for relative and absolute quantitation (iTRAQ) [Ross et al., 2004]. 
Recently, the group of Prof. Tholey also performed a LC-MS based cleavage site for the 
metalloproteases ADAM10 and ADAM17 using proteome-derived peptide libraries 
[Tucher et al., 2014]. Of note, a variety of label-free analyses were published recently. For 
instance, Fong and colleagues deciphered the overall sheddome of resting and activated 
human platelets by LC-MS/MS analysis of one-dimensional platelet supernatant proteins LC-
MS/MS in combination with strong cation exchange chromatography. Notably, out of 1049 
identified supernatant proteins, 69 proteins contained a transmembrane domain, including 
some putative substrates of ADAM10 and ADAM17 [Fong et al., 2011]. In addition, Meissner 
and colleagues characterized the sheddome of TLR4-activated macrophages [Meissner et al., 
2013]. Using only 150,000 cells per condition, they identified 775 supernatant proteins 
including 59 cytokines. For comparison only, the analyses of WGA-enriched supernatant 
proteins by 2D-DiGE requires 2x108 MEF cells. 
Another advance in degradomics has been achieved by introducing N-terminomic 
techniques. This includes terminal amine isotopic labeling of substrates (TAILS) and allows 
the identification and quantification of substrate degradation. In addition, TAILS and other 
N-terminomic approaches also reveal information on cleavage sites [Doucet et al., 2008; 
Kleifeld et al., 2010]. Although mass spectrometry also faces several disadvantage, including 
the resolution of low abundant proteins [Wasinger et al., 2013], recent studies propagate 
the use of solely MS-based approaches for degradomic studies. For instance, the MMP-2 
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degradome was characterized by TAILS, revealing approximately 200 MMP-2 substrates and 
information on respective cleavage sites [Prudova et al., 2004]. In addition, the co-operative 
actions of meprin β and ADAM10 were investigated by iTRAQ-TAILS, resulting in 151 shed 
protein fragments [Jefferson et al., 2013]. Thus, mass spectrometry-based techniques result 
in significantly higher numbers of identified protein fragments, compared to 2D-DiGE 
approaches and might be the approach of choice for future degradomic studies. 
6.6.4 Disadvantages of ADAM17 in degradomic studies 
Degradomics screenings include the comparison of a proteome exposed to the protease of 
interest and an unexposed proteome [Butler and Overall, 2009]. Such analyses are mostly 
performed within cell culture system or tissues of wild-type and knock-out animals [e.g. 
Vaisar et al., 2009; Dean and Overall, 2007; Dean et al., 2007]. However, these approaches 
are affected by „proteolytic side effects“ in a complex protease web. Another strategy in 
degradomics includes the exposure of an extracted proteome to a recombinant protease in 
vitro. These strategies led to overall insight into the cleavage capacities of MMP-2 [Kleifeld et 
al., 2009] and MMP-14 [Hwang et al., 2004]. Of course, these in vitro approaches not 
necessarily reflect the overall in vivo degradome. However, MMPs seem to be more 
accessible to be studied by various approaches as compared to ADAM17. Complete ADAM17 
knock-out mice are not viable [Peschon et al., 1998], thus the ADAM17 degradome has been 
mostly studied in cell culture systems. However, in vitro studies on ADAM17 so far failed due 
to its poor clonability. Thus, the frequently used recombinant variants of ADAM17 lack 
several domains [Kawahara et al., 2014] or recombinant expression of ADAM17 in various 
cells is performed with heterologous proteins. As the membrane placement of ADAM17 is 
one of the features that dictates its specific proteolytic function [White, 2013], it will be 
interesting to find out to which extent the derived in vitro degradome covers the overall or 
cell-type specific ADAM17 degradome. Especially, elucidation of cleaved intracellular 
proteins might change the picture of ADAM17 as a membrane-located sheddase, reflecting 
the overall intracellular location of ADAM17 [Schlöndorff et al., 2000; Ebsen et al., 2013]. 
6.6.5 Studying plasma membrane proteins of MEF cells  
The problematic resolution of plasma membrane proteins by conventional two-dimensional 
electrophoresis is one of the major disadvantages of the standard 2D-DiGE approach 
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[Chevalier, 2010]. To circumvent this issue, alternative two-dimensional techniques were 
used for the separation, enrichment and visualization of cell-surface proteins. These 
approaches avoid isoelectric focussing by combining two mass-related separations using two 
different detergents, e.g. the 16-BAC/SDS-PAGE [Zahedi et al., 2012] or the CTAB/SDS-PAGE 
[Philipp et al., 2012]. As detailed in the results paragraph, 2D-CTAB/SDS-PAGE has been 
successfully adapted into the core project and was linked to differential labeling (2D-
CTAB/SDS-DiGE). The second major problem for gel-based proteomics is to find a suitable 
protocol for sample preparation. Several published approaches and commercially available 
kits for plasma membrane protein extraction propose a pure preparation of this subcellular 
fraction. As detailed in the results paragraph, several techniques were adapted and applied 
to MEF cells. This includes the use of a commercially available „two-phase system“   for the 
separation of plasma membrane fractions and a combined approaches using lectin-mediated 
precipitation. Monitoring of the purity of the resulted fractions via known marker proteins 
by Western blot analysis always indicated an enrichment of plasma membrane proteins. 
However, subsequent separation of these membrane fractions by CTAB/SDS-PAGE resulted 
in the identification of a few membrane proteins. In contrast, most identified proteins were 
of intracellular origin. Again, the low number of identified membrane proteins might be due 
to the limited resolution and detection of low abundant proteins [Chevalier, 2010]. 
Nonetheless, recent studies showed an improved resolution of enriched plasma membrane 
proteins. For instance, Philipp and colleagues enriched membrane proteins from 
Plasmodium falciparum-infected erythrocytes to elucidate the mechanism of erythrocyte 
infection by CTAB/SDS-PAGE and 16-BAC/SDS-PAGE [Philipp et al., 2012]. In this case, 
hemolytic treatment of erythrocytes leads to the formation of erythrocyte ghosts that 
represent free erythrocyte membranes and can be harvested easily. Unfortunately, this is a 
rather unique feature of erythrocytes. In addition, most studies of plasma membrane 
proteins monitored the protein enrichment via known marker proteins, which implicates 
purities sufficient for subsequent Western blot analyses. However, there is still a severe 
difference between enriched and pure membrane fractions. Thus, proteomic investigation of 
membrane samples might only be enhanced by mass spectrometry-based techniques 
[Savas et al., 2011]. 
Recently, giant plasma membrane vesicles (GPMVs) were introduced as a suitable tool to 
study cholesterol-rich membrane regions and membrane dynamics [Levental et al., 2011]. 
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However, Bauer and colleagues used this approach for the enrichment of membrane 
proteins mammalian cells [Bauer et al., 2009]. There, digested GPMV proteins were analyzed 
by LC-MS/MS and displayed a plasma membrane protein content of 93 %. As summarized in 
the results paragraph, we successfully adapted the protocol for GPMV formation in the 
context of MEF cells. However, subsequent separation of enriched GPMV proteins resulted 
in a low resolution of plasma membrane proteins, as predominately actin and other highly 
abundant intracellular proteins were identified. Unfortunately, several modifications of the 
original protocol did not increase the resolution of plasma membrane proteins.  
Besides subcellular fractionation, cell-surface labelling represents an alternative approach to 
study alterations of the membrane proteome. Cell-surface labelling is performed on intact 
cells at low temperature to avoid intracellular uptake of the labeling compound. After 
saturation of the labelling agent, cells are lyzed and subjected to further analysis. The use of 
biotin-NHS ester compounds is a rather prominent approach for enrichment of cell-surface 
proteins and subsequent Western blot analysis and has also been used in ADAM research 
[Horiuchi et al., 2007]. We decided to use a commercially available kit for cell-surface protein 
extraction from MEF cells prior to protein separation by two-dimensional gel 
electrophoresis. As displayed in the results paragraph, the generated samples were 
compatible with two-dimensional separation, but showed no enrichment of certain protein 
spots as compared to separated whole-cell lysates. Recently, Niehage and colleagues 
enriched proteins from human mesenchymal stroma cells by biotinylation prior to one-
dimensional in-gel separation and subsequent protein identification by LC-MS/MS 
[Niehage et al., 2011]. There, they identified approximately 200 plasma membrane 
molecules, including several integrins and cadherins. However, they also displayed 
limitations of the biotinylation approach as approximately 700 proteins were supposed to be 
intracellular proteins. Thus, the impurity of samples derived from biotinylation might 
hamper the resolution of membrane proteins by gel-based approaches.  
Also fluorescent CyDyesTM have been proposed for differential labelling of cell-surface 
proteins [Mayrhofer et al., 2008]. Meanwhile, this approach has been described for various 
cellular systems, including chinese hamster ovary (CHO) cells [Hagner-McWhirter et al., 
2008], undifferentiated murine embryonic stem cells [Nunomura et al., 2005] and gram-
positive bacteria [Anaya et al., 2007]. Thus, we applied cell-surface labelling using 
fluorescent CyDyesTM to wild-type MEF cells. However, subsequent separation of the 
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labelled sample and a whole-cell lysate by two-dimensional gel electrophoresis showed no 
differences indicating an uptake of the CyDyesTM by the MEF cells.  
In conclusion, different techniques for the enrichment of membrane proteins were applied 
to MEF cells. Despite an enrichment of membrane proteins according to Western blot 
analyses, gel-based proteomic analyses revealed only few membrane proteins. 
6.6.6 The extracellular matrix (ECM) 
As detailed in the results paragraph, the analyses of MEF cell culture supernatants indicated 
an ADAM17-dependent alteration of ECM remodelling or degradation. In order to verify 
these findings and to study changes in ECM composition in more detail, we adapted 
appropriate techniques for ECM protein enrichment. So far, preparation of ECM from 
cultured MEF cells has not been described, but approaches, based on decellularization and 
harvesting of remaining ECM are published for other cell, e.g. mesenchymal stromal cells 
[Harvey et al., 2013]. We successfully adapted the protocol for ECM protein enrichments of 
Harvey and colleagues and separated the resulting sample by 2D-DiGE. Subsequent protein 
identification revealed increased levels of various annexins and of the serine protease HtrA1 
that also showed reduced levels in ADAM17ex/ex MEF cell supernatants and is involved in 
fibronectin degradation and MMP regulation [Grau et al., 2005]. In addition, the analyzed 
samples contained a variety of nuclear proteins, whereas major ECM proteins (e.g. collagens 
or fibronectin) were not observed. Unfortunately, further enrichment of MEF cell ECM 
proteins by WGA precipitation only delivered low protein amounts. Of note, an initial 
experiment for preparation of ECM proteins from murine   livers   using   the   “Texas 3-step“ 
approach [de Castro Brás et al., 2013] was performed. Although this experiment only 
revealed little indications for enriched ECM proteins, a subsequent WGA precipitation might 
increase the purity of this sample. However, further efforts for ECM preparation were 
aborted as no ADAM17ex/ex mice were available for this in vivo characterization. 
6.7 Limitations of the ADAM17ex/ex MEF system 
Overall seventy different proteins are supposed to be shed by ADAM17 [reviewed by Gooz, 
2009]. As summarized in the introduction various cellular systems and experimental 
approaches were used to elucidate the ADAM17 sheddome. This includes overexpression, 
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knock-down and knock-out of ADAM17, but also stimulation and inhibition of 
metalloprotease activity by various compounds (compare Tab. 1.2). Nonetheless, the 
characterization of the ADAM17 sheddome in a more context-dependent manner is still 
missing.  
Therefore, we wanted to address the characterization of the context-dependent ADAM17-
sheddome using different cells and tissues derived from the ADAM17ex/ex murine model 
[Chalaris et al., 2010]. At the beginning of this project, wild-type and ADAM17ex/ex-derived 
MEF cells were available and were used for the adaption of various approaches for the 
aimed sheddome characterization. As already discussed, gel-based analyses of MEF cell 
culture supernatants revealed several differentially abundant protein fragments. However, 
TNFα  and  NCAM-1 represent the only known ADAM17 substrates identified in this project. 
Notably, other protein fragments are reported substrates of other proteases and might 
reflect   “proteolytic   side   effects”   via   the   protease web. In addition, MEF cell supernatants 
contained a variety of secreted proteins. Thus, intrinsic limitations of the 2D-DiGE approach 
might be the reason for the low number of identified ADAM17 substrates. On the other 
hand, ADAM17-mediated shedding might only play a minor role in MEF cell biology. 
To address this issue, we also analyzed other ADAM17-deficient cells, including non-small 
lung cancer cells and cells derived from ADAM17ex/ex mice. As mentioned in the methods 
section, at least 2x108 cells are required to yield sufficient protein amounts subsequent 
supernatant analysis by 2D-DiGE analysis. Unfortunately, ADAM17 knock-down non-small 
cell lung cancer cells [Baumgart et al., 2010] showed strongly reduced proliferation as 
compared to wild-type non-small cell lung cancer cells. If supplemented with exogenous 
EGF, the proliferation of the ADAM17 knock-down cells was stabilized to a certain extent 
[Baumgart et al., 2010], but still prevented the generation of necessary amounts of cells. 
Along this line, reduced proliferation was also observed for primary cell cultures of colon and 
intestinal cells, derived from ADAM17ex/ex MEF cells. Interestingly, Kawahara and colleagues 
also showed reduced proliferation of ADAM17–/– MEF cells [Kawahara et al., 2014]. 
However, ADAM17ex/ex and ADAM17–/– MEF cells did not show a severe reduction of 
proliferation as compared to the ADAM17ex/ex intestinal cells. Thus, the effect of reduced 
ADAM17 activity differs between different cell types, indicating a cell-type specific role of 
this protease. Even more, this substantiates the demand for a more context-dependent 
(=cell-type specific) evaluation of the ADAM17 sheddome.  
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Notably, bone marrow-derived macrophages were derived from wild-type and ADAM17ex/ex 
mice were used for several ex vivo studies [e.g. Schwarz et al., 2014]. Initial experiments 
regarding the sheddome characterization of these cells were also performed and revealed 
compatibility to the already adapted enrichment techniques. Moreover, derived cell 
numbers were sufficient for supernatant analyses by 2D-DiGE. Unfortunately, there were not 
enough mice available for further sheddome and secretome characterizations of these cells. 
Finally, in vivo studies that rely on the comparison of wild-type and protease knock-out 
samples (e.g. wild-type versus ADAM17ex/ex) are hampered, as the observed effects might be 
induced by the removal of the investigated protease [Fortelny et al., 2014]. Thus, the 
biological system might react to the removal of the protease, leading to altered gene 
expression profiles of proteases, inhibitors and substrates [Auf dem Keller et al. 2013; 
Krüger, 2009]. In addition, biological consequences of altered substrate cleavage in vivo, e.g. 
cleaved transcription factors [Goulet et al., 2004] or activation or degradation of other 
proteases and inhibitors [e.g. Dean and Overall, 2007; Auf dem Keller et al., 2013], interfere 
with the real effect of the reduced activity of the investigated protease. Thus, proteomic 
studies will not only detect direct effects of a certain protease, but also indirect effects via 
the interaction of mediators of proteolysis via the protease web [Fortelny et al., 2014]. In 
line with this, the benefits of the ADAM17ex/ex MEF system might be low, as ADAM17–/– MEF 
cells are available and were already used for the characterization of various ADAM17 
substrates [e.g. Sahin et al., 2004]. However, a direct comparison of supernatant proteins 
from ADAM17ex/ex and ADAM17–/– MEF cells might help to separate the effects of ADAM17 
from  “proteolytic  side  effects”.   
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7 Summary 
The ectodomain shedding of numerous transmembrane proteins by the A Disintegrin And 
Metalloprotease 17 (ADAM17) governs a variety of physiological and developmental 
processes. Focusing on murine embryonic fibroblasts (MEFs) of ADAM17wt/wt and 
ADAM17ex/ex (hypomorphic) mice, we investigated ADAM17-mediated changes in 
conditioned cell culture supernatants, in membrane preparations and in whole cell lysates 
using a 2D-DiGE proteomic approach. The detection of high amounts   of   cleaved   TNFα   in  
supernatants   of   TNFα-overexpressing wild-type but not ADAM17ex/ex MEF cells 
demonstrated the general suitability of the employed 2D-DiGE approach for the 
identification of shed protein fragments. Interestingly, the analyses of whole-cell lysates 
revealed that ADAM17 might also influence intracellular protein levels since a variety of 
proteins (e.g. annexins) showed altered abundances at reduced levels of ADAM17. From 
conditioned MEF supernatants, seventy differentially abundant secreted and cell-surface 
proteins were identified. These included collagens and other extracellular matrix 
components, several proteases and several protein fragments. Thus, wild-type and 
ADAM17ex/ex MEF cells clearly differ in their ability to secrete or shed proteins. However, 
only fourteen different protein fragments were less abundant in ADAM17ex/ex MEF cell 
supernatants,   including  only  two  known  ADAM17  substrates  (TNFα  and  NCAM-1). Notably, 
most full length proteins that were detected as fragments lack a transmembrane region and 
are thus no bona fide ADAM17 substrates. The high amounts of the perlecan LG3 peptide 
and of the type-I collagen C-terminal propeptide in supernatants of wild-type MEF cells point 
to a reduced collagen maturation and degradation in ADAM17ex/ex MEF cells. Since we also 
observed reduced levels of the C-procollagenase  “bone  morphogenic  protein  1”  and  reduced  
matrix metalloproteinase activity in ADAM17ex/ex MEF cell culture supernatants, the 
observed processing of collagen and perlecan might   reflect   “proteolytic   side   effects”   by  
other  proteases  in  a  complex  “protease  web”. 
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8 Zusammenfassung 
Die Metalloprotease A Disintegrin And Metalloprotease 17 (ADAM17) vermittelt das 
Freisetzen der extrazellulären Domänen verschiedener Transmembranprotein (ectodomain 
shedding) und ist somit an verschiedensten physiologischen und entwicklungsbiologischen 
Prozessen beteiligt. Mit einem Fokus auf murine embryonale Fibroblasten (MEF) von 
ADAM17wt/wt und ADAM17ex/ex (hypomorphen) Mäusen haben wir ADAM17-abhängige 
Veränderungen in konditionierten Zellkulturüberständen, Membranfraktionen und 
Zelllysaten analysiert. Die Tauglichkeit der verwendeten 2D-DiGE Methode zur 
Identifizierung von Proteinfragmenten konnte dabei an Kulturüberständen von TNFα-
überexprimierenden MEF-Zellen demonstriert werden. Im Gegensatz zu ADAM17ex/ex MEF-
Zellen, konnten so in Kulturüberständen von wildtyp MEF-Zellen hohe Mengen an löslichem 
TNFα beobachtet werden. Darüber hinaus deutete die Analyse von Zelllysaten auch auf 
intrazelluläre Effekte von ADAM17 hin, da zahlreiche Protein (z.B. Annexine) veränderte 
Abundanzen unter reduzierter ADAM17 Aktivität zeigten. Aus konditionierten MEF-
Kulturüberständen konnten siebzig differentiell abundante sekretierte und 
Zelloberflächenproteine identifiziert werden, darunter Kollagene und andere Komponenten 
der extrazellulären Matrix, verschiedene Proteasen und mehrere Proteinfragmente. Wildtyp 
und ADAM17ex/ex MEF-Zellen zeigen somit deutliche Unterschiede in Sekretion und 
Shedding von Proteinen. Insgesamt wurden jedoch lediglich vierzehn Proteinfragmente mit 
veränderter Abundanz in ADAM17ex/ex MEF-Zellen identifiziert, darunter zwei bekannte 
Substrate von ADAM17 (TNFα und NCAM-1). Interessanter Weise weisen die meisten 
Proteine, welche als Proteinfragmente identifiziert wurden keine Transmembrandomäne auf 
und sind somit kein bona fide ADAM17 Substrate. Der erhöhte Gehalt an dem Perlecan LG3-
Peptid und dem C-terminalen Propeptid des Typ-I Kollagens in wildtyp MEF-
Kulturüberständen deutet daneben auf eine Verminderte Reifung und Degradierung von 
Kollagenen in ADAM17ex/ex MEF-Zellen hin. Da wir außerdem eine reduzierte Abundanz der 
C-Procollagenase “bone morphogenic protein 1” und verminderte Matrixmetalloprotease-
Aktivitäten in Kulturüberständen von ADAM17ex/ex MEF-Zellen beobachteten, könnten die 
beobachtete Veränderung der Kollagen- und Perlecanprozessierung ein “proteolytischer 
Nebeneffekt”  durch andere Proteasen in einem komplexen „proteolytischen Netzwerk“ sein. 
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10 Addendum 
This section summarizes all images of performed 2D-DiGE analyses, presented in this thesis. 
In addtion, all protein spots that were selected for protein identification are indicated. 
Please note that corresponding protein information including protein fold-change values and 
MALDI-ToF/ToF-derived protein data can be found on the enclosed compact disk. 
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10.1 DIGE145 – Supernatant analysis 
2D-DiGE analysis of wild-type (MEF 1#3) and ADAM17ex/ex (MEF1#1) MEF cell supernatants 
enriched by centrifugal filter units. 
 
Fig. 10.1: Supernatant analysis DIGE145. Cell culture supernatant proteins of wild-type (MEF 1#3) and 
ADAM17ex/ex (MEF 1#1) MEF cells were enriched by centrifugal filter units, differentially labelled and separated 
by 2D-DiGE. Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. 
Numbers indicate protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are 
enclosed on the compact disc (File: A10.1 – DIGE145). 
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10.2 DIGE150 – Supernatant analysis 
Two independent 2D-DiGE analysis of TNFα-overexpressing wild-type (MEF 1#3TNFα) and 
ADAM17ex/ex (MEF1#1 TNFα) MEF cell supernatants enriched by centrifugal filter units. 
10.2.1 Gel 12595 (DIGE150a) 
 
Fig. 10.2: Supernatant analysis DIGE150_12595. Cell culture supernatant proteins of TNFα-overexpresing 
wild-type (MEF 1#3TNFα) and ADAM17ex/ex (MEF 1#1TNFα) MEF cells were enriched by centrifugal filter units, 
differentially labelled and separated by 2D-DiGE. Two-dimensional gel was post-stained with FlamingoTM and 
imaged using the TyphoonTRIO. Numbers indicate protein spots picked for protein identification by MALDI-
ToF/ToF. Corresponding data are enclosed on the compact disc (File: A10.2 – DIGE150_12595). 
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10.2.2 Gel 12722 (DIGE150b) 
 
Fig. 10.3: Supernatant analysis DIGE150_12722. Cell culture supernatant proteins of TNFα-overexpresing 
wild-type (MEF 1#3TNFα) and ADAM17ex/ex (MEF 1#1TNFα) MEF cells were enriched by centrifugal filter units, 
differentially labelled and separated by 2D-DiGE. Two-dimensional gel was post-stained with FlamingoTM and 
imaged using the TyphoonTRIO. Numbers indicate protein spots picked for protein identification by MALDI-
ToF/ToF. Corresponding data are enclosed on the compact disc (File: A10.2 – DIGE150_12722). 
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10.3 DIGE153 – Supernatant analysis 
2D-DiGE analysis of wild-type (MEF 1#3) and ADAM17ex/ex (MEF1#1) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
Fig. 10.4:  Supernatant analysis DIGE153. Cell culture supernatant proteins of wild-type (MEF 1#3) and 
ADAM17ex/ex (MEF 1#1) MEF cells were enriched by centrifugal filter units, differentially labelled and separated 
by 2D-DiGE. Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. 
Numbers indicate protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are 
enclosed on the compact disc (File: A10.3 – DIGE153). 
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10.4 DIGE169 – Supernatant analysis 
Independent 2D-DiGE analyses of different sets of wild-type and ADAM17ex/ex MEF cell 
supernatants enriched by WGA-mediated precipitation. 
10.4.1 Gel 68572 
2D-DiGE analysis of wild-type (MEF 1#3) and ADAM17ex/ex (MEF1#1) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
Fig. 10.5: Supernatant analysis DIGE169_68572. Cell culture supernatant proteins of wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.4 – DIGE169_68572). 
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10.4.2 Gel 68573 
2D-DiGE analysis of wild-type (MEF 1#7) and ADAM17ex/ex (MEF1#8) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
Fig. 10.6: Supernatant analysis DIGE169_68573. Cell culture supernatant proteins of wild-type (MEF 1#7) 
and ADAM17ex/ex (MEF 1#8) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.4 – DIGE169_68573). 
 
 
 
 
 
Chapter 10: Addendum 147 
10.4.3 Gel 68574 
2D-DiGE analysis of wild-type (MEF 2#1) and ADAM17ex/ex (MEF2#8) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
Fig. 10.7: Supernatant analysis DIGE169_68574. Cell culture supernatant proteins of wild-type (MEF 2#1) 
and ADAM17ex/ex (MEF 2#8) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.4 – DIGE169_68574). 
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10.5 DIGE172 – Supernatant analysis 
Independent 2D-DiGE analyses of different sets of wild-type and ADAM17ex/ex MEF cell 
supernatants enriched by WGA-mediated precipitation. 
10.5.1 Gel 68917 
2D-DiGE analysis of wild-type (MEF 1#3) and ADAM17ex/ex (MEF1#1) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
Fig. 10.8: Supernatant analysis DIGE172_68917. Cell culture supernatant proteins of wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.5 – DIGE172_68917). 
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10.5.2 Gel 68918 
2D-DiGE analysis of wild-type (MEF 1#7) and ADAM17ex/ex (MEF1#8) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
 
Fig. 10.9: Supernatant analysis DIGE172_68918. Cell culture supernatant proteins of wild-type (MEF 1#7) 
and ADAM17ex/ex (MEF 1#8) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.5 – DIGE172_68918). 
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10.5.3 Gel 68919 
2D-DiGE analysis of wild-type (MEF 2#1) and ADAM17ex/ex (MEF2#8) MEF cell supernatants 
enriched by WGA-mediated precipitation. 
 
Fig. 10.10: Supernatant analysis DIGE172_68919. Cell culture supernatant proteins of wild-type (MEF 2#1) 
and ADAM17ex/ex (MEF 2#8) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.5 – DIGE172_68919). 
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10.6 DIGE182 – Supernatant analysis 
2D-DiGE analysis of deglycosylated wild-type (MEF 1#3) and ADAM17ex/ex (MEF1#1) MEF cell 
supernatant proteins enriched by WGA-mediated precipitation. 
 
Fig. 10.11: Supernatant analysis DIGE182. Cell culture supernatant proteins of wild-type (MEF 1#3) and 
ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, deglycosylated, differentially labelled and separated 
by 2D-DiGE. Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. 
Numbers indicate protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are 
enclosed on the compact disc (File: A10.6 – DIGE182). 
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10.7 DIGE158 – Analysis of whole-cell lysates 
Independent 2D-DiGE analyses of wild-type (MEF 1#3) and ADAM17ex/ex MEF whole-cell 
lysates. 
10.7.1 Gel 76295 
 
Fig. 10.12: Whole-cell lysate analysis DIGE158_76295. Whole-cell lysates of TPA-treated wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.7 – DIGE158_76295). 
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10.7.2 Gel 76296 
 
Fig. 10.13: Whole-cell lysate analysis DIGE158_76296. Whole-cell lysates of TPA-treated wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.7 – DIGE158_76296). 
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10.7.3 Gel 76297 
 
Fig. 10.14: Whole-cell lysate analysis DIGE158_76297. Whole-cell lysates of TPA-treated wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.7 – DIGE158_76297). 
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10.8 DIGE160 – Analysis of whole-cell lysates 
Independent 2D-DiGE analyses of wild-type (MEF 1#3) and ADAM17ex/ex MEF whole-cell 
lysates. 
10.8.1 Gel 76300 
 
Fig. 10.15: Whole-cell lysate analysis DIGE160_76300. Whole-cell lysates of TPA-treated wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.8 – DIGE160_76300). 
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10.8.2 Gel 76301 
 
Fig. 10.16: Whole-cell lysate analysis DIGE160_76301. Whole-cell lysates of TPA-treated wild-type (MEF 1#3) 
and ADAM17ex/ex (MEF 1#1) MEF cells were enriched by WGA, differentially labelled and separated by 2D-DiGE. 
Two-dimensional gel was post-stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate 
protein spots picked for protein identification by MALDI-ToF/ToF. Corresponding data are enclosed on the 
compact disc (File: A10.8 – DIGE160_76301). 
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10.9 DIGE184 – Analysis of ECM from cultured MEF cells 
2D-DiGE analysis of extracellular matrix proteins derived from cultured wild-type (MEF 1#3) 
and ADAM17ex/ex MEF cells by decellularization. 
 
Fig. 10.17: Cellular ECM analysis DIGE184. Extracellular matrix of TPA-treated wild-type (MEF 1#3) and 
ADAM17ex/ex (MEF 1#1) MEF cells was enriched by decellularization. Samples were differentially labelled and 
separated by 2D-DiGE. Two-dimensional gel was post-stained with FlamingoTM and imaged using the 
TyphoonTRIO. Numbers indicate protein spots picked for protein identification by MALDI-ToF/ToF. 
Corresponding data are enclosed on the compact disc (File: A10.9 – DIGE184). 
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10.10 CTAB-DIGE: Two-Phase system 
2D-CTAB/SDS-DiGE analysis of plama membrane proteins from wild-type (MEF 1#3) and 
ADAM17ex/ex (MEF 1#1) MEF cells enriched using a commercially available two-phase system. 
 
Fig. 10.18: CTAB-DIGE analysis of MEF membrane fractions enriched using a two-phase system. Putative 
membrane proteins of TPA-treated wild-type (MEF 1#3) and ADAM17ex/ex (MEF 1#1) MEF cells were 
differentially labelled and separated by 2D-CTAB/SDS-DiGE. Two-dimensional gel was post-stained with 
FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate protein spots picked for protein 
identification by MALDI-ToF/ToF. Corresponding data are enclosed on the compact disc (File: A10.10 – CTAB-
DIGE-1). 
 
 
 
 
Chapter 10: Addendum 159 
10.11 CTAB-DIGE: Giant Plasma Membrane Vesicles 
2D-CTAB/SDS-DiGE analysis of wild-type (MEF 1#3) and ADAM17ex/ex (MEF 1#1) MEF cell-
derived giant plasma membrane vesicles. 
 
Fig. 10.19: CTAB-DIGE analysis of Giant Plasma Membrane Vesicles (GPMVs). GPMV-derived proteins of of 
TPA-treated wild-type (MEF 1#3) and ADAM17ex/ex (MEF 1#1) MEF cells were differentially labelled and 
separated by 2D-CTAB/SDS-DiGE. Two-dimensional gel was post-stained with FlamingoTM and imaged using the 
TyphoonTRIO. Numbers indicate protein spots picked for protein identification by MALDI-ToF/ToF. 
Corresponding data are enclosed on the compact disc (File: A10.11 – CTAB-DIGE-2). 
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10.12 CTAB-DIGE: Two-Phase system and Concanavalin A  
2D-CTAB/SDS-DiGE analysis of wild-type (MEF 1#3) and ADAM17ex/ex MEF cell membrane 
proteins enriched by combination of a commercial two-phase system and ConA-mediated 
precipitation. 
 
Fig. 10.20: CTAB-DIGE analysis of MEF membrane fractions enriched using a two-phase system and 
Concanavalin A. Putative membrane proteins of TPA-treated wild-type (MEF 1#3) and ADAM17ex/ex (MEF 1#1) 
MEF cells were differentially labelled and separated by 2D-CTAB/SDS-DiGE. Two-dimensional gel was post-
stained with FlamingoTM and imaged using the TyphoonTRIO. Numbers indicate protein spots picked for protein 
identification by MALDI-ToF/ToF. Corresponding data are enclosed on the compact disc (File: A10.12 – CTAB-
DIGE-3). 
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